| (+)-alpha-tocopherol | multiple interactions | ISO | RGD:70502 | 6480464 | alpha-Tocopherol inhibits the reaction [arsenite results in increased expression of TP53 protein]; more ... | CTD | PMID:12126965 |
| (+)-catechin | multiple interactions | ISO | RGD:11440 | 6480464 | Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of TRP53 protein] | CTD | PMID:15879681 |
| (-)-citrinin | increases expression | ISO | RGD:70502 | 6480464 | Citrinin results in increased expression of TP53 protein | CTD | PMID:20929984 |
| (-)-citrinin | increases expression | EXP | | 6480464 | Citrinin results in increased expression of TP53 protein modified form | CTD | PMID:22564900 |
| (-)-citrinin | increases expression | ISO | RGD:11440 | 6480464 | Citrinin results in increased expression of TRP53 protein | CTD | PMID:21622943 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:70502 | 6480464 | epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of TP53 protein] | CTD | PMID:15795422 |
| (-)-epigallocatechin 3-gallate | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to epigallocatechin gallate | CTD | PMID:15764647 PMID:23285096 |
| (-)-epigallocatechin 3-gallate | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 mRNA affects the susceptibility to epigallocatechin gallate | CTD | PMID:19406223 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:70502 | 6480464 | epigallocatechin gallate results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:15657356 PMID:19406223 |
| (-)-epigallocatechin 3-gallate | affects expression | EXP | | 6480464 | epigallocatechin gallate affects the expression of TP53 protein | CTD | PMID:22000973 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:11440 | 6480464 | epigallocatechin gallate promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 mRNA] | CTD | PMID:18656336 |
| (-)-epigallocatechin 3-gallate | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to epigallocatechin gallate | CTD | PMID:15764647 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:70502 | 6480464 | epigallocatechin gallate results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:15657356 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:70502 | 6480464 | epigallocatechin gallate results in increased expression of and results in increased phosphorylation of and results in increased activity of TP53 protein | CTD | PMID:15764647 |
| (R)-lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Methotrexate results in increased expression of TP53 protein] | CTD | PMID:19900424 |
| (S)-colchicine | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Colchicine results in increased phosphorylation of JUN protein]; more ... | CTD | PMID:12221076 |
| (S)-naringenin | multiple interactions | ISO | RGD:70502 | 6480464 | naringenin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of TP53 protein] | CTD | PMID:15795422 |
| (S)-nicotine | multiple interactions | ISO | RGD:70502 | 6480464 | Nicotine inhibits the reaction [gemcitabine results in increased expression of TP53 protein]; more ... | CTD | PMID:16601104 |
| (S)-nicotine | decreases expression | ISO | RGD:70502 | 6480464 | Nicotine results in decreased expression of TP53 protein | CTD | PMID:19139119 more ... |
| (S)-nicotine | decreases expression | ISO | RGD:70502 | 6480464 | Nicotine results in decreased expression of TP53 protein | CTD | PMID:16011614 more ... |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of TP53 mRNA | CTD | PMID:20339300 PMID:20426880 |
| (S)-nicotine | decreases expression | ISO | RGD:70502 | 6480464 | Nicotine results in decreased expression of TP53 protein | CTD | PMID:16011614 more ... |
| (S)-nicotine | decreases expression | ISO | RGD:11440 | 6480464 | Nicotine results in decreased expression of TRP53 protein | CTD | PMID:18835254 |
| (S)-nicotine | affects response to substance | EXP | | 6480464 | TP53 protein affects the susceptibility to Nicotine | CTD | PMID:15983034 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of TP53 mRNA | CTD | PMID:20426880 PMID:20339300 |
| (S)-nicotine | affects expression | EXP | | 6480464 | Nicotine affects the expression of TP53 mRNA | CTD | PMID:10837795 |
| (S)-nicotine | multiple interactions | ISO | RGD:70502 | 6480464 | rosiglitazone inhibits the reaction [Nicotine results in decreased expression of TP53 protein] | CTD | PMID:19139119 |
| (S)-nicotine | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Nicotine results in increased phosphorylation of MAPK1 protein]; more ... | CTD | PMID:20727180 |
| (S)-nicotine | decreases expression | ISO | RGD:70502 | 6480464 | Nicotine results in decreased expression of TP53 mRNA | CTD | PMID:18247414 |
| (S)-nicotine | increases expression | ISO | RGD:70502 | 6480464 | Nicotine results in increased expression of TP53 protein | CTD | PMID:20727180 |
| (S)-nicotine | decreases expression | ISO | RGD:70502 | 6480464 | Nicotine results in decreased expression of TP53 protein | CTD | PMID:18805435 more ... |
| (S)-nicotine | multiple interactions | ISO | RGD:70502 | 6480464 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Nicotine results in decreased expression of TP53 protein] | CTD | PMID:18805435 |
| 1,1'-azobis(N,N-dimethylformamide) | increases glutathionylation | ISO | RGD:70502 | 6480464 | Diamide results in increased glutathionylation of TP53 protein | CTD | PMID:17555331 |
| 1,4-benzoquinone | increases expression | ISO | RGD:70502 | 6480464 | benzoquinone results in increased expression of TP53 protein | CTD | PMID:20499891 |
| 1,4-dithiothreitol | multiple interactions | ISO | RGD:70502 | 6480464 | Dithiothreitol inhibits the reaction [Glutathione results in increased glutathionylation of TP53 protein]; more ... | CTD | PMID:17555331 |
| 1-methylphenanthrene | increases phosphorylation | EXP | | 6480464 | 1-methylphenanthrene results in increased phosphorylation of TP53 protein | CTD | PMID:17941746 |
| 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of TP53 mRNA | CTD | PMID:17522070 |
| 11-deoxycorticosterone | multiple interactions | EXP | | 6480464 | A 127722 inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of TP53 protein]; more ... | CTD | PMID:22431579 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:11440 | 6480464 | Ethinyl Estradiol results in increased expression of TRP53 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:11440 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRP53 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of TP53 mRNA | CTD | PMID:16940010 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:11440 | 6480464 | Ethinyl Estradiol affects the expression of TRP53 mRNA | CTD | PMID:17555576 |
| 17beta-estradiol | multiple interactions | ISO | RGD:70502 | 6480464 | Estradiol results in increased expression of and results in increased activity of and affects the localization of TP53 protein | CTD | PMID:16053526 |
| 17beta-estradiol | multiple interactions | ISO | RGD:70502 | 6480464 | Estradiol inhibits the reaction [TP53 protein binds to MIR34B promoter] | CTD | PMID:22113133 |
| 17beta-estradiol | affects expression | ISO | RGD:70502 | 6480464 | Estradiol affects the expression of TP53 mRNA | CTD | PMID:22574217 |
| 17beta-estradiol | multiple interactions | ISO | RGD:70502 | 6480464 | [Lindane co-treated with Estradiol] results in increased expression of TP53 protein | CTD | PMID:18174961 |
| 17beta-estradiol | increases expression | ISO | RGD:70502 | 6480464 | Estradiol results in increased expression of TP53 protein | CTD | PMID:18174961 PMID:19647730 |
| 17beta-estradiol | increases expression | ISO | RGD:11440 | 6480464 | Estradiol results in increased expression of TRP53 protein; more ... | CTD | PMID:22314386 |
| 17beta-estradiol | affects expression | ISO | RGD:70502 | 6480464 | Estradiol affects the expression of TRP53 mRNA | CTD | PMID:11896290 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of TP53 protein | CTD | PMID:14685795 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of TP53 mRNA | CTD | PMID:17522070 |
| 17beta-estradiol | increases expression | ISO | RGD:70502 | 6480464 | Estradiol results in increased expression of TP53 protein | CTD | PMID:19647730 |
| 17beta-estradiol | multiple interactions | ISO | RGD:70502 | 6480464 | Estradiol affects the localization of and results in decreased activity of TP53 protein; more ... | CTD | PMID:15870704 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA] | CTD | PMID:17202838 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | ISO | RGD:70502 | 6480464 | [Curcumin co-treated with Metribolone] results in increased phosphorylation of TP53 protein | CTD | PMID:21134073 |
| 1H-pyrazole | increases expression | ISO | RGD:11440 | 6480464 | pyrazole results in increased expression of TRP53 mRNA | CTD | PMID:17945193 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:70502 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of and results in increased expression of TP53 protein] | CTD | PMID:20840854 |
| 2,2,2-tetramine | multiple interactions | ISO | RGD:70502 | 6480464 | Paraquat promotes the reaction [Trientine results in increased phosphorylation of TP53 protein] | CTD | PMID:11369509 |
| 2,2,2-tetramine | multiple interactions | ISO | RGD:70502 | 6480464 | Trientine results in increased expression of and results in increased activity of TP53 protein | CTD | PMID:14513838 |
| 2,2,2-tetramine | increases phosphorylation | ISO | RGD:70502 | 6480464 | Trientine results in increased phosphorylation of TP53 protein | CTD | PMID:11369509 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:70502 | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TP53 mRNA]; more ... | CTD | PMID:17070097 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:11440 | 6480464 | Tetrachlorodibenzodioxin affects the expression of TRP53 mRNA | CTD | PMID:14708085 PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11440 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TRP53 mRNA | CTD | PMID:14718646 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of TP53 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11440 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TRP53 mRNA | CTD | PMID:14718646 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11440 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TRP53 mRNA | CTD | PMID:21167638 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11440 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TRP53 mRNA | CTD | PMID:15310856 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:70502 | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide results in decreased susceptibility to [Tetrachlorodibenzodioxin results in decreased susceptibility to [1-nitropyrene results in increased expression of TP53 protein]]; more ... | CTD | PMID:22044530 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11440 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TRP53 mRNA | CTD | PMID:15667827 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11440 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TRP53 mRNA | CTD | PMID:17942748 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases phosphorylation | ISO | RGD:11440 | 6480464 | Tetrachlorodibenzodioxin results in increased phosphorylation of TRP53 protein | CTD | PMID:19085997 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TP53 mRNA | CTD | PMID:19520675 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases degradation | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased degradation of TP53 protein | CTD | PMID:15459018 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TP53 protein | CTD | PMID:8640813 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of TP53 protein]; more ... | CTD | PMID:15093247 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | AHR protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of TP53 protein]]; more ... | CTD | PMID:15459018 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the susceptibility to Tetrachlorodibenzodioxin | CTD | PMID:10802220 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11440 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TRP53 mRNA | CTD | PMID:17942748 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:11440 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TRP53 mRNA | CTD | PMID:17943652 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:11440 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRP53 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:11440 | 6480464 | [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of TRP53 mRNA | CTD | PMID:21167638 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:11440 | 6480464 | Tetrachlorodibenzodioxin affects the expression of TRP53 mRNA | CTD | PMID:14708085 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:11440 | 6480464 | SRC protein promotes the reaction [Tetrachlorodibenzodioxin affects the expression of TRP53 mRNA] | CTD | PMID:14708085 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:70502 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TP53 mRNA; more ... | CTD | PMID:17070097 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:70502 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Etoposide results in increased phosphorylation of and results in increased activity of TP53 protein]; more ... | CTD | PMID:20299546 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:70502 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of TP53 mRNA; more ... | CTD | PMID:19578757 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:11440 | 6480464 | D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of TRP53 protein] | CTD | PMID:22427801 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:11440 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of TRP53 protein | CTD | PMID:22427801 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of TP53 mRNA | CTD | PMID:21346803 |
| 2,6-di-tert-butyl-4-methylphenol | increases expression | EXP | | 6480464 | Butylated Hydroxytoluene results in increased expression of TP53 mRNA | CTD | PMID:9780227 |
| 2,6-dichloroindophenol | multiple interactions | ISO | RGD:70502 | 6480464 | [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased phosphorylation of TP53 protein | CTD | PMID:21034357 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of TP53 mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of TP53 protein | CTD | PMID:15565650 more ... |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of TP53 protein | CTD | PMID:7728945 more ... |
| 2-acetamidofluorene | increases response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein modified form results in increased susceptibility to 2-Acetylaminofluorene | CTD | PMID:17317680 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of CCNB2 mRNA]; more ... | CTD | PMID:17317680 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | Vanadium promotes the reaction [2-Acetylaminofluorene results in increased expression of TP53 protein] | CTD | PMID:15565650 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of TP53 protein; more ... | CTD | PMID:11915028 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of TP53 mRNA | CTD | PMID:14633663 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of TP53 protein | CTD | PMID:11003613 |
| 2-acetamidofluorene | increases expression | ISO | RGD:70502 | 6480464 | 2-Acetylaminofluorene results in increased expression of TP53 protein | CTD | PMID:12888115 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of TP53 protein | CTD | PMID:10708481 more ... |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of TP53 protein | CTD | PMID:7728945 more ... |
| 2-acetamidofluorene | decreases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in decreased expression of TP53 protein | CTD | PMID:19167416 |
| 2-deoxy-D-glucose | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein inhibits the reaction [Deoxyglucose results in decreased abundance of Adenosine Triphosphate] | CTD | PMID:21042727 |
| 2-methoxyethanol | increases expression | EXP | | 6480464 | methyl cellosolve results in increased expression of TP53 mRNA | CTD | PMID:19643169 |
| 2-naphthylamine | decreases expression | ISO | RGD:70502 | 6480464 | 2-Naphthylamine results in decreased expression of TP53 mRNA | CTD | PMID:18247414 |
| 2-nitropropane | increases expression | ISO | RGD:11440 | 6480464 | 2-nitropropane results in increased expression of TRP53 protein | CTD | PMID:16720738 more ... |
| 2-nitropropane | increases expression | ISO | RGD:11440 | 6480464 | 2-nitropropane results in increased expression of TRP53 protein | CTD | PMID:12189182 more ... |
| 2-nitropropane | increases expression | ISO | RGD:11440 | 6480464 | 2-nitropropane results in increased expression of TRP53 protein | CTD | PMID:12189182 more ... |
| 2-nitropropane | increases expression | ISO | RGD:11440 | 6480464 | 2-nitropropane results in increased expression of TRP53 protein | CTD | PMID:16720738 more ... |
| 2-nitropropane | multiple interactions | ISO | RGD:11440 | 6480464 | APEX1 protein inhibits the reaction [2-nitropropane results in increased expression of TRP53 protein] | CTD | PMID:19268524 |
| 2-nitropropane | multiple interactions | ISO | RGD:11440 | 6480464 | POLB protein inhibits the reaction [2-nitropropane results in increased expression of TRP53 protein] | CTD | PMID:12189182 |
| 2-nitropropane | increases expression | ISO | RGD:11440 | 6480464 | 2-nitropropane results in increased expression of TRP53 protein | CTD | PMID:19268524 more ... |
| 2-nitrotoluene | increases mutagenesis | ISO | RGD:11440 | 6480464 | 2-nitrotoluene results in increased mutagenesis of TRP53 gene | CTD | PMID:13678655 |
| 3',4',7-trihydroxyisoflavone | multiple interactions | ISO | RGD:70502 | 6480464 | 3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of TP53 mRNA]; more ... | CTD | PMID:22914566 |
| 3',4',7-trihydroxyisoflavone | increases expression | ISO | RGD:70502 | 6480464 | 3',4',7-trihydroxyisoflavone results in increased expression of TP53 mRNA | CTD | PMID:22914566 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | EXP | | 6480464 | 1,3-dimethylthiourea inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TP53 protein] | CTD | PMID:17035936 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of TP53 protein | CTD | PMID:14993511 more ... |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of TP53 protein | CTD | PMID:15113391 more ... |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | ISO | RGD:11440 | 6480464 | Puromycin Aminonucleoside results in increased expression of TRP53 protein | CTD | PMID:17035936 PMID:15987750 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of TP53 protein | CTD | PMID:14993511 more ... |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of TP53 protein | CTD | PMID:15113391 more ... |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of TP53 protein | CTD | PMID:17035936 more ... |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | ISO | RGD:11440 | 6480464 | Puromycin Aminonucleoside results in increased expression of TRP53 protein | CTD | PMID:15987750 PMID:17035936 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | ISO | RGD:11440 | 6480464 | Dexamethasone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TRP53 protein] | CTD | PMID:15987750 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | ISO | RGD:11440 | 6480464 | 1,3-dimethylthiourea inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TRP53 protein] | CTD | PMID:17035936 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of TP53 protein | CTD | PMID:16152783 more ... |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TP53 protein] | CTD | PMID:14993511 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | RGD:70502 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TP53 protein | CTD | PMID:19751709 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | RGD:70502 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [Benzo(a)pyrene affects the localization of TP53 protein]; more ... | CTD | PMID:20840854 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | RGD:70502 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TP53 mRNA | CTD | PMID:21703328 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | RGD:70502 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [Etoposide results in increased expression of TP53 protein]; more ... | CTD | PMID:19751709 |
| 3,3'-diindolylmethane | multiple interactions | ISO | RGD:70502 | 6480464 | 3,3'-diindolylmethane results in increased expression of and results in increased phosphorylation of and results in increased activity of TP53 protein; more ... | CTD | PMID:22290291 |
| 3-aminobenzamide | multiple interactions | ISO | RGD:70502 | 6480464 | 3-aminobenzamide inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of TP53 protein]; more ... | CTD | PMID:22226932 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:11440 | 6480464 | Methylcholanthrene promotes the reaction [TRP53 protein binds to ABCB1B promoter]; more ... | CTD | PMID:11096091 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:11440 | 6480464 | Methylcholanthrene promotes the reaction [TRP53 protein binds to FMO3 5' UTR] | CTD | PMID:20570689 |
| 4'-epidoxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Epirubicin results in increased expression of TP53 mRNA | CTD | PMID:22914566 |
| 4'-epidoxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased expression of TP53 mRNA]; more ... | CTD | PMID:22914566 |
| 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid | multiple interactions | ISO | RGD:70502 | 6480464 | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Oxygen deficiency results in increased expression of TP53 protein] | CTD | PMID:10951577 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | affects localization | ISO | RGD:70502 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone affects the localization of TP53 protein | CTD | PMID:20421341 PMID:19931552 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | RGD:70502 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TP53 protein | CTD | PMID:19931552 PMID:21776270 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | RGD:11440 | 6480464 | [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of TRP53 mRNA | CTD | PMID:21167638 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases ADP-ribosylation | ISO | RGD:70502 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased ADP-ribosylation of TP53 protein | CTD | PMID:20421341 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases phosphorylation | ISO | RGD:70502 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of TP53 protein | CTD | PMID:20421341 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | RGD:70502 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TP53 protein | CTD | PMID:19931552 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | ISO | RGD:70502 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of TP53 protein | CTD | PMID:18805435 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | RGD:70502 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone inhibits the reaction [sodium arsenite affects the localization of TP53 protein]; more ... | CTD | PMID:19931552 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | affects localization | ISO | RGD:70502 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone affects the localization of TP53 protein | CTD | PMID:19931552 PMID:20421341 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | RGD:70502 | 6480464 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of TP53 protein] | CTD | PMID:18805435 |
| 4-hydroperoxycyclophosphamide | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [perfosfamide results in increased expression of TP53] | CTD | PMID:18034189 |
| 4-hydroperoxycyclophosphamide | multiple interactions | ISO | RGD:11440 | 6480464 | perfosfamide results in increased expression of and results in increased phosphorylation of and results in increased activity of TRP53 protein | CTD | PMID:17068108 |
| 4-hydroperoxycyclophosphamide | increases expression | ISO | RGD:70502 | 6480464 | perfosfamide results in increased expression of TP53 | CTD | PMID:18034189 |
| 4-hydroxynon-2-enal | increases mutagenesis | ISO | RGD:70502 | 6480464 | 4-hydroxy-2-nonenal results in increased mutagenesis of TP53 gene | CTD | PMID:11050162 |
| 4-hydroxynon-2-enal | affects abundance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the abundance of 4-hydroxy-2-nonenal | CTD | PMID:22229939 |
| 4-hydroxynon-2-enal | increases expression | ISO | RGD:70502 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of TP53 mRNA; more ... | CTD | PMID:15607904 |
| 4-hydroxyphenyl retinamide | affects expression | ISO | RGD:70502 | 6480464 | Fenretinide affects the expression of TP53 | CTD | PMID:16720286 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:70502 | 6480464 | Fenretinide results in increased expression of TP53 protein | CTD | PMID:16540676 more ... |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:70502 | 6480464 | Fenretinide results in increased expression of TP53 protein | CTD | PMID:16570282 more ... |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:70502 | 6480464 | Fenretinide results in increased expression of TP53 protein | CTD | PMID:17159502 more ... |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:70502 | 6480464 | Fenretinide results in increased expression of TP53 mRNA | CTD | PMID:17216584 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:70502 | 6480464 | Fenretinide results in increased expression of TP53 protein | CTD | PMID:17159502 more ... |
| 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:70502 | 6480464 | Fenretinide results in decreased expression of TP53 mRNA | CTD | PMID:7811993 |
| 4-nitrophenol | affects glucuronidation | ISO | RGD:70502 | 6480464 | TP53 protein affects the glucuronidation of 4-nitrophenol | CTD | PMID:11695553 |
| 4-nitroquinoline N-oxide | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the susceptibility to 4-Nitroquinoline-1-oxide | CTD | PMID:16543248 |
| 4-nitroquinoline N-oxide | decreases expression | EXP | | 6480464 | 4-Nitroquinoline-1-oxide results in decreased expression of TP53 protein | CTD | PMID:20599846 |
| 5-aminolevulinic acid | increases expression | ISO | RGD:70502 | 6480464 | Aminolevulinic Acid analog results in increased expression of TP53 | CTD | PMID:17311614 |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:70502 | 6480464 | decitabine results in decreased methylation of TP53 promoter | CTD | PMID:19037090 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 protein | CTD | PMID:15753979 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 mRNA | CTD | PMID:16025287 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 protein | CTD | PMID:15753979 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 mRNA | CTD | PMID:19950695 more ... |
| 5-aza-2'-deoxycytidine | increases phosphorylation | ISO | RGD:70502 | 6480464 | decitabine results in increased phosphorylation of TP53 protein | CTD | PMID:18636160 PMID:19732952 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 protein | CTD | PMID:17977830 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 mRNA | CTD | PMID:16025287 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 protein | CTD | PMID:19037090 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 mRNA | CTD | PMID:20480522 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 protein | CTD | PMID:16025287 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 mRNA | CTD | PMID:19950695 more ... |
| 5-aza-2'-deoxycytidine | increases phosphorylation | ISO | RGD:70502 | 6480464 | decitabine results in increased phosphorylation of TP53 protein | CTD | PMID:19732952 PMID:18636160 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 protein | CTD | PMID:15753979 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 mRNA | CTD | PMID:19037991 more ... |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70502 | 6480464 | [decitabine promotes the reaction [TP53 protein binds to CDKN1A promoter]] which results in increased expression of CDKN1A protein; more ... | CTD | PMID:14722112 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70502 | 6480464 | decitabine promotes the reaction [TP53 protein binds to FPR1 promoter] | CTD | PMID:19037090 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70502 | 6480464 | [decitabine co-treated with TP53 protein] results in increased expression of RAB6C mRNA; more ... | CTD | PMID:18992151 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70502 | 6480464 | [decitabine affects the methylation of BAX gene] affects the reaction [TP53 protein results in increased expression of BAX mRNA]; more ... | CTD | PMID:18608210 |
| 5-aza-2'-deoxycytidine | affects localization | ISO | RGD:70502 | 6480464 | decitabine affects the localization of TP53 protein modified form | CTD | PMID:17991895 |
| 5-aza-2'-deoxycytidine | affects localization | ISO | RGD:70502 | 6480464 | decitabine affects the localization of TP53 protein | CTD | PMID:19037090 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70502 | 6480464 | Caffeine inhibits the reaction [decitabine results in increased expression of TP53 protein]; more ... | CTD | PMID:17977830 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [decitabine results in increased expression of CDKN1A protein] | CTD | PMID:15753979 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [decitabine results in increased expression of RRM2B mRNA] | CTD | PMID:19010910 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [decitabine results in increased expression of CDKN1A protein] | CTD | PMID:18223691 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [decitabine results in decreased expression of ALDH6A1 mRNA]; more ... | CTD | PMID:19363521 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [decitabine affects the expression of APAF1 mRNA] | CTD | PMID:17133271 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 protein | CTD | PMID:17977830 more ... |
| 5-aza-2'-deoxycytidine | increases phosphorylation | ISO | RGD:70502 | 6480464 | decitabine results in increased phosphorylation of TP53 protein | CTD | PMID:18636160 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of TP53 mRNA | CTD | PMID:19037991 more ... |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70502 | 6480464 | decitabine results in increased expression of and results in increased localization of and results in increased activity of TP53 protein; more ... | CTD | PMID:17389721 |
| 5-aza-2'-deoxycytidine | decreases ubiquitination | ISO | RGD:70502 | 6480464 | decitabine results in decreased ubiquitination of TP53 protein | CTD | PMID:17977830 |
| 5-aza-2'-deoxycytidine | increases acetylation | ISO | RGD:70502 | 6480464 | decitabine results in increased acetylation of TP53 protein | CTD | PMID:17977830 |
| 5-azacytidine | increases expression | ISO | RGD:70502 | 6480464 | Azacitidine results in increased expression of TP53 protein | CTD | PMID:15547111 |
| 5-azacytidine | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Azacitidine | CTD | PMID:15547111 |
| 5-azacytidine | multiple interactions | ISO | RGD:70502 | 6480464 | pifithrin inhibits the reaction [Azacitidine results in increased expression of TP53 protein]; more ... | CTD | PMID:15547111 |
| 5-fluoro-2'-deoxyuridine | increases expression | ISO | RGD:70502 | 6480464 | Floxuridine results in increased expression of TP53 protein | CTD | PMID:19015155 |
| 5-fluorouracil | increases expression | ISO | RGD:11440 | 6480464 | Fluorouracil results in increased expression of TRP53 protein | CTD | PMID:16949053 PMID:9050858 |
| 5-fluorouracil | increases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of TP53 mRNA | CTD | PMID:12792779 more ... |
| 5-fluorouracil | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Fluorouracil | CTD | PMID:14665630 more ... |
| 5-fluorouracil | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 promoter mutant form results in decreased susceptibility to Fluorouracil | CTD | PMID:22445862 |
| 5-fluorouracil | increases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of TP53 mRNA | CTD | PMID:12792779 PMID:22445862 |
| 5-fluorouracil | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Fluorouracil | CTD | PMID:14665630 more ... |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of TP53INP1 mRNA] | CTD | PMID:16557594 PMID:17982676 |
| 5-fluorouracil | increases phosphorylation | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased phosphorylation of TP53 protein | CTD | PMID:15489892 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of TP53 protein | CTD | PMID:12082016 more ... |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A protein] | CTD | PMID:15546879 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of TP53 protein | CTD | PMID:15896711 more ... |
| 5-fluorouracil | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Fluorouracil | CTD | PMID:14665630 more ... |
| 5-fluorouracil | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Fluorouracil | CTD | PMID:17339891 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of TP53 protein | CTD | PMID:16584549 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:11440 | 6480464 | Fluorouracil results in increased expression of TRP53 protein | CTD | PMID:9050858 PMID:16949053 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A protein] | CTD | PMID:15546879 more ... |
| 5-fluorouracil | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Fluorouracil | CTD | PMID:17339891 more ... |
| 5-fluorouracil | increases phosphorylation | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased phosphorylation of TP53 protein | CTD | PMID:17971768 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of TP53 protein | CTD | PMID:17056233 more ... |
| 5-fluorouracil | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Fluorouracil | CTD | PMID:14704126 PMID:16686938 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A protein] | CTD | PMID:17699798 more ... |
| 5-fluorouracil | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Fluorouracil | CTD | PMID:14665630 more ... |
| 5-fluorouracil | increases phosphorylation | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased phosphorylation of TP53 protein | CTD | PMID:19010883 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of TP53 protein | CTD | PMID:19098008 more ... |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of FAS protein] | CTD | PMID:17982676 PMID:15546879 |
| 5-fluorouracil | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Fluorouracil | CTD | PMID:15608686 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of TP53 protein | CTD | PMID:16963839 more ... |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:17982676 PMID:17634554 |
| 5-fluorouracil | increases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of TP53 | CTD | PMID:14646558 PMID:11750847 |
| 5-fluorouracil | decreases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in decreased expression of TP53 mRNA | CTD | PMID:16709241 PMID:18930000 |
| 5-fluorouracil | increases response to substance | ISO | RGD:11440 | 6480464 | TRP53 results in increased susceptibility to Fluorouracil | CTD | PMID:9050858 |
| 5-fluorouracil | increases activity | ISO | RGD:11440 | 6480464 | Fluorouracil results in increased activity of TRP53 protein | CTD | PMID:16949053 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Fluorouracil results in increased expression of TP53 protein] | CTD | PMID:15459018 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of TP53 protein | CTD | PMID:15459018 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | Fluorouracil promotes the reaction [Acetaminophen results in increased phosphorylation of TP53 protein] | CTD | PMID:16330492 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 results in increased susceptibility to [Poly I-C co-treated with Fluorouracil] | CTD | PMID:20367642 |
| 5-fluorouracil | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Fluorouracil | CTD | PMID:16686938 PMID:14704126 |
| 5-fluorouracil | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 results in increased susceptibility to Fluorouracil | CTD | PMID:14646558 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to [Fluorouracil co-treated with Cisplatin] | CTD | PMID:15254702 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to [Cisplatin co-treated with Fluorouracil] | CTD | PMID:16077963 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of TP53INP1 mRNA] | CTD | PMID:17982676 PMID:16557594 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFSF10 mRNA]; more ... | CTD | PMID:19106633 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of FAS protein] | CTD | PMID:15546879 PMID:17982676 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A protein] | CTD | PMID:17982676 more ... |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of CASP8 protein]; more ... | CTD | PMID:17637740 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in decreased expression of MYC mRNA]; more ... | CTD | PMID:16557594 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to [Fluorouracil co-treated with Cisplatin] | CTD | PMID:15999354 |
| 5-fluorouracil | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Fluorouracil | CTD | PMID:15534911 more ... |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in increased expression of TLR3 mRNA] | CTD | PMID:18779317 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in increased expression of FAS protein] | CTD | PMID:15161716 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in increased expression of BBC3 protein] | CTD | PMID:14665630 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in increased expression of ANXA2 mRNA]; more ... | CTD | PMID:15152939 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of EGFR protein]; more ... | CTD | PMID:17982676 |
| 5-fluorouracil | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 gene polymorphism affects the susceptibility to Fluorouracil | CTD | PMID:18498133 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 affects the reaction [resveratrol affects the reaction [Fluorouracil results in increased activity of CASP6 protein]] | CTD | PMID:18497562 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | [TP53 affects the expression of TYMS] which affects the susceptibility to Fluorouracil | CTD | PMID:18600534 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased expression of TP53 protein]; more ... | CTD | PMID:15546879 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | [nutlin 3 results in increased stability of TP53 protein] which results in increased susceptibility to Fluorouracil | CTD | PMID:21205074 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | Pravastatin inhibits the reaction [Fluorouracil results in decreased degradation of TP53 protein] | CTD | PMID:15625077 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | IFNA1 protein promotes the reaction [Fluorouracil results in increased phosphorylation of TP53 protein] | CTD | PMID:17971768 |
| 5-fluorouracil | increases phosphorylation | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased phosphorylation of TP53 protein | CTD | PMID:19010883 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of TP53 protein | CTD | PMID:12792779 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of TP53 mRNA | CTD | PMID:12792779 |
| 5-fluorouracil | increases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of TP53 | CTD | PMID:11750847 PMID:14646558 |
| 5-fluorouracil | decreases expression | ISO | RGD:70502 | 6480464 | Fluorouracil results in decreased expression of TP53 mRNA | CTD | PMID:18930000 PMID:16709241 |
| 5-fluorouracil | increases activity | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased activity of TP53 protein | CTD | PMID:18779317 PMID:19010883 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | Fluorouracil promotes the reaction [[TP53 protein binds to SP1 protein] which binds to CDKN1A promoter] | CTD | PMID:15489892 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | Fluorouracil results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:17634554 PMID:17982676 |
| 5-fluorouracil | decreases degradation | ISO | RGD:70502 | 6480464 | Fluorouracil results in decreased degradation of TP53 protein | CTD | PMID:15625077 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | Fluorouracil promotes the reaction [TP53 protein binds to CES2 intron]; more ... | CTD | PMID:16963839 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased expression of TP53 protein] | CTD | PMID:16168113 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | Fluorouracil promotes the reaction [andrographolide results in increased expression of TP53] | CTD | PMID:19097688 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | Fluorouracil promotes the reaction [allose results in increased expression of TP53 protein] | CTD | PMID:18930000 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | [Fluorouracil co-treated with Genistein] results in increased expression of TP53 mRNA; more ... | CTD | PMID:15896711 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | Cycloheximide inhibits the reaction [Fluorouracil results in increased expression of TP53 protein]; more ... | CTD | PMID:15016801 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70502 | 6480464 | [CHEK1 protein co-treated with TP53 protein] affects the susceptibility to Fluorouracil; more ... | CTD | PMID:18698031 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:11440 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein | CTD | PMID:12734332 |
| 7,12-dimethyltetraphene | decreases expression | ISO | RGD:11440 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 protein | CTD | PMID:18791811 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:11440 | 6480464 | resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 protein] | CTD | PMID:18791811 |
| 7,12-dimethyltetraphene | increases activity | ISO | RGD:70502 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased activity of TP53 protein | CTD | PMID:20655369 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:70502 | 6480464 | [[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]; more ... | CTD | PMID:22009531 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:11440 | 6480464 | [9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein | CTD | PMID:22009531 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:11440 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein | CTD | PMID:12734332 PMID:20043298 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:11440 | 6480464 | Eugenol promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein] | CTD | PMID:20043298 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:11440 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein | CTD | PMID:20043298 PMID:12734332 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:70502 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TP53 | CTD | PMID:11802967 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:70502 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TP53 protein | CTD | PMID:10642304 |
| 8-bromo-3',5'-cyclic GMP | increases expression | EXP | | 6480464 | 8-bromocyclic GMP results in increased expression of TP53 protein | CTD | PMID:9888876 |
| 9,11,13-octadecatrienoic acid | increases expression | ISO | RGD:70502 | 6480464 | eleostearic acid results in increased expression of TP53 protein | CTD | PMID:15961301 |
| acetylsalicylic acid | increases acetylation | ISO | RGD:70502 | 6480464 | Aspirin results in increased acetylation of TP53 protein | CTD | PMID:19212664 |
| acetylsalicylic acid | increases expression | ISO | RGD:11440 | 6480464 | Aspirin results in increased expression of TRP53 protein | CTD | PMID:16880202 |
| acetylsalicylic acid | increases expression | ISO | RGD:70502 | 6480464 | Aspirin results in increased expression of TP53 protein | CTD | PMID:12535653 |
| acridine orange | multiple interactions | ISO | RGD:70502 | 6480464 | Acridine Orange results in increased stability of and results in increased activity of TP53 protein | CTD | PMID:16177561 |
| acrolein | decreases activity | ISO | RGD:70502 | 6480464 | Acrolein results in decreased activity of TP53 protein | CTD | PMID:16753831 PMID:12807757 |
| acrolein | increases mutagenesis | ISO | RGD:70502 | 6480464 | Acrolein results in increased mutagenesis of TP53 gene | CTD | PMID:17030796 |
| acrolein | decreases activity | ISO | RGD:70502 | 6480464 | Acrolein results in decreased activity of TP53 protein | CTD | PMID:12807757 PMID:16753831 |
| acrolein | affects binding | ISO | RGD:70502 | 6480464 | Acrolein binds to TP53 gene | CTD | PMID:17030796 |
| acrolein | multiple interactions | ISO | RGD:70502 | 6480464 | Acrolein inhibits the reaction [Benzo(a)pyrene results in increased activity of TP53 protein] | CTD | PMID:12807757 |
| acrolein | affects metabolic processing | ISO | RGD:70502 | 6480464 | Acrolein affects the metabolism of TP53 protein | CTD | PMID:12807757 |
| acrylamide | increases mutagenesis | ISO | RGD:70502 | 6480464 | Acrylamide results in increased mutagenesis of TP53 gene | CTD | PMID:15240786 |
| acrylamide | multiple interactions | ISO | RGD:70502 | 6480464 | Acrylamide results in increased phosphorylation of and results in increased expression of TP53 protein | CTD | PMID:19426797 |
| acrylamide | increases expression | ISO | RGD:70502 | 6480464 | Acrylamide results in increased expression of TP53 protein modified form | CTD | PMID:20734998 |
| actinomycin D | multiple interactions | ISO | RGD:70502 | 6480464 | Cadmium Chloride inhibits the reaction [Dactinomycin results in increased expression of and results in increased activity of TP53 protein]; more ... | CTD | PMID:10531375 |
| actinomycin D | increases activity | ISO | RGD:70502 | 6480464 | Dactinomycin results in increased activity of TP53 protein | CTD | PMID:12869419 PMID:20655369 |
| actinomycin D | multiple interactions | ISO | RGD:70502 | 6480464 | Morphine inhibits the reaction [Dactinomycin results in increased expression of TP53 protein modified form]; more ... | CTD | PMID:12927789 |
| actinomycin D | increases expression | ISO | RGD:70502 | 6480464 | Dactinomycin results in increased expression of TP53 protein modified form | CTD | PMID:12927789 |
| actinomycin D | increases expression | ISO | RGD:70502 | 6480464 | Dactinomycin results in increased expression of TP53 protein | CTD | PMID:17581298 |
| actinomycin D | increases activity | ISO | RGD:70502 | 6480464 | Dactinomycin results in increased activity of TP53 protein | CTD | PMID:12869419 |
| actinomycin D | multiple interactions | ISO | RGD:70502 | 6480464 | Dactinomycin results in increased expression of and affects the localization of TP53 protein | CTD | PMID:12807743 |
| actinomycin D | multiple interactions | ISO | RGD:70502 | 6480464 | Dactinomycin promotes the reaction [MRPL41 protein results in increased stability of and affects the localization of TP53 protein] | CTD | PMID:16024796 |
| aflatoxin B1 | affects expression | ISO | RGD:70502 | 6480464 | Aflatoxin B1 affects the expression of TP53 protein | CTD | PMID:20106945 |
| aflatoxin B1 | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Aflatoxin B1 results in increased expression of BTG2 mRNA]; more ... | CTD | PMID:22100608 |
| aflatoxin B1 | increases expression | ISO | RGD:70502 | 6480464 | Aflatoxin B1 results in increased expression of TP53 protein | CTD | PMID:22100608 |
| aflatoxin B1 | multiple interactions | ISO | RGD:70502 | 6480464 | CYP3A4 protein promotes the reaction [Aflatoxin B1 results in increased activity of TP53 protein] | CTD | PMID:20655369 |
| aflatoxin B1 | increases activity | ISO | RGD:70502 | 6480464 | Aflatoxin B1 results in increased activity of TP53 protein | CTD | PMID:20655369 |
| aflatoxin B1 | increases mutagenesis | ISO | RGD:70502 | 6480464 | Aflatoxin B1 results in increased mutagenesis of TP53 gene | CTD | PMID:12619106 PMID:15946497 |
| aflatoxin B1 | increases mutagenesis | ISO | RGD:70502 | 6480464 | Aflatoxin B1 results in increased mutagenesis of TP53 gene | CTD | PMID:15946497 PMID:12619106 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of TP53 protein | CTD | PMID:9163691 |
| alantolactone | increases expression | ISO | RGD:70502 | 6480464 | alantolactone results in increased expression of TP53 protein | CTD | PMID:22721982 |
| albuterol | increases expression | ISO | RGD:70502 | 6480464 | Albuterol results in increased expression of TP53 | CTD | PMID:11802967 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:11440 | 6480464 | Tretinoin results in decreased expression of TRP53 mRNA | CTD | PMID:16604517 |
| all-trans-retinoic acid | increases expression | ISO | RGD:70502 | 6480464 | Tretinoin results in increased expression of TP53 protein | CTD | PMID:15254726 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:70502 | 6480464 | Tretinoin results in increased expression of TP53 protein | CTD | PMID:16752155 more ... |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:70502 | 6480464 | Tretinoin inhibits the reaction [[Copper binds to Isatin binds to trimethylenediamine] which results in increased expression of TP53 protein] | CTD | PMID:17327230 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:70502 | 6480464 | [Tretinoin results in increased uptake of Glucose] inhibits the reaction [bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II) results in increased expression of TP53 protein] | CTD | PMID:21548882 |
| all-trans-retinoic acid | increases expression | ISO | RGD:70502 | 6480464 | Tretinoin results in increased expression of TP53 protein | CTD | PMID:16935849 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:70502 | 6480464 | Tretinoin results in increased expression of TP53 protein | CTD | PMID:16473924 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:70502 | 6480464 | Tretinoin results in increased expression of TP53 protein | CTD | PMID:16935849 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:70502 | 6480464 | Tretinoin results in increased expression of TP53 protein | CTD | PMID:16752155 more ... |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:70502 | 6480464 | Tretinoin results in increased ubiquitination of and results in increased degradation of TP53 protein | CTD | PMID:16740359 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of TP53 protein | CTD | PMID:17962954 |
| all-trans-retinoic acid | increases expression | ISO | RGD:70502 | 6480464 | Tretinoin results in increased expression of TP53 mRNA | CTD | PMID:16054129 |
| all-trans-retinoic acid | increases expression | ISO | RGD:70502 | 6480464 | Tretinoin results in increased expression of TP53 protein | CTD | PMID:16473924 more ... |
| all-trans-retinoic acid | increases activity | ISO | RGD:70502 | 6480464 | Tretinoin results in increased activity of TP53 protein | CTD | PMID:15674351 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:70502 | 6480464 | Tretinoin inhibits the reaction [Cisplatin results in increased acetylation of TP53 protein]; more ... | CTD | PMID:21532991 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:70502 | 6480464 | Tretinoin inhibits the reaction [geldanamycin affects the localization of TP53 protein] | CTD | PMID:17293044 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:70502 | 6480464 | Tretinoin results in decreased expression of TP53 protein | CTD | PMID:16461808 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:70502 | 6480464 | [Tretinoin co-treated with zoledronic acid] results in decreased expression of TP53 protein | CTD | PMID:20349282 |
| all-trans-retinoic acid | affects expression | ISO | RGD:70502 | 6480464 | Tretinoin affects the expression of TP53 | CTD | PMID:16720286 |
| allethrin | affects expression | EXP | | 6480464 | Allethrin affects the expression of TP53 protein | CTD | PMID:22356257 |
| alpha-hexachlorocyclohexane | increases expression | EXP | | 6480464 | alpha-hexachlorocyclohexane results in increased expression of TP53 mRNA | CTD | PMID:16940010 |
| alpha-hexachlorocyclohexane | affects expression | EXP | | 6480464 | alpha-hexachlorocyclohexane affects the expression of TRP53 mRNA | CTD | PMID:16940010 |
| alpha-hexachlorocyclohexane | decreases expression | EXP | | 6480464 | alpha-hexachlorocyclohexane results in decreased expression of TP53 mRNA | CTD | PMID:16940010 |
| alternariol | increases expression | ISO | RGD:70502 | 6480464 | alternariol results in increased expression of TP53 protein | CTD | PMID:22542754 |
| aluminium oxide | increases expression | ISO | RGD:70502 | 6480464 | Aluminum Oxide analog results in increased expression of TP53 mRNA | CTD | PMID:23132795 |
| amifostine | multiple interactions | ISO | RGD:70502 | 6480464 | [Amifostine co-treated with TP53] results in increased expression of MYC mRNA | CTD | PMID:14555708 |
| amifostine | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Amifostine results in decreased phosphorylation of CDK1 protein]; more ... | CTD | PMID:16628227 |
| amifostine | increases expression | ISO | RGD:70502 | 6480464 | Amifostine results in increased expression of TP53 protein | CTD | PMID:12618886 |
| amifostine | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 affects the susceptibility to Amifostine | CTD | PMID:12618886 |
| amifostine | increases activity | ISO | RGD:70502 | 6480464 | Amifostine results in increased activity of TP53 protein | CTD | PMID:16628227 |
| ammonium chloride | increases expression | EXP | | 6480464 | Ammonium Chloride results in increased expression of TP53 protein | CTD | PMID:16483693 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of TP53 mRNA | CTD | PMID:16483693 |
| amodiaquine | increases activity | ISO | RGD:70502 | 6480464 | Amodiaquine results in increased activity of TP53 protein | CTD | PMID:12082016 |
| amosite asbestos | affects localization | ISO | RGD:70502 | 6480464 | Asbestos, Amosite affects the localization of TP53 protein | CTD | PMID:16357363 |
| amosite asbestos | multiple interactions | EXP | | 6480464 | Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 protein] | CTD | PMID:16357363 |
| amosite asbestos | increases expression | EXP | | 6480464 | Asbestos, Amosite results in increased expression of TP53 protein | CTD | PMID:16357363 |
| amosite asbestos | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Asbestos, Amosite | CTD | PMID:16357363 |
| amosite asbestos | multiple interactions | ISO | RGD:70502 | 6480464 | Deferoxamine inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 mRNA]; more ... | CTD | PMID:16357363 |
| amosite asbestos | increases expression | ISO | RGD:70502 | 6480464 | Asbestos, Amosite results in increased expression of TP53 protein; more ... | CTD | PMID:16357363 |
| amphetamine | increases expression | ISO | RGD:11440 | 6480464 | Amphetamine results in increased expression of TRP53 mRNA; more ... | CTD | PMID:15731293 |
| amsacrine | increases activity | ISO | RGD:70502 | 6480464 | Amsacrine analog results in increased activity of TP53 protein | CTD | PMID:12082016 |
| amsacrine | multiple interactions | ISO | RGD:70502 | 6480464 | Amsacrine results in increased stability of and results in increased activity of TP53 protein | CTD | PMID:16177561 |
| amsacrine | increases glutathionylation | ISO | RGD:70502 | 6480464 | Amsacrine results in increased glutathionylation of TP53 protein | CTD | PMID:17555331 |
| amsacrine | increases expression | ISO | RGD:70502 | 6480464 | Amsacrine results in increased expression of TP53 protein | CTD | PMID:11774253 |
| andrographolide | multiple interactions | ISO | RGD:70502 | 6480464 | andrographolide results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:18619950 |
| andrographolide | multiple interactions | ISO | RGD:70502 | 6480464 | Fluorouracil promotes the reaction [andrographolide results in increased expression of TP53] | CTD | PMID:19097688 |
| andrographolide | increases expression | ISO | RGD:70502 | 6480464 | andrographolide results in increased expression of TP53 | CTD | PMID:19097688 |
| aphidicolin | multiple interactions | ISO | RGD:11440 | 6480464 | [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRP53 protein]; more ... | CTD | PMID:22003191 |
| apigenin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Apigenin results in increased expression of CDKN1A protein] | CTD | PMID:11790449 |
| apigenin | increases expression | ISO | RGD:70502 | 6480464 | Apigenin results in increased expression of TP53 protein | CTD | PMID:16023288 |
| apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of TP53 protein] | CTD | PMID:22431579 |
| arsenic acid | increases expression | ISO | RGD:11440 | 6480464 | arsenic acid results in increased expression of TRP53 mRNA | CTD | PMID:8946558 |
| arsenic atom | affects expression | ISO | RGD:70502 | 6480464 | Arsenic affects the expression of TP53 mRNA | CTD | PMID:18414638 |
| arsenic atom | increases mutagenesis | ISO | RGD:70502 | 6480464 | Arsenic results in increased mutagenesis of TP53 exon | CTD | PMID:21756780 |
| arsenic atom | increases methylation | ISO | RGD:70502 | 6480464 | Arsenic results in increased methylation of TP53 promoter | CTD | PMID:16251483 PMID:21756780 |
| arsenic atom | decreases methylation | ISO | RGD:70502 | 6480464 | Arsenic results in decreased methylation of TP53 exon | CTD | PMID:21756780 |
| arsenic atom | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 polymorphism affects the susceptibility to Arsenic | CTD | PMID:21982800 |
| arsenic atom | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 gene polymorphism results in increased susceptibility to Arsenic | CTD | PMID:16930632 |
| arsenic atom | increases methylation | ISO | RGD:70502 | 6480464 | Arsenic results in increased methylation of TP53 promoter | CTD | PMID:16251483 |
| arsenic atom | increases mutagenesis | ISO | RGD:70502 | 6480464 | Arsenic results in increased mutagenesis of TP53 gene | CTD | PMID:15967209 |
| arsenic atom | increases expression | ISO | RGD:70502 | 6480464 | Arsenic results in increased expression of TP53 protein mutant form | CTD | PMID:12899209 |
| arsenic atom | decreases expression | ISO | RGD:70502 | 6480464 | Arsenic results in decreased expression of TP53 mRNA | CTD | PMID:19945496 |
| arsenic trichloride | increases phosphorylation | ISO | RGD:11440 | 6480464 | arsenic trichloride results in increased phosphorylation of TRP53 protein | CTD | PMID:16283526 |
| arsenite(3-) | multiple interactions | ISO | RGD:70502 | 6480464 | 3-(4-methylphenylsulfonyl)-2-propenenitrile promotes the reaction [arsenite promotes the reaction [TP53 protein binds to CREBBP protein]]; more ... | CTD | PMID:20199942 |
| arsenite(3-) | increases expression | ISO | RGD:70502 | 6480464 | arsenite results in increased expression of TP53 mRNA; more ... | CTD | PMID:12126965 PMID:22260869 |
| arsenite(3-) | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [arsenite results in increased expression of TP53 protein]; more ... | CTD | PMID:22260869 |
| arsenite(3-) | multiple interactions | ISO | RGD:70502 | 6480464 | [[arsenite results in increased activity of PRKDC protein] which results in increased phosphorylation of and results in increased activity of MAPK9 protein] promotes the reaction [MAPK9 protein binds to TP53 protein]; more ... | CTD | PMID:22366412 |
| arsenite(3-) | multiple interactions | ISO | RGD:11440 | 6480464 | arsenite results in decreased phosphorylation of and results in decreased activity of TRP53 protein | CTD | PMID:16739126 |
| arsenite(3-) | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein affects the reaction [arsenite results in decreased expression of AGMAT mRNA]; more ... | CTD | PMID:18929588 |
| arsenite(3-) | increases expression | ISO | RGD:70502 | 6480464 | arsenite results in increased expression of TP53 mRNA; more ... | CTD | PMID:12126965 |
| arsenite(3-) | affects methylation | ISO | RGD:70502 | 6480464 | arsenite affects the methylation of TP53 promoter | CTD | PMID:11489357 |
| arsenite(3-) | multiple interactions | ISO | RGD:70502 | 6480464 | alpha-Tocopherol inhibits the reaction [arsenite results in increased expression of TP53 protein]; more ... | CTD | PMID:12126965 |
| asbestos | increases response to substance | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form results in increased susceptibility to Asbestos | CTD | PMID:15136429 |
| aspartame | increases expression | ISO | RGD:11440 | 6480464 | Aspartame results in increased expression of TRP53 | CTD | PMID:17354619 |
| astaxanthin | multiple interactions | EXP | | 6480464 | astaxanthine inhibits the reaction [Cyclophosphamide results in increased expression of TP53 protein] | CTD | PMID:20038455 |
| ATP | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein inhibits the reaction [Deoxyglucose results in decreased abundance of Adenosine Triphosphate] | CTD | PMID:21042727 |
| atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of TP53 protein | CTD | PMID:9486943 |
| atrazine | multiple interactions | EXP | | 6480464 | kolaviron inhibits the reaction [Atrazine affects the expression of TP53] | CTD | PMID:21726175 |
| atrazine | affects expression | EXP | | 6480464 | Atrazine affects the expression of TP53 | CTD | PMID:21726175 |
| atrazine | multiple interactions | ISO | RGD:70502 | 6480464 | kolaviron inhibits the reaction [Atrazine results in decreased expression of TP53 mRNA]; more ... | CTD | PMID:21333729 |
| atrazine | decreases expression | ISO | RGD:70502 | 6480464 | Atrazine results in decreased expression of TP53 mRNA; more ... | CTD | PMID:21333729 |
| atrazine | affects localization | EXP | | 6480464 | Atrazine affects the localization of TP53 protein | CTD | PMID:9486943 |
| atropine | multiple interactions | ISO | RGD:70502 | 6480464 | Atropine inhibits the reaction [Malathion results in increased expression of TP53 protein]; more ... | CTD | PMID:12762645 |
| azadirachtin A | increases expression | ISO | RGD:70502 | 6480464 | azadirachtin results in increased expression of TP53 protein; more ... | CTD | PMID:20429769 |
| azathioprine | increases expression | ISO | RGD:70502 | 6480464 | Azathioprine results in increased expression of TP53 protein | CTD | PMID:14961032 |
| azathioprine | increases mutagenesis | ISO | RGD:70502 | 6480464 | Azathioprine results in increased mutagenesis of TP53 gene | CTD | PMID:17979968 |
| azetidine | affects localization | ISO | RGD:11440 | 6480464 | azetidine affects the localization of TRP53 protein | CTD | PMID:18813348 |
| baicalein | increases expression | ISO | RGD:70502 | 6480464 | baicalein results in increased expression of TP53 protein | CTD | PMID:21457722 |
| baicalin | increases expression | ISO | RGD:70502 | 6480464 | baicalin results in increased expression of TP53 protein | CTD | PMID:21457722 |
| bathocuproine disulfonic acid | multiple interactions | ISO | RGD:70502 | 6480464 | bathocuproine sulfonate inhibits the reaction [[pyrrolidine dithiocarbamic acid results in increased abundance of Copper] which results in increased oxidation of and results in increased expression of TP53 protein] | CTD | PMID:11964141 |
| benzene | increases phosphorylation | ISO | RGD:70502 | 6480464 | Benzene results in increased phosphorylation of TP53 protein | CTD | PMID:8076368 |
| benzene | increases mutagenesis | ISO | RGD:70502 | 6480464 | Benzene results in increased mutagenesis of TP53 gene | CTD | PMID:19862502 |
| benzene | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the susceptibility to Benzene | CTD | PMID:19326098 PMID:20018183 |
| benzene | increases expression | ISO | RGD:70502 | 6480464 | Benzene results in increased expression of TP53 mRNA | CTD | PMID:21382456 |
| benzene | increases expression | ISO | RGD:11440 | 6480464 | Benzene results in increased expression of TRP53 protein | CTD | PMID:18281070 PMID:17162533 |
| benzene | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the susceptibility to Benzene | CTD | PMID:20018183 |
| benzene | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein affects the reaction [Benzene results in increased expression of CDKN1A mRNA] | CTD | PMID:11896287 PMID:12857942 |
| benzene | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein inhibits the reaction [Benzene results in increased expression of DMTF1]; more ... | CTD | PMID:15935813 |
| benzene | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein affects the reaction [Benzene results in increased expression of CDKN1A protein] | CTD | PMID:11274754 |
| benzene | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein affects the reaction [Benzene results in increased expression of CDKN1A mRNA] | CTD | PMID:12857942 PMID:11896287 |
| benzene | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein affects the reaction [Benzene results in increased expression of BAX mRNA]; more ... | CTD | PMID:11896287 |
| benzene | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein affects the reaction [Benzene results in decreased expression of CCR7 mRNA]; more ... | CTD | PMID:12928149 |
| benzene | increases expression | ISO | RGD:11440 | 6480464 | Benzene results in increased expression of TRP53 protein | CTD | PMID:17162533 PMID:18281070 |
| benzene | increases response to substance | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form results in increased susceptibility to Benzene | CTD | PMID:19478238 |
| benzene | increases expression | ISO | RGD:11440 | 6480464 | Benzene results in increased expression of TRP53 mRNA | CTD | PMID:11896287 |
| benzene | increases phosphorylation | EXP | | 6480464 | Benzene results in increased phosphorylation of TP53 protein | CTD | PMID:8076368 |
| benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of TP53 protein | CTD | PMID:18093815 |
| benzene | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 gene SNP results in increased susceptibility to Benzene | CTD | PMID:16728435 |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:10837373 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70502 | 6480464 | PARG mutant form inhibits the reaction [Benzo(a)pyrene results in increased expression of TP53 mRNA]; more ... | CTD | PMID:22266578 |
| benzo[a]pyrene | increases mutagenesis | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased mutagenesis of TP53 gene | CTD | PMID:22319594 |
| benzo[a]pyrene | decreases expression | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene results in decreased expression of TRP53 mRNA | CTD | PMID:20869020 PMID:22641617 |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 mRNA | CTD | PMID:19027820 PMID:22889811 |
| benzo[a]pyrene | increases phosphorylation | EXP | | 6480464 | Benzo(a)pyrene results in increased phosphorylation of TP53 protein | CTD | PMID:17961608 PMID:18634860 |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:10837373 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11440 | 6480464 | benz(a)anthracene promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 protein]; more ... | CTD | PMID:22120587 |
| benzo[a]pyrene | increases expression | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene results in increased expression of TRP53 protein | CTD | PMID:19428948 more ... |
| benzo[a]pyrene | increases phosphorylation | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene results in increased phosphorylation of TRP53 protein | CTD | PMID:19041363 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene results in increased expression of TRP53 mRNA | CTD | PMID:19896525 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70502 | 6480464 | fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of TP53 protein] | CTD | PMID:22120587 |
| benzo[a]pyrene | affects expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene affects the expression of TP53 mRNA | CTD | PMID:21393351 |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:10837373 more ... |
| benzo[a]pyrene | increases activity | EXP | | 6480464 | Benzo(a)pyrene results in increased activity of TRP53 protein | CTD | PMID:19931295 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased phosphorylation of and results in increased expression of TP53 protein | CTD | PMID:20840854 PMID:21457773 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70502 | 6480464 | 2,4,4'-trichlorobiphenyl promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of and results in increased expression of TP53 protein]; more ... | CTD | PMID:20840854 |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:10837373 more ... |
| benzo[a]pyrene | increases phosphorylation | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene results in increased phosphorylation of TRP53 protein | CTD | PMID:19041363 PMID:19874837 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [TNF protein co-treated with Benzo(a)pyrene] results in increased phosphorylation of TP53 protein | CTD | PMID:21745554 |
| benzo[a]pyrene | affects localization | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene affects the localization of TP53 protein | CTD | PMID:20840854 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:19408242 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:9789950 more ... |
| benzo[a]pyrene | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 affects the susceptibility to Benzo(a)pyrene | CTD | PMID:10837373 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 affects the reaction [Benzo(a)pyrene results in increased expression of BAX mRNA]; more ... | CTD | PMID:10837373 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein modified form | CTD | PMID:21604763 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of TP53 mRNA | CTD | PMID:19408242 PMID:20064080 |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein modified form | CTD | PMID:22044530 |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:11782367 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:10837373 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | increases response to substance | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form results in increased susceptibility to Benzo(a)pyrene | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene results in increased expression of TRP53 mRNA | CTD | PMID:19896525 PMID:19961161 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:20064080 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:16041517 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11440 | 6480464 | Plant Extracts inhibits the reaction [Benzo(a)pyrene results in decreased expression of TRP53 mRNA] | CTD | PMID:20869020 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11440 | 6480464 | epicatechin gallate promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 mRNA]; more ... | CTD | PMID:18656336 |
| benzo[a]pyrene | increases expression | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene results in increased expression of TRP53 protein | CTD | PMID:19428948 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene results in increased expression of and results in increased activity of TRP53 protein | CTD | PMID:11096091 |
| benzo[a]pyrene | increases expression | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene results in increased expression of TRP53 mRNA | CTD | PMID:19961161 PMID:19896525 |
| benzo[a]pyrene | decreases expression | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene results in decreased expression of TRP53 mRNA | CTD | PMID:20869020 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene promotes the reaction [TRP53 protein binds to FMO3 5' UTR] | CTD | PMID:20570689 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11440 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] affects the expression of ABCF3 mRNA; more ... | CTD | PMID:21715664 |
| benzo[a]pyrene | affects localization | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene affects the localization of TRP53 protein | CTD | PMID:17240030 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in increased expression of TP53 mRNA]; more ... | CTD | PMID:20064080 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of TP53 protein; more ... | CTD | PMID:19408242 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:19408242 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of TP53 mRNA | CTD | PMID:20064080 PMID:19408242 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of and results in increased phosphorylation of TP53 protein; more ... | CTD | PMID:15459018 |
| benzo[a]pyrene | increases expression | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 mRNA | CTD | PMID:18656336 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70502 | 6480464 | Vitamin E inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of TP53 protein]; more ... | CTD | PMID:15837074 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Benzo(a)pyrene results in decreased expression of BRCA1 mRNA] | CTD | PMID:11782367 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70502 | 6480464 | pifithrin inhibits the reaction [Benzo(a)pyrene results in increased expression of TP53 protein] | CTD | PMID:16258175 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70502 | 6480464 | Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased expression of TP53 protein] | CTD | PMID:16041517 |
| benzo[a]pyrene | increases phosphorylation | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased phosphorylation of TP53 protein | CTD | PMID:15837074 |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 mRNA | CTD | PMID:19027820 |
| benzo[a]pyrene | increases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:15808406 more ... |
| benzo[a]pyrene | increases activity | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased activity of TP53 protein | CTD | PMID:12807757 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:15698582 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene promotes the reaction [TP53 protein binds to MDM2 protein]; more ... | CTD | PMID:15625077 |
| benzo[a]pyrene | affects activity | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene affects the activity of TP53 protein | CTD | PMID:20624995 |
| benzo[a]pyrene | decreases expression | ISO | RGD:70502 | 6480464 | Benzo(a)pyrene results in decreased expression of TP53 mRNA | CTD | PMID:18247414 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70502 | 6480464 | Acrolein inhibits the reaction [Benzo(a)pyrene results in increased activity of TP53 protein]; more ... | CTD | PMID:12807757 |
| benzo[a]pyrene | affects localization | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene affects the localization of TRP53 protein | CTD | PMID:17240030 PMID:9006915 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11440 | 6480464 | alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene affects the localization of TRP53 protein] | CTD | PMID:9006915 |
| benzo[a]pyrene | increases phosphorylation | ISO | RGD:11440 | 6480464 | Benzo(a)pyrene results in increased phosphorylation of TRP53 protein | CTD | PMID:19041363 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of TP53 protein | CTD | PMID:20064080 more ... |
| benzo[b]fluoranthene | increases expression | ISO | RGD:70502 | 6480464 | benzo(b)fluoranthene results in increased expression of TP53 protein | CTD | PMID:21776270 |
| berberine | increases expression | ISO | RGD:70502 | 6480464 | Berberine results in increased expression of TP53 protein; more ... | CTD | PMID:20656010 |
| beryllium sulfate | multiple interactions | ISO | RGD:70502 | 6480464 | beryllium sulfate promotes the reaction [TP53 protein binds to CDKN1A promoter] | CTD | PMID:17395767 |
| beryllium sulfate | increases expression | ISO | RGD:70502 | 6480464 | beryllium sulfate results in increased expression of TP53 protein | CTD | PMID:17395767 PMID:20974702 |
| beryllium sulfate | increases expression | ISO | RGD:70502 | 6480464 | beryllium sulfate results in increased expression of TP53 protein | CTD | PMID:20974702 PMID:17395767 |
| bicalutamide | increases expression | ISO | RGD:70502 | 6480464 | bicalutamide results in increased expression of TP53 protein | CTD | PMID:15638997 |
| bifenthrin | increases expression | ISO | RGD:11440 | 6480464 | bifenthrin results in increased expression of TRP53 mRNA | CTD | PMID:20097460 |
| biphenyl-2-ol | multiple interactions | ISO | RGD:70502 | 6480464 | [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of TP53 gene; more ... | CTD | PMID:10334203 |
| biphenyl-4-amine | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to 4-biphenylamine | CTD | PMID:11804609 |
| biphenyl-4-amine | affects binding | ISO | RGD:70502 | 6480464 | 4-biphenylamine binds to TP53 gene | CTD | PMID:12376482 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:70502 | 6480464 | Mustard Gas results in increased expression of TP53 protein | CTD | PMID:11428642 PMID:9665388 |
| bis(2-chloroethyl) sulfide | increases phosphorylation | ISO | RGD:70502 | 6480464 | Mustard Gas results in increased phosphorylation of TP53 protein | CTD | PMID:19845377 more ... |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:70502 | 6480464 | Mustard Gas results in increased expression of TP53 protein | CTD | PMID:11428642 more ... |
| bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:70502 | 6480464 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Mustard Gas results in increased expression of TP53 protein]; more ... | CTD | PMID:22119920 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:11440 | 6480464 | Mustard Gas results in increased expression of TRP53 protein | CTD | PMID:19560481 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:70502 | 6480464 | Mustard Gas results in increased expression of TP53 protein | CTD | PMID:19748996 more ... |
| bis(2-chloroethyl) sulfide | increases phosphorylation | ISO | RGD:70502 | 6480464 | Mustard Gas results in increased phosphorylation of TP53 protein | CTD | PMID:19845377 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:70502 | 6480464 | Mustard Gas results in increased expression of TP53 protein | CTD | PMID:11428642 more ... |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:70502 | 6480464 | Mustard Gas results in increased expression of TP53 protein | CTD | PMID:9665388 more ... |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:11440 | 6480464 | Diethylhexyl Phthalate inhibits the reaction [Selenomethionine results in decreased expression of TRP53 protein]; more ... | CTD | PMID:20659492 |
| bisphenol A | increases expression | ISO | RGD:70502 | 6480464 | bisphenol A results in increased expression of TP53 protein | CTD | PMID:21277958 |
| bleomycin A2 | increases expression | ISO | RGD:11440 | 6480464 | Bleomycin results in increased expression of TRP53 protein | CTD | PMID:9683175 |
| bleomycin A2 | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Bleomycin | CTD | PMID:20135637 |
| brassinolide | increases expression | ISO | RGD:70502 | 6480464 | brassinolide results in increased expression of TP53 protein | CTD | PMID:20833159 |
| bromochloroacetic acid | multiple interactions | EXP | | 6480464 | bromochloroacetic acid promotes the reaction [Bromates results in increased phosphorylation of TP53 protein] | CTD | PMID:21864635 |
| budesonide | decreases expression | ISO | RGD:70502 | 6480464 | Budesonide results in decreased expression of TP53 protein | CTD | PMID:15475437 |
| busulfan | multiple interactions | ISO | RGD:70502 | 6480464 | Busulfan affects the phosphorylation of and affects the activity of TP53 protein | CTD | PMID:16882877 |
| C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of TP53 mRNA | CTD | PMID:19167457 |
| C60 fullerene | multiple interactions | ISO | RGD:70502 | 6480464 | fullerene C60 analog results in increased phosphorylation of and results in increased expression of TP53 protein | CTD | PMID:20045429 |
| cadmium atom | increases expression | ISO | RGD:11440 | 6480464 | Cadmium results in increased expression of TRP53 protein | CTD | PMID:12189181 |
| cadmium atom | increases expression | ISO | RGD:11440 | 6480464 | Cadmium results in increased expression of TP53 protein | CTD | PMID:21467746 PMID:23095357 |
| cadmium atom | multiple interactions | EXP | | 6480464 | Cadmium results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:21467746 |
| cadmium atom | increases expression | ISO | RGD:11440 | 6480464 | Cadmium results in increased expression of TP53 protein | CTD | PMID:21467746 |
| cadmium atom | multiple interactions | EXP | | 6480464 | Cadmium results in increased expression of and results in increased ubiquitination of TP53 protein | CTD | PMID:18463101 |
| cadmium atom | increases phosphorylation | EXP | | 6480464 | Cadmium results in increased phosphorylation of TP53 protein | CTD | PMID:18463101 |
| cadmium atom | increases expression | ISO | RGD:70502 | 6480464 | Cadmium results in increased expression of TP53 protein | CTD | PMID:12189181 |
| cadmium atom | decreases activity | ISO | RGD:11440 | 6480464 | Cadmium results in decreased activity of TRP53 protein | CTD | PMID:10531375 |
| cadmium atom | increases activity | EXP | | 6480464 | Cadmium results in increased activity of TP53 protein | CTD | PMID:16730872 |
| cadmium atom | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Cadmium | CTD | PMID:17174997 |
| cadmium atom | multiple interactions | ISO | RGD:70502 | 6480464 | Cadmium results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:17174997 |
| cadmium atom | multiple interactions | ISO | RGD:70502 | 6480464 | Cadmium inhibits the reaction [Hydrogen Peroxide results in increased expression of and results in increased activity of TP53 protein]; more ... | CTD | PMID:10531375 |
| cadmium atom | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form inhibits the reaction [TNF results in increased susceptibility to Cadmium]; more ... | CTD | PMID:12189181 |
| cadmium dichloride | multiple interactions | ISO | RGD:70502 | 6480464 | Cadmium Chloride inhibits the reaction [Dactinomycin results in increased expression of and results in increased activity of TP53 protein]; more ... | CTD | PMID:10531375 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of TP53 protein | CTD | PMID:16600092 PMID:19615436 |
| cadmium dichloride | increases expression | ISO | RGD:11440 | 6480464 | Cadmium Chloride results in increased expression of TRP53 mRNA | CTD | PMID:15501611 more ... |
| cadmium dichloride | multiple interactions | ISO | RGD:11440 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of TRP53 mRNA | CTD | PMID:12135628 |
| cadmium dichloride | multiple interactions | ISO | RGD:11440 | 6480464 | Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TRP53 protein] | CTD | PMID:11516527 PMID:12135628 |
| cadmium dichloride | increases expression | ISO | RGD:11440 | 6480464 | Cadmium Chloride results in increased expression of TRP53 mRNA | CTD | PMID:22314386 more ... |
| cadmium dichloride | increases expression | ISO | RGD:11440 | 6480464 | Cadmium Chloride results in increased expression of TRP53 mRNA | CTD | PMID:18974090 |
| cadmium dichloride | increases expression | ISO | RGD:11440 | 6480464 | Cadmium Chloride results in increased expression of TRP53 mRNA | CTD | PMID:18974090 PMID:22314386 |
| cadmium dichloride | increases expression | ISO | RGD:11440 | 6480464 | Cadmium Chloride results in increased expression of TRP53 protein | CTD | PMID:22314386 |
| cadmium dichloride | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the susceptibility to Cadmium Chloride | CTD | PMID:21252392 |
| cadmium dichloride | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein affects the reaction [Cadmium Chloride results in increased expression of CASP3 protein modified form] | CTD | PMID:21252392 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:11440 | 6480464 | Cadmium Chloride results in increased phosphorylation of TRP53 protein | CTD | PMID:19887573 |
| cadmium dichloride | decreases activity | ISO | RGD:11440 | 6480464 | Cadmium Chloride results in decreased activity of TRP53 protein | CTD | PMID:10531375 |
| cadmium dichloride | multiple interactions | ISO | RGD:11440 | 6480464 | CAT protein inhibits the reaction [Cadmium Chloride results in increased phosphorylation of TRP53 protein]; more ... | CTD | PMID:19887573 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Selenium inhibits the reaction [Cadmium Chloride results in increased expression of TP53 protein] | CTD | PMID:16600092 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of TP53 protein | CTD | PMID:16600092 |
| cadmium dichloride | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Cadmium Chloride | CTD | PMID:17174997 |
| cadmium dichloride | increases activity | EXP | | 6480464 | Cadmium Chloride results in increased activity of TP53 protein | CTD | PMID:16730872 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cadmium Chloride results in increased phosphorylation of TP53 protein | CTD | PMID:12676607 |
| cadmium dichloride | increases expression | ISO | RGD:70502 | 6480464 | Cadmium Chloride results in increased expression of TP53 protein | CTD | PMID:12676607 |
| cadmium dichloride | multiple interactions | ISO | RGD:70502 | 6480464 | Cadmium Chloride results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:17174997 |
| caffeine | multiple interactions | ISO | RGD:70502 | 6480464 | Caffeine inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of TP53 protein] | CTD | PMID:22226932 |
| caffeine | multiple interactions | ISO | RGD:11440 | 6480464 | Caffeine results in increased phosphorylation of and results in increased activity of TRP53 protein | CTD | PMID:12907610 |
| caffeine | decreases mutagenesis | ISO | RGD:11440 | 6480464 | Caffeine results in decreased mutagenesis of TRP53 gene | CTD | PMID:15975959 |
| caffeine | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [Diethylnitrosamine results in increased expression of TP53 protein]; more ... | CTD | PMID:11751435 |
| caffeine | increases phosphorylation | ISO | RGD:70502 | 6480464 | Caffeine results in increased phosphorylation of TP53 protein | CTD | PMID:12811820 |
| caffeine | multiple interactions | ISO | RGD:70502 | 6480464 | Caffeine inhibits the reaction [oxaliplatin results in increased expression of TP53 protein modified form] | CTD | PMID:19735649 |
| caffeine | multiple interactions | ISO | RGD:70502 | 6480464 | Caffeine inhibits the reaction [silybin results in increased phosphorylation of TP53 protein] | CTD | PMID:16777994 |
| caffeine | multiple interactions | ISO | RGD:70502 | 6480464 | Caffeine inhibits the reaction [Nitric Oxide results in increased phosphorylation of TP53 protein]; more ... | CTD | PMID:16024610 |
| caffeine | multiple interactions | ISO | RGD:70502 | 6480464 | Caffeine inhibits the reaction [kaempferol results in increased phosphorylation of TP53 protein] | CTD | PMID:19028473 |
| caffeine | multiple interactions | ISO | RGD:70502 | 6480464 | Caffeine inhibits the reaction [Cytarabine results in increased expression of TP53 protein]; more ... | CTD | PMID:17977830 |
| caffeine | multiple interactions | ISO | RGD:70502 | 6480464 | Caffeine inhibits the reaction [bortezomib results in increased phosphorylation of TP53 protein] | CTD | PMID:12393500 |
| calcitriol | increases expression | ISO | RGD:70502 | 6480464 | Calcitriol results in increased expression of TP53 protein | CTD | PMID:12071473 |
| calcium atom | decreases expression | ISO | RGD:70502 | 6480464 | Calcium results in decreased expression of TP53 protein | CTD | PMID:16043423 |
| calcium atom | affects localization | ISO | RGD:70502 | 6480464 | TP53 protein affects the localization of Calcium | CTD | PMID:15059885 |
| calcium(0) | decreases expression | ISO | RGD:70502 | 6480464 | Calcium results in decreased expression of TP53 protein | CTD | PMID:16043423 |
| calcium(0) | affects localization | ISO | RGD:70502 | 6480464 | TP53 protein affects the localization of Calcium | CTD | PMID:15059885 |
| camptothecin | increases expression | ISO | RGD:70502 | 6480464 | Camptothecin results in increased expression of TP53 protein | CTD | PMID:20978201 more ... |
| camptothecin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Camptothecin | CTD | PMID:23285096 PMID:9673414 |
| camptothecin | increases expression | ISO | RGD:70502 | 6480464 | Camptothecin results in increased expression of TP53 protein | CTD | PMID:12082016 more ... |
| camptothecin | increases expression | ISO | RGD:70502 | 6480464 | Camptothecin results in increased expression of TP53 protein | CTD | PMID:19481069 more ... |
| camptothecin | increases expression | ISO | RGD:70502 | 6480464 | Camptothecin results in increased expression of TP53 protein | CTD | PMID:9673414 more ... |
| camptothecin | increases expression | ISO | RGD:70502 | 6480464 | Camptothecin results in increased expression of TP53 protein | CTD | PMID:12082016 more ... |
| camptothecin | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [Camptothecin results in increased activity of TP53 protein] | CTD | PMID:13679428 PMID:11279278 |
| camptothecin | increases phosphorylation | EXP | | 6480464 | Camptothecin results in increased phosphorylation of TP53 protein | CTD | PMID:13679428 |
| camptothecin | increases activity | EXP | | 6480464 | Camptothecin results in increased activity of TP53 protein | CTD | PMID:11279278 PMID:13679428 |
| camptothecin | multiple interactions | EXP | | 6480464 | Camptothecin promotes the reaction [TP53 protein binds to CREBBP protein]; more ... | CTD | PMID:13679428 |
| camptothecin | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein mutant form results in decreased susceptibility to Camptothecin | CTD | PMID:10692111 |
| camptothecin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Camptothecin | CTD | PMID:9673414 |
| camptothecin | multiple interactions | ISO | RGD:70502 | 6480464 | Camptothecin results in increased stability of and results in increased expression of and results in increased phosphorylation of and results in increased activity of TP53 protein | CTD | PMID:11741290 |
| camptothecin | increases glutathionylation | ISO | RGD:70502 | 6480464 | Camptothecin results in increased glutathionylation of TP53 protein | CTD | PMID:17555331 |
| camptothecin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Camptothecin results in increased phosphorylation of TP53 protein | CTD | PMID:17555331 |
| camptothecin | increases expression | ISO | RGD:70502 | 6480464 | Camptothecin results in increased expression of TP53 protein | CTD | PMID:12082016 more ... |
| camptothecin | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [Camptothecin results in increased expression of TP53 protein modified form]; more ... | CTD | PMID:17555331 |
| camptothecin | multiple interactions | ISO | RGD:70502 | 6480464 | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Camptothecin results in increased expression of TP53 protein] | CTD | PMID:19481069 |
| camptothecin | increases expression | ISO | RGD:70502 | 6480464 | Camptothecin results in increased expression of TP53 protein | CTD | PMID:17555331 more ... |
| camptothecin | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [Camptothecin results in increased activity of TP53 protein] | CTD | PMID:11279278 PMID:13679428 |
| camptothecin | increases activity | EXP | | 6480464 | Camptothecin results in increased activity of TP53 protein | CTD | PMID:13679428 PMID:11279278 |
| candesartan | increases expression | EXP | | 6480464 | candesartan results in increased expression of TP53 mRNA; more ... | CTD | PMID:11409658 |
| capsaicin | increases expression | ISO | RGD:70502 | 6480464 | Capsaicin results in increased expression of TP53 protein | CTD | PMID:16540674 more ... |
| capsaicin | increases expression | ISO | RGD:70502 | 6480464 | Capsaicin results in increased expression of TP53 protein | CTD | PMID:16540674 more ... |
| capsaicin | multiple interactions | ISO | RGD:70502 | 6480464 | Capsaicin results in increased phosphorylation of and results in increased expression of TP53 protein | CTD | PMID:19502594 PMID:19139269 |
| capsaicin | increases expression | ISO | RGD:70502 | 6480464 | Capsaicin results in increased expression of TP53 protein | CTD | PMID:18991268 more ... |
| capsaicin | increases expression | ISO | RGD:70502 | 6480464 | Capsaicin results in increased expression of TP53 mRNA | CTD | PMID:9461043 PMID:19502594 |
| capsaicin | increases expression | ISO | RGD:70502 | 6480464 | Capsaicin results in increased expression of TP53 protein | CTD | PMID:19846903 more ... |
| capsaicin | increases expression | ISO | RGD:70502 | 6480464 | Capsaicin results in increased expression of TP53 protein | CTD | PMID:18991268 PMID:20646592 |
| capsaicin | increases expression | ISO | RGD:11440 | 6480464 | Capsaicin results in increased expression of TRP53 | CTD | PMID:20069556 |
| capsaicin | increases expression | ISO | RGD:70502 | 6480464 | Capsaicin results in increased expression of TP53 mRNA | CTD | PMID:19502594 |
| capsaicin | increases expression | ISO | RGD:70502 | 6480464 | Capsaicin results in increased expression of TP53 protein | CTD | PMID:20646592 PMID:18991268 |
| capsaicin | decreases degradation | ISO | RGD:70502 | 6480464 | Capsaicin results in decreased degradation of TP53 protein | CTD | PMID:17292493 |
| capsaicin | multiple interactions | ISO | RGD:70502 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Capsaicin results in increased expression of and results in increased phosphorylation of and results in increased activity of TP53 protein]; more ... | CTD | PMID:17292493 |
| capsaicin | multiple interactions | ISO | RGD:70502 | 6480464 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased expression of TP53 protein] | CTD | PMID:19502594 |
| capsaicin | increases degradation | ISO | RGD:70502 | 6480464 | Capsaicin results in increased degradation of TP53 protein | CTD | PMID:19699254 |
| capsaicin | multiple interactions | ISO | RGD:70502 | 6480464 | Capsaicin promotes the reaction [resveratrol results in increased expression of TP53 protein]; more ... | CTD | PMID:19846903 |
| capsaicin | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [Capsaicin results in increased phosphorylation of TP53 protein]; more ... | CTD | PMID:14871840 |
| capsaicin | multiple interactions | ISO | RGD:70502 | 6480464 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of TP53 protein]; more ... | CTD | PMID:22226932 |
| capsaicin | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 affects the susceptibility to Capsaicin | CTD | PMID:19846903 |
| capsaicin | multiple interactions | ISO | RGD:70502 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Capsaicin results in increased degradation of TP53 protein]; more ... | CTD | PMID:19699254 |
| capsaicin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Capsaicin results in increased phosphorylation of TP53 protein | CTD | PMID:14871840 |
| capsaicin | multiple interactions | ISO | RGD:70502 | 6480464 | Capsaicin results in increased phosphorylation of and results in increased expression of TP53 protein | CTD | PMID:19139269 PMID:19502594 |
| capsaicin | increases expression | ISO | RGD:70502 | 6480464 | Capsaicin results in increased expression of TP53 mRNA | CTD | PMID:19502594 PMID:9461043 |
| carbachol | multiple interactions | ISO | RGD:11440 | 6480464 | Carbachol inhibits the reaction [APP protein modified form results in increased expression of TRP53 protein] | CTD | PMID:10758335 |
| carbofuran | multiple interactions | ISO | RGD:70502 | 6480464 | Carbofuran results in decreased stability of and results in increased degradation of and results in increased mutagenesis of TP53 gene | CTD | PMID:22445671 |
| carboplatin | increases expression | ISO | RGD:70502 | 6480464 | Carboplatin results in increased expression of TP53 protein | CTD | PMID:9664115 |
| carboplatin | increases expression | ISO | RGD:70502 | 6480464 | Carboplatin results in increased expression of TP53 protein | CTD | PMID:15131059 PMID:9664115 |
| carmustine | increases expression | ISO | RGD:70502 | 6480464 | Carmustine results in increased expression of TP53 protein | CTD | PMID:15735757 more ... |
| carmustine | increases expression | ISO | RGD:70502 | 6480464 | Carmustine results in increased expression of TP53 protein | CTD | PMID:16193384 more ... |
| carmustine | increases expression | ISO | RGD:70502 | 6480464 | Carmustine results in increased expression of TP53 protein | CTD | PMID:18632648 more ... |
| carmustine | increases expression | ISO | RGD:70502 | 6480464 | Carmustine results in increased expression of TP53 protein | CTD | PMID:18632648 more ... |
| carmustine | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 results in increased susceptibility to Carmustine | CTD | PMID:10455409 |
| carmustine | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in decreased susceptibility to Carmustine | CTD | PMID:16193384 |
| carmustine | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein modified form affects the susceptibility to Carmustine | CTD | PMID:11861384 |
| carmustine | multiple interactions | ISO | RGD:70502 | 6480464 | MDM4 protein promotes the reaction [Carmustine results in increased expression of TP53 protein] | CTD | PMID:20472715 |
| carmustine | increases expression | ISO | RGD:70502 | 6480464 | Carmustine results in increased expression of TP53 protein | CTD | PMID:15735757 more ... |
| carmustine | multiple interactions | ISO | RGD:70502 | 6480464 | [Carmustine co-treated with O(6)-benzylguanine] results in increased expression of TP53 protein | CTD | PMID:15735757 |
| carvedilol | affects expression | EXP | | 6480464 | carvedilol affects the expression of TP53 protein | CTD | PMID:22000973 |
| cefalotin | increases expression | ISO | RGD:70502 | 6480464 | Cephalothin results in increased expression of TP53 protein | CTD | PMID:15012731 |
| cefotaxime | increases expression | ISO | RGD:70502 | 6480464 | Cefotaxime results in increased expression of TP53 protein | CTD | PMID:15012731 |
| celecoxib | multiple interactions | ISO | RGD:70502 | 6480464 | [FEC protocol co-treated with celecoxib] results in decreased expression of TP53 protein | CTD | PMID:16507397 |
| celecoxib | multiple interactions | ISO | RGD:70502 | 6480464 | celecoxib results in increased expression of and results in increased phosphorylation of TP53 protein; more ... | CTD | PMID:18760266 |
| celecoxib | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 results in increased susceptibility to celecoxib | CTD | PMID:19706164 |
| celecoxib | increases expression | ISO | RGD:70502 | 6480464 | celecoxib results in increased expression of TP53 protein | CTD | PMID:19706164 |
| celecoxib | multiple interactions | ISO | RGD:70502 | 6480464 | celecoxib results in increased activity of and results in increased localization of TP53 protein; more ... | CTD | PMID:19706164 |
| celecoxib | multiple interactions | ISO | RGD:11440 | 6480464 | celecoxib promotes the reaction [Doxorubicin results in increased expression of TRP53 protein] | CTD | PMID:15458769 |
| celecoxib | multiple interactions | ISO | RGD:11440 | 6480464 | [celecoxib co-treated with docetaxel] results in increased expression of TRP53 protein | CTD | PMID:16052515 |
| celecoxib | increases expression | ISO | RGD:70502 | 6480464 | celecoxib results in increased expression of TP53 mRNA | CTD | PMID:18202791 |
| cetrorelix | increases expression | ISO | RGD:70502 | 6480464 | cetrorelix results in increased expression of TP53 protein | CTD | PMID:21062912 |
| chlorambucil | increases expression | ISO | RGD:70502 | 6480464 | Chlorambucil results in increased expression of TP53 | CTD | PMID:8822937 |
| chlorambucil | multiple interactions | ISO | RGD:70502 | 6480464 | IL4 protein inhibits the reaction [[Theophylline co-treated with Chlorambucil] results in increased expression of TP53] | CTD | PMID:8822937 |
| chlorambucil | increases expression | ISO | RGD:70502 | 6480464 | Chlorambucil results in increased expression of TP53 protein | CTD | PMID:18092340 |
| chloroethene | multiple interactions | ISO | RGD:70502 | 6480464 | CYP2E1 gene polymorphism promotes the reaction [Vinyl Chloride affects the mutagenesis of TP53 gene] | CTD | PMID:12705718 |
| chloroethene | decreases expression | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in decreased expression of TP53 mRNA | CTD | PMID:22076037 |
| chloroethene | increases expression | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in increased expression of TP53 protein | CTD | PMID:12670519 more ... |
| chloroethene | increases mutagenesis | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in increased mutagenesis of TP53 gene | CTD | PMID:17384900 more ... |
| chloroethene | increases expression | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in increased expression of TP53 protein | CTD | PMID:14979067 more ... |
| chloroethene | increases mutagenesis | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in increased mutagenesis of TP53 gene | CTD | PMID:12010862 more ... |
| chloroethene | increases mutagenesis | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in increased mutagenesis of TP53 gene | CTD | PMID:12010862 more ... |
| chloroethene | increases expression | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in increased expression of TP53 protein | CTD | PMID:12670519 more ... |
| chloroethene | increases mutagenesis | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in increased mutagenesis of TP53 gene | CTD | PMID:16881598 more ... |
| chloroethene | increases expression | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in increased expression of TP53 protein | CTD | PMID:16474264 more ... |
| chloroethene | multiple interactions | ISO | RGD:70502 | 6480464 | XRCC1 gene polymorphism promotes the reaction [Vinyl Chloride results in increased mutagenesis of TP53 gene] | CTD | PMID:16881598 PMID:12010862 |
| chloroethene | increases mutagenesis | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in increased mutagenesis of TP53 gene | CTD | PMID:16881598 more ... |
| chloroethene | multiple interactions | ISO | RGD:70502 | 6480464 | CYP2E1 gene polymorphism promotes the reaction [Vinyl Chloride results in increased mutagenesis of TP53 gene] | CTD | PMID:12010862 PMID:17384900 |
| chloroethene | multiple interactions | ISO | RGD:70502 | 6480464 | XRCC1 gene polymorphism promotes the reaction [Vinyl Chloride affects the mutagenesis of TP53 gene] | CTD | PMID:14602524 |
| chloroethene | multiple interactions | ISO | RGD:70502 | 6480464 | XRCC1 gene polymorphism promotes the reaction [Vinyl Chloride results in increased mutagenesis of TP53 gene] | CTD | PMID:12010862 PMID:16881598 |
| chloroethene | increases mutagenesis | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in increased mutagenesis of TP53 gene | CTD | PMID:12670519 more ... |
| chloroethene | increases expression | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in increased expression of TP53 protein | CTD | PMID:16474264 more ... |
| chloroethene | increases expression | ISO | RGD:70502 | 6480464 | Vinyl Chloride results in increased expression of TP53 protein mutant form | CTD | PMID:16474264 |
| chloroethene | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 gene SNP results in increased susceptibility to Vinyl Chloride | CTD | PMID:18226366 |
| chloroethene | multiple interactions | ISO | RGD:70502 | 6480464 | GSTM1 gene polymorphism affects the reaction [XRCC1 gene polymorphism affects the reaction [Vinyl Chloride affects the mutagenesis of TP53 gene]]; more ... | CTD | PMID:16097394 |
| chloroethene | multiple interactions | ISO | RGD:70502 | 6480464 | CYP2E1 gene polymorphism promotes the reaction [Vinyl Chloride results in increased mutagenesis of TP53 gene] | CTD | PMID:17384900 PMID:12010862 |
| chloroform | increases expression | EXP | | 6480464 | Chloroform results in increased expression of TP53 mRNA | CTD | PMID:17522070 |
| chloroform | increases phosphorylation | EXP | | 6480464 | Chloroform results in increased phosphorylation of TP53 protein | CTD | PMID:8076368 |
| chloroform | increases phosphorylation | ISO | RGD:70502 | 6480464 | Chloroform results in increased phosphorylation of TP53 protein | CTD | PMID:8076368 |
| chloropicrin | increases expression | ISO | RGD:70502 | 6480464 | chloropicrin results in increased expression of TP53 protein | CTD | PMID:22516760 |
| chloroquine | increases activity | ISO | RGD:70502 | 6480464 | Chloroquine results in increased activity of TP53 | CTD | PMID:18089834 |
| chloroquine | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 mutant form inhibits the reaction [Chloroquine results in increased activity of CASP3 protein] | CTD | PMID:11589424 |
| chloroquine | increases activity | ISO | RGD:70502 | 6480464 | Chloroquine results in increased activity of TP53 protein | CTD | PMID:12082016 |
| chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of TP53 mRNA | CTD | PMID:12464398 PMID:17452286 |
| chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of TP53 mRNA | CTD | PMID:17452286 PMID:12464398 |
| choline | decreases expression | EXP | | 6480464 | Choline results in decreased expression of TP53 mRNA | CTD | PMID:16014740 |
| choline | decreases expression | ISO | RGD:11440 | 6480464 | Choline results in decreased expression of TRP53 mRNA | CTD | PMID:16014740 |
| chromium atom | increases activity | ISO | RGD:70502 | 6480464 | Chromium results in increased activity of TP53 protein | CTD | PMID:14971653 |
| chromium atom | multiple interactions | ISO | RGD:70502 | 6480464 | RAS protein promotes the reaction [Chromium results in increased activity of TP53 protein] | CTD | PMID:14971653 |
| chromium(6+) | increases response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein results in increased susceptibility to chromium hexavalent ion | CTD | PMID:12324196 |
| chromium(6+) | decreases expression | ISO | RGD:70502 | 6480464 | chromium hexavalent ion results in decreased expression of TP53 protein | CTD | PMID:22666341 |
| chrysene | multiple interactions | ISO | RGD:11440 | 6480464 | chrysene promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 protein] | CTD | PMID:22120587 |
| chrysene | increases expression | ISO | RGD:11440 | 6480464 | chrysene results in increased expression of TRP53 protein | CTD | PMID:22120587 |
| cidofovir anhydrous | increases expression | ISO | RGD:70502 | 6480464 | cidofovir results in increased expression of TP53 protein | CTD | PMID:11697818 |
| cilostazol | increases expression | ISO | RGD:70502 | 6480464 | cilostazol results in increased expression of TP53 protein | CTD | PMID:10642304 |
| cilostazol | multiple interactions | EXP | | 6480464 | cilostazol inhibits the reaction [Nitroprusside results in increased phosphorylation of TP53 protein] | CTD | PMID:18311796 |
| cis-caffeic acid | affects expression | ISO | RGD:70502 | 6480464 | caffeic acid affects the expression of TP53 protein | CTD | PMID:11522280 |
| cis-caffeic acid | multiple interactions | ISO | RGD:70502 | 6480464 | caffeic acid promotes the reaction [Thapsigargin results in decreased expression of TP53 mRNA] | CTD | PMID:19442820 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one promotes the reaction [Cisplatin results in increased localization of TP53 protein mutant form]; more ... | CTD | PMID:21109480 |
| cisplatin | increases expression | ISO | RGD:11440 | 6480464 | Cisplatin results in increased expression of TRP53 protein | CTD | PMID:18558085 more ... |
| cisplatin | multiple interactions | ISO | RGD:11440 | 6480464 | ABCB1 protein promotes the reaction [Cisplatin results in increased expression of TRP53 protein] | CTD | PMID:22269388 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | ABCB1 protein promotes the reaction [Cisplatin results in increased expression of TRP53 protein] | CTD | PMID:22269388 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Cisplatin results in increased expression of XPC protein]; more ... | CTD | PMID:22331493 |
| cisplatin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Cisplatin | CTD | PMID:16193384 more ... |
| cisplatin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cisplatin results in increased phosphorylation of TP53 protein | CTD | PMID:20145152 more ... |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 | CTD | PMID:15496615 more ... |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 protein | CTD | PMID:12082016 more ... |
| cisplatin | increases phosphorylation | ISO | RGD:11440 | 6480464 | Cisplatin results in increased phosphorylation of TRP53 protein | CTD | PMID:20883750 more ... |
| cisplatin | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Cisplatin | CTD | PMID:22331493 |
| cisplatin | multiple interactions | ISO | RGD:11440 | 6480464 | [2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased activity of ATM protein] inhibits the reaction [Cisplatin results in increased phosphorylation of TRP53 protein]; more ... | CTD | PMID:22003191 |
| cisplatin | increases expression | ISO | RGD:11440 | 6480464 | Cisplatin results in increased expression of TRP53 protein | CTD | PMID:20510337 more ... |
| cisplatin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Cisplatin | CTD | PMID:16193384 more ... |
| cisplatin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cisplatin results in increased phosphorylation of TP53 protein | CTD | PMID:21660965 more ... |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 protein | CTD | PMID:16601104 more ... |
| cisplatin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Cisplatin | CTD | PMID:16193384 more ... |
| cisplatin | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in decreased susceptibility to Cisplatin | CTD | PMID:15990222 PMID:16020667 |
| cisplatin | increases phosphorylation | ISO | RGD:11440 | 6480464 | Cisplatin results in increased phosphorylation of TRP53 protein | CTD | PMID:21285353 more ... |
| cisplatin | increases expression | ISO | RGD:11440 | 6480464 | Cisplatin results in increased expression of TRP53 protein | CTD | PMID:18558085 more ... |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 protein | CTD | PMID:21429301 more ... |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | MIR630 mRNA inhibits the reaction [Cisplatin results in increased phosphorylation of TP53 protein] | CTD | PMID:20145152 |
| cisplatin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cisplatin results in increased phosphorylation of TP53 protein | CTD | PMID:21285353 more ... |
| cisplatin | increases phosphorylation | ISO | RGD:11440 | 6480464 | Cisplatin results in increased phosphorylation of TRP53 protein | CTD | PMID:21552291 more ... |
| cisplatin | increases expression | ISO | RGD:11440 | 6480464 | Cisplatin results in increased expression of TRP53 mRNA | CTD | PMID:19428948 more ... |
| cisplatin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Cisplatin | CTD | PMID:16211088 more ... |
| cisplatin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cisplatin results in increased phosphorylation of TP53 protein | CTD | PMID:21552291 more ... |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 protein | CTD | PMID:16601104 more ... |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 | CTD | PMID:21880462 more ... |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 protein | CTD | PMID:21624110 more ... |
| cisplatin | increases phosphorylation | ISO | RGD:11440 | 6480464 | Cisplatin results in increased phosphorylation of TRP53 protein | CTD | PMID:20883750 more ... |
| cisplatin | increases expression | ISO | RGD:11440 | 6480464 | Cisplatin results in increased expression of TRP53 mRNA | CTD | PMID:20883750 more ... |
| cisplatin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Cisplatin | CTD | PMID:21447800 more ... |
| cisplatin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cisplatin results in increased phosphorylation of TP53 protein | CTD | PMID:21552291 more ... |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 mRNA | CTD | PMID:20878077 PMID:15454482 |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 | CTD | PMID:21880462 more ... |
| cisplatin | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the susceptibility to Cisplatin | CTD | PMID:12185594 PMID:17670903 |
| cisplatin | increases phosphorylation | ISO | RGD:11440 | 6480464 | Cisplatin results in increased phosphorylation of TRP53 protein | CTD | PMID:21552291 more ... |
| cisplatin | increases expression | ISO | RGD:11440 | 6480464 | Cisplatin results in increased expression of TRP53 protein | CTD | PMID:20510337 more ... |
| cisplatin | increases expression | ISO | RGD:11440 | 6480464 | Cisplatin results in increased expression of TRP53 mRNA | CTD | PMID:20702592 more ... |
| cisplatin | decreases expression | ISO | RGD:11440 | 6480464 | Cisplatin results in decreased expression of TRP53 protein | CTD | PMID:20566416 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | AMN protein inhibits the reaction [Cisplatin results in increased expression of TRP53 protein] | CTD | PMID:20514524 |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TRP53 protein | CTD | PMID:20514524 |
| cisplatin | multiple interactions | EXP | | 6480464 | Pravastatin inhibits the reaction [Cisplatin results in increased expression of TP53 protein] | CTD | PMID:20650967 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of TP53 protein | CTD | PMID:20650967 |
| cisplatin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Cisplatin | CTD | PMID:16193384 more ... |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein inhibits the reaction [ESR2 protein results in increased susceptibility to Cisplatin] | CTD | PMID:20623183 |
| cisplatin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cisplatin results in increased phosphorylation of TP53 protein | CTD | PMID:21532991 more ... |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 protein | CTD | PMID:21624110 more ... |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 mRNA | CTD | PMID:15454482 PMID:20878077 |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 | CTD | PMID:21552291 more ... |
| cisplatin | increases response to substance | EXP | | 6480464 | TP53 protein results in increased susceptibility to Cisplatin | CTD | PMID:15315938 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin results in increased phosphorylation of and results in increased stability of TP53 protein | CTD | PMID:18310471 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin results in increased expression of and results in increased phosphorylation of and results in increased activity of TP53 protein; more ... | CTD | PMID:15315938 |
| cisplatin | increases acetylation | EXP | | 6480464 | Cisplatin results in increased acetylation of TP53 protein | CTD | PMID:21416250 |
| cisplatin | increases phosphorylation | ISO | RGD:11440 | 6480464 | Cisplatin results in increased phosphorylation of TP53 protein | CTD | PMID:21151649 |
| cisplatin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 results in increased susceptibility to Cisplatin | CTD | PMID:21258400 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to [Fluorouracil co-treated with Cisplatin] | CTD | PMID:15254702 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to [Cisplatin co-treated with Fluorouracil] | CTD | PMID:16077963 |
| cisplatin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Cisplatin | CTD | PMID:16211088 more ... |
| cisplatin | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in decreased susceptibility to Cisplatin | CTD | PMID:16020667 PMID:15990222 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Y 27632 results in decreased susceptibility to Cisplatin]; more ... | CTD | PMID:20878077 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Cisplatin results in increased expression of PMAIP1 mRNA] | CTD | PMID:17216584 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | [TP53 protein binds to MDM2 protein] which results in decreased susceptibility to Cisplatin | CTD | PMID:21509038 |
| cisplatin | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein modified form affects the susceptibility to Cisplatin | CTD | PMID:11861384 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to [Fluorouracil co-treated with Cisplatin] | CTD | PMID:15999354 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Cisplatin results in increased susceptibility to TNFSF10 protein] | CTD | PMID:21152876 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Cisplatin results in increased degradation of HIF1A protein] | CTD | PMID:17498666 |
| cisplatin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 mutant form results in increased susceptibility to Cisplatin | CTD | PMID:21875941 |
| cisplatin | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 gene mutant form results in decreased susceptibility to Cisplatin | CTD | PMID:15578696 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | [TFAP2A protein co-treated with TP53 gene mutant form] results in decreased susceptibility to Cisplatin | CTD | PMID:21489314 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | RAD23B mutant form inhibits the reaction [Cisplatin results in increased expression of TP53 protein] | CTD | PMID:21742020 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Piroxicam promotes the reaction [Cisplatin results in increased expression of TP53 protein] | CTD | PMID:21858171 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | [nutlin 3 results in increased stability of TP53 protein] which results in increased susceptibility to Cisplatin | CTD | PMID:21205074 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | nutlin 3 promotes the reaction [Cisplatin results in increased expression of TP53 protein]; more ... | CTD | PMID:21624110 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Noscapine promotes the reaction [Cisplatin results in increased expression of TP53 protein] | CTD | PMID:20674069 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Nicotine inhibits the reaction [Cisplatin results in increased expression of TP53 protein] | CTD | PMID:16601104 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | MSH2 protein promotes the reaction [Cisplatin results in increased phosphorylation of TP53 protein] | CTD | PMID:21285353 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Cisplatin results in increased stability of and results in increased activity of TP53 protein | CTD | PMID:14562046 |
| cisplatin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cisplatin results in increased phosphorylation of TP53 protein | CTD | PMID:21285353 more ... |
| cisplatin | increases glutathionylation | ISO | RGD:70502 | 6480464 | Cisplatin results in increased glutathionylation of TP53 protein | CTD | PMID:17555331 |
| cisplatin | increases localization | ISO | RGD:70502 | 6480464 | Cisplatin results in increased localization of TP53 protein; more ... | CTD | PMID:21109480 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of TRP53 | CTD | PMID:21795690 |
| cisplatin | multiple interactions | ISO | RGD:11440 | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Cisplatin results in increased expression of TRP53 protein] | CTD | PMID:18558085 |
| cisplatin | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the susceptibility to Cisplatin | CTD | PMID:17670903 PMID:12185594 |
| cisplatin | multiple interactions | ISO | RGD:11440 | 6480464 | TIMD2 inhibits the reaction [Cisplatin results in increased expression of TRP53 protein] | CTD | PMID:20702592 |
| cisplatin | increases response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein results in increased susceptibility to Cisplatin | CTD | PMID:21552291 |
| cisplatin | multiple interactions | ISO | RGD:11440 | 6480464 | MSH2 protein promotes the reaction [Cisplatin results in increased phosphorylation of TRP53 protein] | CTD | PMID:21285353 |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 protein modified form | CTD | PMID:21274007 |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 protein | CTD | PMID:16193384 more ... |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 mRNA | CTD | PMID:20878077 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of and results in increased acetylation of TP53 protein; more ... | CTD | PMID:21660965 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of and affects the localization of TP53 protein | CTD | PMID:12807743 |
| cisplatin | increases expression | ISO | RGD:70502 | 6480464 | Cisplatin results in increased expression of TP53 | CTD | PMID:15496615 more ... |
| cisplatin | increases acetylation | ISO | RGD:70502 | 6480464 | Cisplatin results in increased acetylation of TP53 protein | CTD | PMID:21532991 |
| cisplatin | decreases phosphorylation | ISO | RGD:70502 | 6480464 | Cisplatin results in decreased phosphorylation of TP53 protein | CTD | PMID:15854392 |
| cisplatin | multiple interactions | ISO | RGD:11440 | 6480464 | coenzyme Q10 inhibits the reaction [Cisplatin results in increased expression of TRP53 protein] | CTD | PMID:20510337 |
| cisplatin | increases phosphorylation | ISO | RGD:11440 | 6480464 | Cisplatin results in increased phosphorylation of TRP53 protein | CTD | PMID:21633170 more ... |
| cisplatin | multiple interactions | ISO | RGD:11440 | 6480464 | Cisplatin results in increased phosphorylation of and results in increased expression of TRP53 protein; more ... | CTD | PMID:17670903 |
| cisplatin | increases expression | ISO | RGD:11440 | 6480464 | Cisplatin results in increased expression of TRP53 protein | CTD | PMID:20702592 more ... |
| cisplatin | increases expression | ISO | RGD:11440 | 6480464 | Cisplatin results in increased expression of TRP53 mRNA | CTD | PMID:19428948 more ... |
| cisplatin | increases expression | ISO | RGD:11440 | 6480464 | Cisplatin results in increased expression of TRP53 | CTD | PMID:21552291 |
| cisplatin | multiple interactions | ISO | RGD:11440 | 6480464 | Cisplatin results in increased expression of and results in increased phosphorylation of TRP53 protein | CTD | PMID:15983031 |
| cisplatin | increases acetylation | ISO | RGD:11440 | 6480464 | Cisplatin results in increased acetylation of TRP53 protein | CTD | PMID:21593185 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Cisplatin promotes the reaction [TP53 protein results in increased expression of BBC3 mRNA]; more ... | CTD | PMID:21532991 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Cisplatin promotes the reaction [TP53 protein binds to STK17A promoter]; more ... | CTD | PMID:21489989 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Cisplatin promotes the reaction [TP53 protein binds to MDM2 promoter]; more ... | CTD | PMID:21552291 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | [Cisplatin co-treated with fisetin] results in increased expression of TP53 protein; more ... | CTD | PMID:21216935 |
| cisplatin | affects localization | ISO | RGD:70502 | 6480464 | Cisplatin affects the localization of TP53 protein | CTD | PMID:21858171 |
| cisplatin | multiple interactions | ISO | RGD:11440 | 6480464 | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [Cisplatin results in increased acetylation of TRP53 protein]]; more ... | CTD | PMID:21593185 |
| cisplatin | multiple interactions | ISO | RGD:11440 | 6480464 | Cisplatin promotes the reaction [TRP53 protein results in increased expression of BAX]; more ... | CTD | PMID:21552291 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | BRCA1 mutant form promotes the reaction [RRM2 mutant form promotes the reaction [TP53 mutant form promotes the reaction [Cisplatin results in increased phosphorylation of H2AFX protein]]]; more ... | CTD | PMID:21875941 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | [ATR co-treated with TP53] results in decreased susceptibility to Cisplatin | CTD | PMID:21258400 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Ascorbic Acid promotes the reaction [Cisplatin results in increased expression of TP53 protein] | CTD | PMID:21429301 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased glutathionylation of TP53 protein] | CTD | PMID:17555331 |
| cisplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of TP53] | CTD | PMID:15496615 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TP53 mRNA | CTD | PMID:17602206 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of TP53 mRNA | CTD | PMID:17602206 |
| clotrimazole | increases expression | ISO | RGD:70502 | 6480464 | Clotrimazole results in increased expression of TP53 protein | CTD | PMID:10223459 |
| clozapine | increases expression | ISO | RGD:70502 | 6480464 | Clozapine results in increased expression of TP53 mRNA | CTD | PMID:16160616 |
| clozapine | multiple interactions | ISO | RGD:70502 | 6480464 | CSF3 protein inhibits the reaction [Clozapine results in increased expression of TP53 mRNA] | CTD | PMID:16160616 |
| cobalt atom | increases expression | ISO | RGD:70502 | 6480464 | Cobalt results in increased expression of TP53 protein | CTD | PMID:21598295 |
| cobalt dichloride | multiple interactions | ISO | RGD:70502 | 6480464 | cobaltous chloride results in increased expression of and results in increased activity of TP53 protein; more ... | CTD | PMID:10951577 |
| cobalt dichloride | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 gene mutant form promotes the reaction [cobaltous chloride results in increased expression of HIF1A protein] | CTD | PMID:16527254 |
| cobalt dichloride | multiple interactions | ISO | RGD:70502 | 6480464 | peoniflorin inhibits the reaction [cobaltous chloride results in increased expression of TP53 mRNA] | CTD | PMID:22269387 |
| cobalt dichloride | increases expression | ISO | RGD:70502 | 6480464 | cobaltous chloride results in increased expression of TP53 mRNA | CTD | PMID:22269387 |
| cobalt dichloride | multiple interactions | ISO | RGD:70502 | 6480464 | cobaltous chloride inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein]; more ... | CTD | PMID:19714248 |
| cobalt dichloride | decreases expression | ISO | RGD:11440 | 6480464 | cobaltous chloride results in decreased expression of TRP53 mRNA | CTD | PMID:16772336 |
| cobalt dichloride | multiple interactions | EXP | | 6480464 | cobaltous chloride promotes the reaction [Diethylnitrosamine results in increased expression of TP53 protein] | CTD | PMID:11751435 |
| cobalt dichloride | increases expression | ISO | RGD:70502 | 6480464 | cobaltous chloride results in increased expression of TP53 protein | CTD | PMID:20974702 |
| cocaine | affects expression | ISO | RGD:11440 | 6480464 | Cocaine affects the expression of TRP53 mRNA | CTD | PMID:15681117 |
| coenzyme Q10 | multiple interactions | ISO | RGD:11440 | 6480464 | coenzyme Q10 inhibits the reaction [Cisplatin results in increased expression of TRP53 protein] | CTD | PMID:20510337 |
| copper atom | multiple interactions | ISO | RGD:70502 | 6480464 | [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of TP53 gene; more ... | CTD | PMID:10334203 |
| copper atom | increases expression | ISO | RGD:70502 | 6480464 | Copper results in increased expression of TP53 protein | CTD | PMID:15880691 PMID:20875833 |
| copper atom | multiple interactions | ISO | RGD:70502 | 6480464 | bathocuproine sulfonate inhibits the reaction [[pyrrolidine dithiocarbamic acid results in increased abundance of Copper] which results in increased oxidation of and results in increased expression of TP53 protein] | CTD | PMID:11964141 |
| copper atom | increases oxidation | ISO | RGD:70502 | 6480464 | Copper results in increased oxidation of TP53 protein | CTD | PMID:11964141 |
| copper atom | increases expression | ISO | RGD:70502 | 6480464 | Copper results in increased expression of TP53 protein | CTD | PMID:20875833 PMID:15880691 |
| copper atom | multiple interactions | ISO | RGD:70502 | 6480464 | [Copper results in increased activity of TP53 protein] which results in increased expression of EI24 mRNA; more ... | CTD | PMID:16391388 |
| copper atom | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Copper | CTD | PMID:15880691 |
| copper atom | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein inhibits the reaction [Copper results in increased phosphorylation of MAPK1 protein]; more ... | CTD | PMID:15880691 |
| copper atom | multiple interactions | ISO | RGD:70502 | 6480464 | [Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased expression of TP53 protein; more ... | CTD | PMID:17327230 |
| copper atom | decreases activity | ISO | RGD:70502 | 6480464 | Copper results in decreased activity of TP53 protein | CTD | PMID:16246896 |
| copper atom | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of TP53 protein | CTD | PMID:22276220 |
| copper atom | multiple interactions | ISO | RGD:70502 | 6480464 | [Thiosemicarbazones binds to Copper] which results in decreased activity of TP53 protein | CTD | PMID:20931265 |
| copper atom | increases expression | ISO | RGD:70502 | 6480464 | Copper results in increased expression of TP53 protein | CTD | PMID:20875833 |
| copper atom | multiple interactions | ISO | RGD:70502 | 6480464 | [N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of TP53 gene | CTD | PMID:11275476 |
| copper(0) | multiple interactions | ISO | RGD:70502 | 6480464 | [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of TP53 gene; more ... | CTD | PMID:10334203 |
| copper(0) | increases expression | ISO | RGD:70502 | 6480464 | Copper results in increased expression of TP53 protein | CTD | PMID:15880691 PMID:20875833 |
| copper(0) | multiple interactions | ISO | RGD:70502 | 6480464 | bathocuproine sulfonate inhibits the reaction [[pyrrolidine dithiocarbamic acid results in increased abundance of Copper] which results in increased oxidation of and results in increased expression of TP53 protein] | CTD | PMID:11964141 |
| copper(0) | increases oxidation | ISO | RGD:70502 | 6480464 | Copper results in increased oxidation of TP53 protein | CTD | PMID:11964141 |
| copper(0) | increases expression | ISO | RGD:70502 | 6480464 | Copper results in increased expression of TP53 protein | CTD | PMID:20875833 PMID:15880691 |
| copper(0) | multiple interactions | ISO | RGD:70502 | 6480464 | [Copper results in increased activity of TP53 protein] which results in increased expression of EI24 mRNA; more ... | CTD | PMID:16391388 |
| copper(0) | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Copper | CTD | PMID:15880691 |
| copper(0) | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein inhibits the reaction [Copper results in increased phosphorylation of MAPK1 protein]; more ... | CTD | PMID:15880691 |
| copper(0) | multiple interactions | ISO | RGD:70502 | 6480464 | [Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased expression of TP53 protein; more ... | CTD | PMID:17327230 |
| copper(0) | decreases activity | ISO | RGD:70502 | 6480464 | Copper results in decreased activity of TP53 protein | CTD | PMID:16246896 |
| copper(0) | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of TP53 protein | CTD | PMID:22276220 |
| copper(0) | multiple interactions | ISO | RGD:70502 | 6480464 | [Thiosemicarbazones binds to Copper] which results in decreased activity of TP53 protein | CTD | PMID:20931265 |
| copper(0) | increases expression | ISO | RGD:70502 | 6480464 | Copper results in increased expression of TP53 protein | CTD | PMID:20875833 |
| copper(0) | multiple interactions | ISO | RGD:70502 | 6480464 | [N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of TP53 gene | CTD | PMID:11275476 |
| copper(2+) sulfate | multiple interactions | ISO | RGD:70502 | 6480464 | Copper Sulfate results in increased phosphorylation of and results in increased expression of TP53 protein | CTD | PMID:15001399 |
| crocidolite asbestos | affects expression | ISO | RGD:70502 | 6480464 | Asbestos, Crocidolite affects the expression of TP53 mRNA | CTD | PMID:17331233 |
| crocidolite asbestos | multiple interactions | ISO | RGD:70502 | 6480464 | Asbestos, Crocidolite results in increased phosphorylation of and results in increased stability of TP53 protein | CTD | PMID:20705543 |
| crocidolite asbestos | increases response to substance | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form results in increased susceptibility to Asbestos, Crocidolite | CTD | PMID:18303189 PMID:12151629 |
| crocidolite asbestos | increases response to substance | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form results in increased susceptibility to Asbestos, Crocidolite | CTD | PMID:12151629 PMID:18303189 |
| crocidolite asbestos | increases mutagenesis | ISO | RGD:11440 | 6480464 | Asbestos, Crocidolite results in increased mutagenesis of TRP53 exon | CTD | PMID:10992274 |
| crocidolite asbestos | increases phosphorylation | ISO | RGD:70502 | 6480464 | Asbestos, Crocidolite results in increased phosphorylation of TP53 protein | CTD | PMID:12676607 |
| crocidolite asbestos | increases expression | ISO | RGD:70502 | 6480464 | Asbestos, Crocidolite results in increased expression of TP53 protein | CTD | PMID:12676607 |
| curcumin | multiple interactions | ISO | RGD:70502 | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [Curcumin results in increased phosphorylation of TP53 protein]; more ... | CTD | PMID:19020741 |
| curcumin | decreases expression | ISO | RGD:11440 | 6480464 | Curcumin results in decreased expression of TP53 protein | CTD | PMID:22714040 |
| curcumin | multiple interactions | ISO | RGD:11440 | 6480464 | Curcumin affects the reaction [KRAS protein affects the localization of TRP53 protein] | CTD | PMID:21519798 |
| curcumin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Curcumin results in increased phosphorylation of TP53 protein | CTD | PMID:17332930 more ... |
| curcumin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Curcumin results in increased phosphorylation of TP53 protein | CTD | PMID:19020741 more ... |
| curcumin | increases expression | ISO | RGD:70502 | 6480464 | [Curcumin results in increased expression of SERPINB5] which results in increased expression of TP53 protein | CTD | PMID:19944674 |
| curcumin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Curcumin results in increased phosphorylation of TP53 protein | CTD | PMID:21134073 more ... |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Cyclophosphamide results in increased mutagenesis of TP53 exon] | CTD | PMID:19227835 |
| curcumin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Curcumin results in increased phosphorylation of TP53 protein | CTD | PMID:17332930 more ... |
| curcumin | increases acetylation | ISO | RGD:70502 | 6480464 | Curcumin results in increased acetylation of TP53 protein | CTD | PMID:17332930 |
| curcumin | multiple interactions | ISO | RGD:70502 | 6480464 | [Curcumin co-treated with Metribolone] results in increased phosphorylation of TP53 protein | CTD | PMID:21134073 |
| curcumin | affects expression | ISO | RGD:70502 | 6480464 | Curcumin analog affects the expression of TP53 mRNA; more ... | CTD | PMID:17041101 |
| curcumin | affects localization | ISO | RGD:70502 | 6480464 | Curcumin affects the localization of TP53 protein | CTD | PMID:17332930 |
| cyanamide | multiple interactions | EXP | | 6480464 | [Ethanol co-treated with Cyanamide] results in increased expression of TP53 mRNA | CTD | PMID:12003908 |
| cycloheximide | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 mutant form results in increased susceptibility to Cycloheximide | CTD | PMID:21875941 |
| cycloheximide | multiple interactions | ISO | RGD:11440 | 6480464 | Cycloheximide inhibits the reaction [Cyclosporine results in increased expression of TRP53 protein] | CTD | PMID:10760090 |
| cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [TGFB1 protein results in increased expression of TP53 protein] | CTD | PMID:9790906 |
| cycloheximide | multiple interactions | ISO | RGD:70502 | 6480464 | Cycloheximide inhibits the reaction [Fluorouracil results in increased expression of TP53 protein] | CTD | PMID:15016801 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | chlorophyllin inhibits the reaction [Cyclophosphamide results in increased mutagenesis of TP53 exon]; more ... | CTD | PMID:19227835 |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of TP53 protein | CTD | PMID:20038455 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | astaxanthine inhibits the reaction [Cyclophosphamide results in increased expression of TP53 protein] | CTD | PMID:20038455 |
| cyclophosphamide | increases activity | ISO | RGD:70502 | 6480464 | Cyclophosphamide metabolite results in increased activity of TP53 protein | CTD | PMID:20655369 |
| cyclophosphamide | increases mutagenesis | ISO | RGD:70502 | 6480464 | Cyclophosphamide results in increased mutagenesis of TP53 exon | CTD | PMID:9610789 |
| cyclophosphamide | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 affects the susceptibility to Cyclophosphamide | CTD | PMID:10766175 |
| cyclophosphamide | increases mutagenesis | EXP | | 6480464 | Cyclophosphamide results in increased mutagenesis of TP53 exon | CTD | PMID:19227835 |
| cyclophosphamide | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Cyclophosphamide | CTD | PMID:15182437 |
| cyclosporin A | increases expression | ISO | RGD:70502 | 6480464 | Cyclosporine results in increased expression of TP53 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:11440 | 6480464 | Cyclosporine results in increased expression of TRP53 protein | CTD | PMID:10760090 |
| cyclosporin A | multiple interactions | ISO | RGD:11440 | 6480464 | Cyclosporine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TRP53 protein] | CTD | PMID:10205001 |
| cyclosporin A | multiple interactions | ISO | RGD:11440 | 6480464 | Cycloheximide inhibits the reaction [Cyclosporine results in increased expression of TRP53 protein] | CTD | PMID:10760090 |
| cyhalothrin | increases expression | ISO | RGD:11440 | 6480464 | cyhalothrin results in increased expression of TRP53 mRNA | CTD | PMID:20097460 |
| cytarabine | multiple interactions | ISO | RGD:70502 | 6480464 | Caffeine inhibits the reaction [Cytarabine results in increased expression of TP53 protein]; more ... | CTD | PMID:17977830 |
| cytarabine | increases expression | EXP | | 6480464 | Cytarabine results in increased expression of TP53 protein | CTD | PMID:14766721 more ... |
| cytarabine | increases expression | EXP | | 6480464 | Cytarabine results in increased expression of TP53 protein | CTD | PMID:14766721 more ... |
| cytarabine | increases expression | ISO | RGD:70502 | 6480464 | Cytarabine results in increased expression of TP53 protein | CTD | PMID:10200513 more ... |
| cytarabine | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cytarabine results in increased phosphorylation of TP53 protein | CTD | PMID:10200513 more ... |
| cytarabine | increases expression | EXP | | 6480464 | Cytarabine results in increased expression of TP53 protein | CTD | PMID:9880587 more ... |
| cytarabine | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cytarabine results in increased phosphorylation of TP53 protein | CTD | PMID:19628630 more ... |
| cytarabine | increases expression | ISO | RGD:70502 | 6480464 | Cytarabine results in increased expression of TP53 protein | CTD | PMID:10200513 more ... |
| cytarabine | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cytarabine results in increased phosphorylation of TP53 protein | CTD | PMID:17977830 more ... |
| cytarabine | increases expression | EXP | | 6480464 | Cytarabine results in increased expression of TP53 protein | CTD | PMID:15203180 more ... |
| cytarabine | increases expression | ISO | RGD:70502 | 6480464 | Cytarabine results in increased expression of TP53 protein | CTD | PMID:12781215 more ... |
| cytarabine | increases expression | ISO | RGD:70502 | 6480464 | Cytarabine results in increased expression of TP53 protein | CTD | PMID:12781215 more ... |
| cytarabine | increases expression | EXP | | 6480464 | Cytarabine results in increased expression of TP53 protein | CTD | PMID:15203180 more ... |
| cytarabine | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cytarabine results in increased phosphorylation of TP53 protein | CTD | PMID:19628630 more ... |
| cytarabine | increases expression | ISO | RGD:70502 | 6480464 | Cytarabine results in increased expression of TP53 protein | CTD | PMID:17977830 more ... |
| cytarabine | increases expression | EXP | | 6480464 | Cytarabine results in increased expression of TP53 protein | CTD | PMID:9880587 more ... |
| cytarabine | multiple interactions | ISO | RGD:70502 | 6480464 | [fludarabine co-treated with Cytarabine co-treated with docetaxel] results in increased expression of TP53 protein | CTD | PMID:9703875 |
| cytarabine | increases phosphorylation | ISO | RGD:70502 | 6480464 | Cytarabine results in increased phosphorylation of TP53 protein | CTD | PMID:17977830 more ... |
| cytarabine | increases expression | ISO | RGD:70502 | 6480464 | [Cytarabine results in increased expression of TP53 protein] which results in increased expression of BAX protein | CTD | PMID:10200513 |
| cytarabine | increases expression | ISO | RGD:70502 | 6480464 | Cytarabine results in increased expression of TP53 protein | CTD | PMID:10200513 more ... |
| D-glucose | multiple interactions | ISO | RGD:70502 | 6480464 | Glucose inhibits the reaction [bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II) results in increased expression of TP53 protein]; more ... | CTD | PMID:21548882 |
| D-glucose | increases acetylation | ISO | RGD:70502 | 6480464 | Glucose results in increased acetylation of TP53 protein | CTD | PMID:20068143 |
| D-glucose | multiple interactions | ISO | RGD:70502 | 6480464 | resveratrol inhibits the reaction [Glucose results in increased acetylation of TP53 protein]; more ... | CTD | PMID:20068143 |
| daidzein | increases expression | ISO | RGD:70502 | 6480464 | daidzein results in increased expression of TP53 protein | CTD | PMID:19800779 |
| daunorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | [Daunorubicin co-treated with Magnetite Nanoparticles] results in increased activity of TP53 protein | CTD | PMID:21518493 |
| daunorubicin | increases activity | ISO | RGD:70502 | 6480464 | Daunorubicin results in increased activity of TP53 protein | CTD | PMID:12112851 |
| daunorubicin | increases expression | ISO | RGD:70502 | 6480464 | Daunorubicin results in increased expression of TP53 mRNA | CTD | PMID:12656675 |
| DDE | increases expression | ISO | RGD:70502 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of TP53 mRNA | CTD | PMID:19545618 |
| dehydroepiandrosterone | increases expression | ISO | RGD:70502 | 6480464 | Dehydroepiandrosterone results in increased expression of TP53 mRNA | CTD | PMID:15752352 |
| deoxycholic acid | increases expression | EXP | | 6480464 | Deoxycholic Acid results in increased expression of TP53 mRNA | CTD | PMID:20137712 |
| deoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of TP53 mRNA] | CTD | PMID:20137712 |
| deoxycholic acid | multiple interactions | EXP | | 6480464 | TP53 protein affects the reaction [[Deoxycholic Acid results in increased expression of CCND1 protein] which affects the localization of BAX protein] | CTD | PMID:17431217 |
| desferrioxamine B | multiple interactions | ISO | RGD:70502 | 6480464 | Deferoxamine inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 mRNA] | CTD | PMID:16357363 |
| desferrioxamine B | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in decreased susceptibility to Deferoxamine | CTD | PMID:16527254 |
| desferrioxamine B | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 gene mutant form promotes the reaction [Deferoxamine results in increased expression of PTGS2 protein]; more ... | CTD | PMID:16527254 |
| dexamethasone | multiple interactions | ISO | RGD:70502 | 6480464 | Dexamethasone inhibits the reaction [TP53 protein binds to FPR1 promoter] | CTD | PMID:19037090 |
| dexamethasone | multiple interactions | ISO | RGD:11440 | 6480464 | Dexamethasone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TRP53 protein] | CTD | PMID:15987750 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of TP53 mRNA | CTD | PMID:17522070 |
| dexamethasone | decreases expression | ISO | RGD:70502 | 6480464 | Dexamethasone results in decreased expression of TP53 protein | CTD | PMID:19037090 |
| dextran sulfate | increases expression | ISO | RGD:11440 | 6480464 | Dextran Sulfate results in increased expression of TRP53 protein | CTD | PMID:16049979 |
| diallyl disulfide | increases expression | ISO | RGD:70502 | 6480464 | diallyl disulfide results in increased expression of TP53 protein | CTD | PMID:19202565 PMID:11925476 |
| diallyl disulfide | increases expression | ISO | RGD:70502 | 6480464 | diallyl disulfide results in increased expression of TP53 protein | CTD | PMID:11925476 PMID:19202565 |
| diallyl disulfide | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [diallyl disulfide results in increased expression of GDF15 protein] | CTD | PMID:11925476 |
| diallyl disulfide | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [diallyl disulfide results in increased expression of TP53 protein]; more ... | CTD | PMID:19202565 |
| diarsenic trioxide | increases expression | ISO | RGD:70502 | 6480464 | arsenic trioxide results in increased expression of TP53 protein | CTD | PMID:11146441 more ... |
| diarsenic trioxide | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein mutant form results in decreased susceptibility to arsenic trioxide | CTD | PMID:21454520 |
| diarsenic trioxide | decreases expression | ISO | RGD:70502 | 6480464 | arsenic trioxide results in decreased expression of TP53 protein mutant form | CTD | PMID:21454520 |
| diarsenic trioxide | increases expression | ISO | RGD:70502 | 6480464 | arsenic trioxide results in increased expression of TP53 protein | CTD | PMID:11146441 more ... |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of TP53 mRNA | CTD | PMID:21145380 |
| diarsenic trioxide | increases expression | ISO | RGD:70502 | 6480464 | arsenic trioxide results in increased expression of TP53 protein | CTD | PMID:11146441 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:70502 | 6480464 | arsenic trioxide results in increased expression of TP53 protein | CTD | PMID:12490120 more ... |
| diarsenic trioxide | affects expression | ISO | RGD:70502 | 6480464 | arsenic trioxide affects the expression of TP53 | CTD | PMID:11775218 |
| diarsenic trioxide | increases expression | ISO | RGD:70502 | 6480464 | arsenic trioxide results in increased expression of TRP53 protein | CTD | PMID:20200477 PMID:20953137 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [arsenic trioxide results in increased activity of TP53 protein] | CTD | PMID:17487067 |
| diarsenic trioxide | increases activity | EXP | | 6480464 | arsenic trioxide results in increased activity of TP53 protein | CTD | PMID:17487067 |
| diarsenic trioxide | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 affects the susceptibility to arsenic trioxide | CTD | PMID:12851490 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [arsenic trioxide results in increased expression of TNFRSF10B protein]; more ... | CTD | PMID:12851490 |
| diarsenic trioxide | increases expression | ISO | RGD:70502 | 6480464 | arsenic trioxide results in increased expression of TP53 mRNA | CTD | PMID:19769630 PMID:17530438 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70502 | 6480464 | arsenic trioxide results in increased expression of and results in increased activity of TP53 protein | CTD | PMID:18167198 |
| diarsenic trioxide | increases expression | ISO | RGD:70502 | 6480464 | arsenic trioxide results in increased expression of TP53 protein | CTD | PMID:15979894 more ... |
| diarsenic trioxide | increases degradation | ISO | RGD:70502 | 6480464 | arsenic trioxide results in increased degradation of TP53 protein | CTD | PMID:19457607 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70502 | 6480464 | [arsenic trioxide co-treated with PML protein] results in increased expression of TP53 | CTD | PMID:20377131 |
| diarsenic trioxide | increases expression | ISO | RGD:70502 | 6480464 | arsenic trioxide results in increased expression of TP53 protein | CTD | PMID:16467208 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:70502 | 6480464 | arsenic trioxide results in increased expression of TP53 mRNA | CTD | PMID:17530438 PMID:19769630 |
| diarsenic trioxide | multiple interactions | ISO | RGD:11440 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of and results in increased phosphorylation of TRP53 protein] | CTD | PMID:21565247 |
| diarsenic trioxide | increases expression | ISO | RGD:70502 | 6480464 | arsenic trioxide results in increased expression of TP53 protein | CTD | PMID:15979894 more ... |
| diazinon | increases expression | EXP | | 6480464 | Diazinon results in increased expression of TP53 mRNA | CTD | PMID:17452286 |
| diazoxide | decreases expression | EXP | | 6480464 | Diazoxide results in decreased expression of TP53 mRNA | CTD | PMID:16426753 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of TP53 protein | CTD | PMID:19466570 |
| dibenzo[a,l]pyrene | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [dibenzo(a,l)pyrene results in increased phosphorylation of TP53 protein]; more ... | CTD | PMID:16005925 |
| dibenzo[a,l]pyrene | increases phosphorylation | EXP | | 6480464 | dibenzo(a,l)pyrene results in increased phosphorylation of TP53 protein | CTD | PMID:16005925 PMID:17961608 |
| dibenzo[a,l]pyrene | increases expression | ISO | RGD:70502 | 6480464 | dibenzo(a,l)pyrene results in increased expression of TP53 protein | CTD | PMID:15548639 |
| dibenzo[a,l]pyrene | increases expression | ISO | RGD:11440 | 6480464 | dibenzo(a,l)pyrene results in increased expression of TRP53 protein | CTD | PMID:20353797 |
| dibenzo[a,l]pyrene | multiple interactions | ISO | RGD:11440 | 6480464 | [dibenzo(a,l)pyrene co-treated with sodium arsenite] results in increased expression of TRP53 protein | CTD | PMID:20353797 |
| dibenzo[a,l]pyrene | increases phosphorylation | EXP | | 6480464 | dibenzo(a,l)pyrene results in increased phosphorylation of TP53 protein | CTD | PMID:16005925 |
| dichloroacetic acid | increases expression | ISO | RGD:11440 | 6480464 | Dichloroacetic Acid results in increased expression of TRP53 protein | CTD | PMID:22705712 |
| dichlorvos | decreases expression | EXP | | 6480464 | Dichlorvos results in decreased expression of TP53 mRNA | CTD | PMID:23053939 |
| diclofenac | multiple interactions | ISO | RGD:11440 | 6480464 | Diclofenac promotes the reaction [Doxorubicin results in increased expression of TRP53 protein] | CTD | PMID:15458769 |
| dicoumarol | multiple interactions | ISO | RGD:70502 | 6480464 | Dicumarol inhibits the reaction [RB1CC1 protein results in increased expression of TP53 protein]; more ... | CTD | PMID:16061648 |
| dicoumarol | increases degradation | ISO | RGD:70502 | 6480464 | Dicumarol results in increased degradation of TP53 protein | CTD | PMID:14634213 |
| dicoumarol | multiple interactions | ISO | RGD:70502 | 6480464 | Dicumarol inhibits the reaction [TP53 protein binds to NQO1 protein] | CTD | PMID:14634213 |
| dicoumarol | multiple interactions | ISO | RGD:70502 | 6480464 | Dicumarol inhibits the reaction [IL1B protein results in increased expression of TP53 protein] | CTD | PMID:17959154 |
| diepoxybutane | increases expression | ISO | RGD:70502 | 6480464 | erythritol anhydride results in increased expression of TP53 protein | CTD | PMID:14998682 |
| diepoxybutane | multiple interactions | ISO | RGD:70502 | 6480464 | ATM protein affects the reaction [erythritol anhydride results in increased phosphorylation of TP53 protein]; more ... | CTD | PMID:20024960 |
| diethanolamine | decreases expression | ISO | RGD:11440 | 6480464 | diethanolamine results in decreased expression of TRP53 mRNA | CTD | PMID:16014740 |
| diethanolamine | decreases expression | EXP | | 6480464 | diethanolamine results in decreased expression of TP53 mRNA | CTD | PMID:16014740 |
| diethyl maleate | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA] | CTD | PMID:22003191 |
| diethylstilbestrol | multiple interactions | EXP | | 6480464 | [allyl sulfide co-treated with Diethylstilbestrol] results in increased expression of TP53 mRNA | CTD | PMID:17125941 |
| diethylstilbestrol | increases expression | ISO | RGD:11440 | 6480464 | Diethylstilbestrol results in increased expression of TRP53 mRNA | CTD | PMID:15545218 PMID:16510352 |
| diethylstilbestrol | increases expression | ISO | RGD:11440 | 6480464 | Diethylstilbestrol results in increased expression of TRP53 mRNA | CTD | PMID:16510352 PMID:15545218 |
| diethylstilbestrol | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 affects the susceptibility to Diethylstilbestrol | CTD | PMID:15545218 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of TP53 mRNA | CTD | PMID:17011747 |
| diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of TP53 mRNA | CTD | PMID:17125941 |
| digitoxin | decreases expression | ISO | RGD:70502 | 6480464 | Digitoxin results in decreased expression of TP53 protein; more ... | CTD | PMID:22037315 |
| dihydrocapsaicin | increases phosphorylation | ISO | RGD:70502 | 6480464 | dihydrocapsaicin results in increased phosphorylation of TP53 protein | CTD | PMID:19139269 |
| dihydrolipoic acid | multiple interactions | ISO | RGD:11440 | 6480464 | Acetylcysteine inhibits the reaction [dihydrolipoic acid results in increased expression of TRP53 mRNA]; more ... | CTD | PMID:21462292 |
| dihydrolipoic acid | increases expression | ISO | RGD:11440 | 6480464 | dihydrolipoic acid results in increased expression of TRP53 mRNA | CTD | PMID:21462292 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of TP53 mRNA | CTD | PMID:17720352 |
| dioxygen | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of TP53 protein]; more ... | CTD | PMID:10951577 |
| dioxygen | increases expression | ISO | RGD:11440 | 6480464 | Oxygen deficiency results in increased expression of TRP53 protein | CTD | PMID:10951577 |
| dioxygen | multiple interactions | ISO | RGD:70502 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of TP53 mRNA; more ... | CTD | PMID:19578757 |
| disodium selenite | increases phosphorylation | ISO | RGD:70502 | 6480464 | Sodium Selenite results in increased phosphorylation of TP53 protein | CTD | PMID:15845651 |
| disodium selenite | multiple interactions | ISO | RGD:70502 | 6480464 | Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of TP53 protein] | CTD | PMID:21515331 |
| disodium selenite | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Sodium Selenite | CTD | PMID:22200533 |
| disodium selenite | multiple interactions | ISO | RGD:11440 | 6480464 | di-(2-ethylhexyl)phthalate inhibits the reaction [Sodium Selenite results in decreased expression of TRP53 protein]; more ... | CTD | PMID:20659492 |
| disodium selenite | decreases expression | ISO | RGD:11440 | 6480464 | Sodium Selenite results in decreased expression of TRP53 protein | CTD | PMID:20659492 |
| disodium selenite | increases expression | ISO | RGD:11440 | 6480464 | Sodium Selenite results in increased expression of TRP53 mRNA | CTD | PMID:16542727 |
| disodium selenite | multiple interactions | ISO | RGD:70502 | 6480464 | Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of TP53 protein] | CTD | PMID:20390378 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:70502 | 6480464 | [docetaxel co-treated with flavopiridol] results in increased expression of TP53 protein; more ... | CTD | PMID:15297405 |
| docetaxel anhydrous | increases expression | ISO | RGD:70502 | 6480464 | docetaxel results in increased expression of TP53 mRNA | CTD | PMID:16080190 PMID:22445862 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:70502 | 6480464 | [docetaxel results in increased expression of TP53 mRNA] which results in decreased expression of ABCB1 mRNA; more ... | CTD | PMID:22445862 |
| docetaxel anhydrous | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 promoter mutant form results in decreased susceptibility to docetaxel | CTD | PMID:22445862 |
| docetaxel anhydrous | increases expression | ISO | RGD:70502 | 6480464 | docetaxel results in increased expression of TP53 protein | CTD | PMID:15970518 more ... |
| docetaxel anhydrous | increases expression | ISO | RGD:70502 | 6480464 | docetaxel results in increased expression of TP53 protein | CTD | PMID:16797627 more ... |
| docetaxel anhydrous | increases expression | ISO | RGD:70502 | 6480464 | docetaxel results in increased expression of TP53 protein | CTD | PMID:16797627 more ... |
| docetaxel anhydrous | increases expression | ISO | RGD:70502 | 6480464 | docetaxel results in increased expression of TP53 protein | CTD | PMID:16080190 more ... |
| docetaxel anhydrous | multiple interactions | ISO | RGD:11440 | 6480464 | [celecoxib co-treated with docetaxel] results in increased expression of TRP53 protein | CTD | PMID:16052515 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein inhibits the reaction [docetaxel results in increased expression of TUBB mRNA] | CTD | PMID:16080190 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:70502 | 6480464 | [fludarabine co-treated with Cytarabine co-treated with docetaxel] results in increased expression of TP53 protein | CTD | PMID:9703875 |
| docetaxel anhydrous | increases ubiquitination | ISO | RGD:70502 | 6480464 | docetaxel results in increased ubiquitination of TP53 protein mutant form | CTD | PMID:15970518 |
| docetaxel anhydrous | increases expression | ISO | RGD:70502 | 6480464 | docetaxel results in increased expression of TP53 protein | CTD | PMID:15970518 more ... |
| docetaxel anhydrous | decreases ubiquitination | ISO | RGD:70502 | 6480464 | docetaxel results in decreased ubiquitination of TP53 protein | CTD | PMID:15970518 |
| docetaxel anhydrous | increases expression | ISO | RGD:70502 | 6480464 | docetaxel results in increased expression of TP53 mRNA | CTD | PMID:16080190 |
| docetaxel anhydrous | decreases expression | ISO | RGD:70502 | 6480464 | docetaxel results in decreased expression of TP53 protein mutant form | CTD | PMID:15970518 |
| donepezil hydrochloride | multiple interactions | EXP | | 6480464 | donepezil inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein] | CTD | PMID:19345205 |
| dopamine | multiple interactions | ISO | RGD:70502 | 6480464 | [Dopamine results in increased expression of HIF1A protein] which results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:19410601 |
| dopamine | increases expression | ISO | RGD:70502 | 6480464 | [Dopamine results in increased expression of HIF1A protein] which results in increased expression of TP53 protein | CTD | PMID:19410601 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ANGPT1 protein inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]] | CTD | PMID:15763944 |
| doxorubicin | multiple interactions | ISO | RGD:11440 | 6480464 | Doxorubicin results in increased phosphorylation of and results in increased activity of TRP53 protein | CTD | PMID:22242153 |
| doxorubicin | affects localization | ISO | RGD:11440 | 6480464 | Doxorubicin affects the localization of TRP53 protein | CTD | PMID:20955365 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of TP53 mRNA | CTD | PMID:15667795 more ... |
| doxorubicin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Doxorubicin | CTD | PMID:14704126 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 mRNA | CTD | PMID:15939500 more ... |
| doxorubicin | increases expression | ISO | RGD:11440 | 6480464 | Doxorubicin results in increased expression of TRP53 protein | CTD | PMID:15458769 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | kaempferol inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]; more ... | CTD | PMID:22155320 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of TP53 protein | CTD | PMID:15983034 more ... |
| doxorubicin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased phosphorylation of TP53 protein | CTD | PMID:15671536 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 protein | CTD | PMID:10969820 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | Propofol inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] | CTD | PMID:22015447 |
| doxorubicin | decreases response to substance | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form results in decreased susceptibility to Doxorubicin | CTD | PMID:16013437 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 protein | CTD | PMID:16857806 more ... |
| doxorubicin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Doxorubicin | CTD | PMID:15823547 more ... |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | cobaltous chloride inhibits the reaction [[Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of BAX mRNA]; more ... | CTD | PMID:19714248 |
| doxorubicin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased phosphorylation of TP53 protein | CTD | PMID:15671536 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 mRNA | CTD | PMID:19351845 more ... |
| doxorubicin | increases expression | ISO | RGD:11440 | 6480464 | Doxorubicin results in increased expression of TRP53 protein | CTD | PMID:15458769 more ... |
| doxorubicin | increases activity | ISO | RGD:11440 | 6480464 | Doxorubicin results in increased activity of TRP53 protein | CTD | PMID:16949053 PMID:12006519 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Doxorubicin results in increased expression of GPX1 mRNA]; more ... | CTD | PMID:15059885 |
| doxorubicin | increases expression | ISO | RGD:11440 | 6480464 | Doxorubicin results in increased expression of TRP53 protein | CTD | PMID:16949053 more ... |
| doxorubicin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Doxorubicin | CTD | PMID:20856197 more ... |
| doxorubicin | decreases response to substance | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form results in decreased susceptibility to Doxorubicin | CTD | PMID:16013437 more ... |
| doxorubicin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased phosphorylation of TP53 protein | CTD | PMID:19106633 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 protein | CTD | PMID:17339365 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 mRNA | CTD | PMID:16001973 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of TP53 protein | CTD | PMID:17285121 more ... |
| doxorubicin | increases expression | ISO | RGD:11440 | 6480464 | Doxorubicin results in increased expression of TRP53 protein | CTD | PMID:15458769 more ... |
| doxorubicin | decreases response to substance | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form results in decreased susceptibility to Doxorubicin | CTD | PMID:17404018 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of TP53 protein | CTD | PMID:20470772 more ... |
| doxorubicin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Doxorubicin | CTD | PMID:14704126 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 protein | CTD | PMID:15763944 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 mRNA | CTD | PMID:16001973 more ... |
| doxorubicin | increases activity | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased activity of TP53 protein | CTD | PMID:15141020 PMID:17124180 |
| doxorubicin | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Doxorubicin | CTD | PMID:15182437 PMID:17912235 |
| doxorubicin | multiple interactions | ISO | RGD:11440 | 6480464 | sulforafan inhibits the reaction [TRP53 gene mutant form results in decreased susceptibility to Doxorubicin] | CTD | PMID:17404018 PMID:16843502 |
| doxorubicin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Doxorubicin | CTD | PMID:15823547 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 protein | CTD | PMID:21356574 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 mRNA | CTD | PMID:15939500 more ... |
| doxorubicin | increases expression | ISO | RGD:11440 | 6480464 | Doxorubicin results in increased expression of TRP53 protein | CTD | PMID:16949053 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of TP53 protein | CTD | PMID:18775851 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of TP53 mRNA | CTD | PMID:18632596 PMID:15667795 |
| doxorubicin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Doxorubicin | CTD | PMID:20856197 more ... |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein inhibits the reaction [sildenafil results in increased susceptibility to Doxorubicin] | CTD | PMID:20155316 |
| doxorubicin | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 gene mutant form results in decreased susceptibility to Doxorubicin | CTD | PMID:17369602 PMID:15578696 |
| doxorubicin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased phosphorylation of TP53 protein | CTD | PMID:15671536 PMID:19106633 |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 protein | CTD | PMID:19351845 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 mRNA | CTD | PMID:16001973 more ... |
| doxorubicin | affects expression | ISO | RGD:70502 | 6480464 | Doxorubicin affects the expression of TP53 protein | CTD | PMID:12006519 PMID:17893511 |
| doxorubicin | increases response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein results in increased susceptibility to Doxorubicin | CTD | PMID:10969820 |
| doxorubicin | multiple interactions | ISO | RGD:11440 | 6480464 | [TRP53 protein results in decreased expression of SOD2 mRNA] which results in increased susceptibility to Doxorubicin | CTD | PMID:10969820 |
| doxorubicin | decreases response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein mutant form results in decreased susceptibility to Doxorubicin | CTD | PMID:19103993 |
| doxorubicin | decreases response to substance | ISO | RGD:11440 | 6480464 | TRP53 gene polymorphism results in decreased susceptibility to Doxorubicin | CTD | PMID:16843502 |
| doxorubicin | decreases response to substance | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form results in decreased susceptibility to Doxorubicin | CTD | PMID:16843502 more ... |
| doxorubicin | multiple interactions | ISO | RGD:11440 | 6480464 | sulforafan inhibits the reaction [TRP53 gene polymorphism results in decreased susceptibility to Doxorubicin] | CTD | PMID:16843502 |
| doxorubicin | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form inhibits the reaction [Doxorubicin results in increased expression of CDKN1A mRNA] | CTD | PMID:16013437 |
| doxorubicin | multiple interactions | ISO | RGD:11440 | 6480464 | sulforafan inhibits the reaction [TRP53 gene mutant form results in decreased susceptibility to Doxorubicin] | CTD | PMID:16843502 PMID:17404018 |
| doxorubicin | increases expression | ISO | RGD:11440 | 6480464 | Doxorubicin results in increased expression of TRP53 protein | CTD | PMID:20363884 more ... |
| doxorubicin | multiple interactions | ISO | RGD:11440 | 6480464 | Doxorubicin results in increased expression of and results in increased phosphorylation of TRP53 protein; more ... | CTD | PMID:14766674 |
| doxorubicin | increases activity | ISO | RGD:11440 | 6480464 | Doxorubicin results in increased activity of TRP53 protein | CTD | PMID:12006519 PMID:16949053 |
| doxorubicin | multiple interactions | ISO | RGD:11440 | 6480464 | Doxorubicin promotes the reaction [TDP 665759 results in increased expression of TRP53 protein]; more ... | CTD | PMID:16432175 |
| doxorubicin | multiple interactions | ISO | RGD:11440 | 6480464 | Doxorubicin promotes the reaction [[HSPB1 protein modified form results in increased activity of TRP53 protein] which results in increased expression of BAX protein]; more ... | CTD | PMID:20363884 |
| doxorubicin | multiple interactions | ISO | RGD:11440 | 6480464 | Doxorubicin affects the reaction [TRP53 protein binds to HSPB1 protein]; more ... | CTD | PMID:18263706 |
| doxorubicin | multiple interactions | ISO | RGD:11440 | 6480464 | celecoxib promotes the reaction [Doxorubicin results in increased expression of TRP53 protein]; more ... | CTD | PMID:15458769 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Ginkgo biloba extract 761 inhibits the reaction [Doxorubicin results in increased expression of TP53 mRNA] | CTD | PMID:18632596 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of TP53 protein | CTD | PMID:20470772 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of TP53 mRNA | CTD | PMID:15667795 PMID:18632596 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased expression of and results in increased phosphorylation of and results in increased stability of and results in increased activity of TP53 protein; more ... | CTD | PMID:16687611 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased expression of and results in increased localization of TP53 protein modified form; more ... | CTD | PMID:18775851 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin affects the reaction [TP53 protein binds to HSPB1 protein]; more ... | CTD | PMID:18263706 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Doxorubicin results in increased expression of TNFSF10 mRNA]; more ... | CTD | PMID:19106633 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Doxorubicin results in increased expression of FAS mRNA] | CTD | PMID:11779855 |
| doxorubicin | multiple interactions | EXP | | 6480464 | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] | CTD | PMID:17285121 |
| doxorubicin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Doxorubicin | CTD | PMID:9395239 more ... |
| doxorubicin | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Doxorubicin | CTD | PMID:17912235 PMID:15182437 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [FHL2 protein affects the reaction [Doxorubicin results in increased expression of CDKN1A protein]] | CTD | PMID:17682292 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Doxorubicin results in increased expression of CDKN1A mRNA] | CTD | PMID:17079232 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Doxorubicin affects the reaction [RELA protein results in increased expression of CDKN1A mRNA]] | CTD | PMID:18269916 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [CHEK1 protein affects the susceptibility to Doxorubicin] | CTD | PMID:18698031 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Doxorubicin results in decreased expression of BIRC5 protein] | CTD | PMID:19363521 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [APP protein affects the susceptibility to Doxorubicin] | CTD | PMID:17608641 |
| doxorubicin | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 gene mutant form results in decreased susceptibility to Doxorubicin | CTD | PMID:15578696 PMID:17369602 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 gene mutant form inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] | CTD | PMID:15578696 |
| doxorubicin | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 gene affects the susceptibility to Doxorubicin | CTD | PMID:17085670 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | TNF protein inhibits the reaction [TP53 gene mutant form results in decreased susceptibility to Doxorubicin] | CTD | PMID:15823547 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | pluronic block copolymer p85 promotes the reaction [Doxorubicin results in increased expression of TP53 mRNA] | CTD | PMID:15939500 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | nutlin 3 promotes the reaction [Doxorubicin results in increased expression of TP53 protein]; more ... | CTD | PMID:21624110 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | NFKB1 protein affects the reaction [Doxorubicin results in increased expression of TP53 protein]; more ... | CTD | PMID:17912235 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | Lovastatin inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] | CTD | PMID:17088865 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | IFNA1 protein promotes the reaction [Doxorubicin results in increased expression of TP53 protein]; more ... | CTD | PMID:17959036 |
| doxorubicin | increases phosphorylation | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased phosphorylation of TP53 protein | CTD | PMID:19106633 PMID:15671536 |
| doxorubicin | increases glutathionylation | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased glutathionylation of TP53 protein | CTD | PMID:17555331 |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 protein | CTD | PMID:11779855 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 mRNA | CTD | PMID:16001973 more ... |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 protein modified form | CTD | PMID:16857806 |
| doxorubicin | increases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of TP53 | CTD | PMID:16013437 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:16432175 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of and results in increased phosphorylation of and results in increased acetylation of TP53 protein | CTD | PMID:17634554 |
| doxorubicin | increases activity | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased activity of TP53 protein | CTD | PMID:17124180 PMID:15141020 |
| doxorubicin | increases acetylation | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased acetylation of TP53 protein | CTD | PMID:16826403 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | Doxorubicin results in increased expression of and affects the phosphorylation of and results in increased localization of TP53 protein | CTD | PMID:17653088 |
| doxorubicin | decreases expression | ISO | RGD:70502 | 6480464 | Doxorubicin results in decreased expression of TP53 mRNA | CTD | PMID:18510171 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | Doxorubicin promotes the reaction [TP53 protein binds to BIRC5 promoter] | CTD | PMID:17124180 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | Doxorubicin inhibits the reaction [TP53 protein binds to MDM2 protein]; more ... | CTD | PMID:19351845 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | [Doxorubicin co-treated with Paclitaxel] results in increased expression of TP53 protein; more ... | CTD | PMID:16168113 |
| doxorubicin | affects localization | ISO | RGD:70502 | 6480464 | Doxorubicin affects the localization of TP53 protein | CTD | PMID:19363521 |
| doxorubicin | affects expression | ISO | RGD:70502 | 6480464 | Doxorubicin affects the expression of TP53 protein | CTD | PMID:17893511 PMID:12006519 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | CSE1L protein promotes the reaction [Doxorubicin results in increased expression of TP53 protein] | CTD | PMID:18377724 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | CDC25C protein inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] | CTD | PMID:19074854 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | AN-7 phosphate cpd promotes the reaction [Doxorubicin results in increased acetylation of TP53 protein]; more ... | CTD | PMID:16826403 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]; more ... | CTD | PMID:20856197 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [ATM protein promotes the reaction [Doxorubicin results in increased activity of TP53 protein]]; more ... | CTD | PMID:15489221 |
| doxorubicin | multiple interactions | ISO | RGD:70502 | 6480464 | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] | CTD | PMID:17285121 |
| elemental selenium | multiple interactions | ISO | RGD:70502 | 6480464 | [Selenium co-treated with SB 203580] results in decreased expression of TP53 protein | CTD | PMID:18583539 |
| elemental selenium | multiple interactions | EXP | | 6480464 | [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of TP53 mRNA] | CTD | PMID:21628957 |
| elemental selenium | decreases expression | ISO | RGD:70502 | 6480464 | Selenium results in decreased expression of TP53 protein | CTD | PMID:17523932 PMID:18583539 |
| elemental selenium | multiple interactions | EXP | | 6480464 | Selenium inhibits the reaction [Cadmium Chloride results in increased expression of TP53 protein] | CTD | PMID:16600092 |
| elemental selenium | increases expression | ISO | RGD:70502 | 6480464 | Selenium results in increased expression of TP53 mRNA | CTD | PMID:19244175 |
| elemental selenium | decreases expression | ISO | RGD:70502 | 6480464 | Selenium results in decreased expression of TP53 protein | CTD | PMID:18583539 PMID:17523932 |
| elemental selenium | multiple interactions | ISO | RGD:70502 | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of TP53 mRNA | CTD | PMID:19244175 |
| erythromycin estolate | decreases expression | EXP | | 6480464 | Erythromycin Estolate results in decreased expression of TP53 mRNA | CTD | PMID:17522070 |
| erythrosine sodium | increases activity | ISO | RGD:70502 | 6480464 | Erythrosine results in increased activity of TP53 protein | CTD | PMID:9168006 |
| esculetin | increases degradation | ISO | RGD:70502 | 6480464 | esculetin results in increased degradation of TP53 protein | CTD | PMID:14634213 |
| ethanol | multiple interactions | EXP | | 6480464 | [Ethanol co-treated with Cyanamide] results in increased expression of TP53 mRNA | CTD | PMID:12003908 |
| etoposide | multiple interactions | ISO | RGD:70502 | 6480464 | Etoposide promotes the reaction [[TP53 protein binds to GDF15 promoter] which results in increased expression of GDF15 mRNA] | CTD | PMID:11895857 |
| etoposide | increases expression | ISO | RGD:70502 | 6480464 | Etoposide results in increased expression of TP53 protein | CTD | PMID:11895857 more ... |
| etoposide | increases activity | ISO | RGD:70502 | 6480464 | Etoposide results in increased activity of TP53 protein | CTD | PMID:16120219 PMID:20655369 |
| etoposide | increases expression | ISO | RGD:70502 | 6480464 | Etoposide results in increased expression of TP53 protein | CTD | PMID:12082016 more ... |
| etoposide | multiple interactions | ISO | RGD:11440 | 6480464 | Etoposide results in increased phosphorylation of and results in increased activity of TRP53 protein | CTD | PMID:22242153 |
| etoposide | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein affects the reaction [Etoposide results in increased expression of BTG2 mRNA] | CTD | PMID:22003191 |
| etoposide | increases activity | ISO | RGD:70502 | 6480464 | Etoposide results in increased activity of TP53 protein | CTD | PMID:20655369 |
| etoposide | increases expression | ISO | RGD:70502 | 6480464 | Etoposide results in increased expression of TP53 protein | CTD | PMID:19751709 more ... |
| etoposide | increases expression | ISO | RGD:70502 | 6480464 | Etoposide results in increased expression of TP53 protein | CTD | PMID:21212465 more ... |
| etoposide | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein inhibits the reaction [ESR2 protein results in increased susceptibility to Etoposide] | CTD | PMID:20623183 |
| etoposide | multiple interactions | ISO | RGD:70502 | 6480464 | Etoposide results in increased phosphorylation of and results in increased activity of TP53 protein | CTD | PMID:20299546 PMID:16882877 |
| etoposide | increases expression | ISO | RGD:70502 | 6480464 | Etoposide results in increased expression of TP53 protein | CTD | PMID:12082016 more ... |
| etoposide | multiple interactions | EXP | | 6480464 | Etoposide results in increased expression of and results in increased phosphorylation of TP53 protein; more ... | CTD | PMID:15459018 |
| etoposide | multiple interactions | EXP | | 6480464 | Niacin deficiency inhibits the reaction [Etoposide results in increased expression of TP53 protein] | CTD | PMID:17516866 |
| etoposide | increases expression | EXP | | 6480464 | Etoposide results in increased expression of TP53 protein | CTD | PMID:17516866 |
| etoposide | multiple interactions | EXP | | 6480464 | Etoposide promotes the reaction [Acetaminophen results in increased phosphorylation of TP53 protein] | CTD | PMID:16330492 |
| etoposide | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 results in increased susceptibility to Etoposide | CTD | PMID:16882877 |
| etoposide | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Etoposide | CTD | PMID:21552291 |
| etoposide | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [CHEK1 protein affects the susceptibility to Etoposide] | CTD | PMID:18698031 |
| etoposide | multiple interactions | ISO | RGD:70502 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Etoposide results in increased acetylation of TP53 protein]; more ... | CTD | PMID:20299546 |
| etoposide | multiple interactions | ISO | RGD:70502 | 6480464 | pifithrin inhibits the reaction [Etoposide results in increased activity of TP53 protein] | CTD | PMID:16882877 |
| etoposide | increases phosphorylation | ISO | RGD:70502 | 6480464 | Etoposide results in increased phosphorylation of TP53 protein | CTD | PMID:21801448 |
| etoposide | multiple interactions | ISO | RGD:70502 | 6480464 | Etoposide results in increased phosphorylation of and results in increased activity of TP53 protein | CTD | PMID:16882877 PMID:20299546 |
| etoposide | increases expression | ISO | RGD:70502 | 6480464 | Etoposide results in increased expression of TP53 protein | CTD | PMID:21212465 more ... |
| etoposide | increases acetylation | ISO | RGD:70502 | 6480464 | Etoposide results in increased acetylation of TP53 protein | CTD | PMID:20299546 |
| etoposide | multiple interactions | ISO | RGD:70502 | 6480464 | Etoposide promotes the reaction [TP53 protein binds to TNFRSF10B promoter] | CTD | PMID:15964798 |
| etoposide | multiple interactions | ISO | RGD:70502 | 6480464 | [CASP8 co-treated with TP53] affects the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP9 protein]; more ... | CTD | PMID:21801448 |
| etoposide | multiple interactions | ISO | RGD:70502 | 6480464 | 2,4,4'-trichlorobiphenyl inhibits the reaction [Etoposide results in increased expression of TP53 protein]; more ... | CTD | PMID:19751709 |
| etoposide | increases expression | ISO | RGD:70502 | 6480464 | Etoposide results in increased expression of TP53 protein | CTD | PMID:11895857 more ... |
| etoposide | increases expression | ISO | RGD:70502 | 6480464 | [Etoposide results in increased expression of TP53 protein] which results in increased expression of GDF15 protein | CTD | PMID:11895857 |
| eugenol | multiple interactions | EXP | | 6480464 | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TP53 protein] | CTD | PMID:19851710 |
| eugenol | increases mutagenesis | ISO | RGD:70502 | 6480464 | Eugenol results in increased mutagenesis of TP53 gene | CTD | PMID:15576237 |
| eugenol | increases expression | ISO | RGD:11440 | 6480464 | Eugenol results in increased expression of TRP53 mRNA; more ... | CTD | PMID:20537511 |
| eugenol | multiple interactions | ISO | RGD:11440 | 6480464 | Eugenol promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein] | CTD | PMID:20043298 |
| fenofibrate | increases expression | EXP | | 6480464 | Fenofibrate results in increased expression of TP53 mRNA | CTD | PMID:17264098 |
| fipronil | affects localization | ISO | RGD:70502 | 6480464 | fipronil affects the localization of TP53 protein | CTD | PMID:21296133 |
| fisetin | multiple interactions | ISO | RGD:70502 | 6480464 | [Cisplatin co-treated with fisetin] results in increased expression of TP53 protein; more ... | CTD | PMID:21216935 |
| fisetin | multiple interactions | ISO | RGD:70502 | 6480464 | fisetin inhibits the reaction [Silicon Dioxide results in increased expression of TP53 mRNA] | CTD | PMID:22931364 |
| fisetin | affects localization | ISO | RGD:70502 | 6480464 | fisetin affects the localization of TP53 protein | CTD | PMID:21216935 |
| fisetin | increases expression | ISO | RGD:70502 | 6480464 | fisetin results in increased expression of TP53 protein | CTD | PMID:21216935 |
| flavanone | multiple interactions | ISO | RGD:70502 | 6480464 | flavanone results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:22056764 |
| flucytosine | increases expression | ISO | RGD:70502 | 6480464 | Flucytosine results in increased expression of TP53 protein | CTD | PMID:15592511 |
| fluoranthene | multiple interactions | ISO | RGD:11440 | 6480464 | fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 mRNA]; more ... | CTD | PMID:22120587 |
| fluoranthene | increases expression | ISO | RGD:11440 | 6480464 | fluoranthene results in increased expression of TRP53 protein | CTD | PMID:22120587 |
| fluoranthene | multiple interactions | ISO | RGD:70502 | 6480464 | fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of TP53 protein] | CTD | PMID:22120587 |
| fluoxetine | increases expression | ISO | RGD:11440 | 6480464 | Fluoxetine results in increased expression of TRP53 mRNA | CTD | PMID:21497159 |
| fluoxetine | increases expression | ISO | RGD:70502 | 6480464 | Fluoxetine results in increased expression of TP53 mRNA | CTD | PMID:18836303 |
| flurbiprofen | multiple interactions | ISO | RGD:70502 | 6480464 | Flurbiprofen results in increased abundance of and results in increased phosphorylation of TP53 protein | CTD | PMID:15710360 |
| flurbiprofen | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Flurbiprofen | CTD | PMID:15710360 |
| flurbiprofen | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein mutant form results in decreased susceptibility to Flurbiprofen | CTD | PMID:15710360 |
| flurbiprofen | increases expression | ISO | RGD:70502 | 6480464 | Flurbiprofen results in increased expression of TP53 protein | CTD | PMID:11687965 |
| folic acid | affects expression | ISO | RGD:70502 | 6480464 | Folic Acid affects the expression of TP53 protein | CTD | PMID:16361273 |
| folic acid | affects expression | ISO | RGD:70502 | 6480464 | Folic Acid affects the expression of TP53 mRNA | CTD | PMID:16361273 PMID:16611376 |
| folic acid | affects expression | ISO | RGD:70502 | 6480464 | Folic Acid affects the expression of TP53 mRNA | CTD | PMID:16611376 PMID:16361273 |
| folic acid | multiple interactions | ISO | RGD:11440 | 6480464 | Folic Acid inhibits the reaction [Valproic Acid results in increased expression of TRP53 protein] | CTD | PMID:16112698 |
| folic acid | multiple interactions | EXP | | 6480464 | [Folic Acid co-treated with Isoflavones] results in decreased expression of TP53 protein | CTD | PMID:20060418 |
| folic acid | multiple interactions | EXP | | 6480464 | Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased methylation of TP53 exon] | CTD | PMID:8863662 |
| folic acid | affects methylation | EXP | | 6480464 | Folic Acid affects the methylation of TP53 protein | CTD | PMID:17056795 |
| formaldehyde | increases expression | ISO | RGD:70502 | 6480464 | Formaldehyde results in increased expression of TP53 protein | CTD | PMID:15715472 |
| formaldehyde | increases expression | ISO | RGD:70502 | 6480464 | Formaldehyde results in increased expression of TP53 protein | CTD | PMID:15715472 PMID:22525295 |
| formaldehyde | increases expression | ISO | RGD:70502 | 6480464 | Formaldehyde results in increased expression of TP53 mRNA | CTD | PMID:22525295 |
| fulvestrant | multiple interactions | ISO | RGD:70502 | 6480464 | fulvestrant inhibits the reaction [Estradiol affects the localization of TP53 protein] | CTD | PMID:15870704 |
| furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of TP53 gene | CTD | PMID:22079235 |
| furan | increases expression | EXP | | 6480464 | furan results in increased expression of TP53 protein | CTD | PMID:20124500 |
| galactose | increases expression | ISO | RGD:70502 | 6480464 | Galactose results in increased expression of TP53 protein | CTD | PMID:23036742 |
| galactose | multiple interactions | ISO | RGD:70502 | 6480464 | Phycocyanin inhibits the reaction [Galactose results in increased expression of TP53 protein] | CTD | PMID:23036742 |
| gallic acid | decreases expression | ISO | RGD:70502 | 6480464 | Gallic Acid results in decreased expression of TP53 mRNA | CTD | PMID:21887735 |
| gamma-hexachlorocyclohexane | multiple interactions | ISO | RGD:70502 | 6480464 | [Lindane co-treated with Estradiol] results in increased expression of TP53 protein | CTD | PMID:18174961 |
| ganciclovir | increases expression | ISO | RGD:70502 | 6480464 | Ganciclovir results in increased expression of TP53 protein | CTD | PMID:15592511 |
| gefitinib | multiple interactions | ISO | RGD:70502 | 6480464 | [TP53 protein results in decreased expression of AURKA protein] which results in increased susceptibility to gefitinib | CTD | PMID:21216229 |
| gefitinib | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to gefitinib | CTD | PMID:21216229 |
| geldanamycin | affects localization | ISO | RGD:70502 | 6480464 | geldanamycin affects the localization of TP53 protein | CTD | PMID:17293044 |
| geldanamycin | multiple interactions | ISO | RGD:70502 | 6480464 | Tretinoin inhibits the reaction [geldanamycin affects the localization of TP53 protein] | CTD | PMID:17293044 |
| genistein | multiple interactions | ISO | RGD:70502 | 6480464 | [Fluorouracil co-treated with Genistein] results in increased expression of TP53 mRNA; more ... | CTD | PMID:15896711 |
| genistein | increases expression | ISO | RGD:70502 | 6480464 | Genistein results in increased expression of TP53 protein | CTD | PMID:19800779 |
| genistein | multiple interactions | ISO | RGD:70502 | 6480464 | [Genistein co-treated with trichostatin A] results in increased expression of TP53 protein | CTD | PMID:22626855 |
| genistein | multiple interactions | ISO | RGD:70502 | 6480464 | Genistein inhibits the reaction [HIST3H3 protein modified form binds to TP53 promoter]; more ... | CTD | PMID:18431742 |
| genistein | affects expression | ISO | RGD:70502 | 6480464 | Genistein affects the expression of TP53 mRNA; more ... | CTD | PMID:18431742 |
| glucose | multiple interactions | ISO | RGD:70502 | 6480464 | Glucose inhibits the reaction [bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II) results in increased expression of TP53 protein]; more ... | CTD | PMID:21548882 |
| glucose | increases acetylation | ISO | RGD:70502 | 6480464 | Glucose results in increased acetylation of TP53 protein | CTD | PMID:20068143 |
| glucose | multiple interactions | ISO | RGD:70502 | 6480464 | resveratrol inhibits the reaction [Glucose results in increased acetylation of TP53 protein]; more ... | CTD | PMID:20068143 |
| glutathione | multiple interactions | ISO | RGD:70502 | 6480464 | [Buthionine Sulfoximine results in decreased abundance of Glutathione] inhibits the reaction [Benzo(a)pyrene results in increased activity of TP53 protein] | CTD | PMID:12807757 |
| glutathione | increases glutathionylation | ISO | RGD:70502 | 6480464 | Glutathione results in increased glutathionylation of TP53 protein | CTD | PMID:17555331 |
| glutathione | decreases abundance | ISO | RGD:70502 | 6480464 | TP53 protein results in decreased abundance of Glutathione | CTD | PMID:12967322 |
| glutathione | increases expression | ISO | RGD:70502 | 6480464 | Glutathione results in increased expression of TP53 protein | CTD | PMID:10897038 |
| glutathione | multiple interactions | ISO | RGD:70502 | 6480464 | Glutathione inhibits the reaction [diallyl disulfide results in increased expression of TP53 protein] | CTD | PMID:19202565 |
| glutathione | multiple interactions | ISO | RGD:70502 | 6480464 | Dithiothreitol inhibits the reaction [Glutathione results in increased glutathionylation of TP53 protein] | CTD | PMID:17555331 |
| glutathione disulfide | multiple interactions | ISO | RGD:70502 | 6480464 | Dithiothreitol inhibits the reaction [Glutathione Disulfide results in increased glutathionylation of TP53 protein] | CTD | PMID:17555331 |
| glutathione disulfide | increases glutathionylation | ISO | RGD:70502 | 6480464 | Glutathione Disulfide results in increased glutathionylation of TP53 protein | CTD | PMID:17555331 |
| glutathione disulfide | multiple interactions | ISO | RGD:70502 | 6480464 | Glutathione Disulfide results in increased expression of and results in increased phosphorylation of and results in increased activity of TP53 protein | CTD | PMID:15993333 |
| glycerol | increases activity | ISO | RGD:70502 | 6480464 | Glycerol results in increased activity of TP53 protein mutant form | CTD | PMID:15975526 |
| gold atom | increases expression | ISO | RGD:11440 | 6480464 | Gold analog results in increased expression of TRP53 mRNA | CTD | PMID:22486372 |
| gold(0) | increases expression | ISO | RGD:11440 | 6480464 | Gold analog results in increased expression of TRP53 mRNA | CTD | PMID:22486372 |
| haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of TP53 mRNA; more ... | CTD | PMID:16462815 |
| heparin | decreases expression | ISO | RGD:70502 | 6480464 | Heparin analog results in decreased expression of TP53 protein | CTD | PMID:20201787 |
| heptachlor | decreases expression | ISO | RGD:70502 | 6480464 | Heptachlor results in decreased expression of TP53 protein | CTD | PMID:9544696 |
| hesperetin | multiple interactions | ISO | RGD:70502 | 6480464 | hesperetin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of TP53 protein] | CTD | PMID:15795422 |
| hydralazine | multiple interactions | ISO | RGD:70502 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of TP53 mRNA | CTD | PMID:17183730 |
| hydralazine | increases activity | ISO | RGD:70502 | 6480464 | Hydralazine results in increased activity of TP53 protein | CTD | PMID:12082016 |
| hydrogen peroxide | multiple interactions | ISO | RGD:70502 | 6480464 | Cadmium Chloride inhibits the reaction [Hydrogen Peroxide results in increased expression of and results in increased activity of TP53 protein]; more ... | CTD | PMID:10531375 |
| hydrogen peroxide | increases expression | ISO | RGD:70502 | 6480464 | Hydrogen Peroxide results in increased expression of TP53 protein | CTD | PMID:11964141 more ... |
| hydrogen peroxide | increases acetylation | ISO | RGD:70502 | 6480464 | Hydrogen Peroxide results in increased acetylation of TP53 protein | CTD | PMID:18681908 |
| hydrogen peroxide | multiple interactions | ISO | RGD:70502 | 6480464 | [Niacinamide results in decreased activity of SIRT1 protein] promotes the reaction [Hydrogen Peroxide results in increased acetylation of TP53 protein]; more ... | CTD | PMID:18681908 |
| hydrogen peroxide | increases expression | ISO | RGD:70502 | 6480464 | Hydrogen Peroxide results in increased expression of TP53 protein | CTD | PMID:11964141 more ... |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of TP53 protein | CTD | PMID:12414117 more ... |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of TP53 protein | CTD | PMID:20041988 more ... |
| hydrogen peroxide | increases expression | ISO | RGD:70502 | 6480464 | Hydrogen Peroxide results in increased expression of TP53 protein | CTD | PMID:9989825 more ... |
| hydrogen peroxide | increases expression | ISO | RGD:11440 | 6480464 | Hydrogen Peroxide results in increased expression of TRP53 protein | CTD | PMID:21705337 |
| hydrogen peroxide | multiple interactions | ISO | RGD:11440 | 6480464 | PTRF protein affects the reaction [Hydrogen Peroxide results in increased expression of TRP53 protein] | CTD | PMID:21705337 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of TP53 protein | CTD | PMID:12414117 more ... |
| hydrogen peroxide | increases expression | ISO | RGD:70502 | 6480464 | Hydrogen Peroxide results in increased expression of TP53 protein | CTD | PMID:15081873 PMID:9989825 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of TP53 protein | CTD | PMID:12414117 more ... |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of TP53 protein | CTD | PMID:12642403 more ... |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of TP53 mRNA | CTD | PMID:14689451 PMID:12414117 |
| hydrogen peroxide | decreases response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:21552291 |
| hydrogen peroxide | increases expression | ISO | RGD:11440 | 6480464 | Hydrogen Peroxide results in increased expression of TRP53 | CTD | PMID:21552291 |
| hydrogen peroxide | increases phosphorylation | ISO | RGD:11440 | 6480464 | Hydrogen Peroxide results in increased phosphorylation of TRP53 | CTD | PMID:21552291 |
| hydrogen peroxide | multiple interactions | ISO | RGD:11440 | 6480464 | Hydrogen Peroxide affects the reaction [Vanadates results in increased activity of TRP53 protein] | CTD | PMID:10922372 |
| hydrogen peroxide | multiple interactions | ISO | RGD:11440 | 6480464 | Hydrogen Peroxide promotes the reaction [TRP53 protein results in increased expression of HMOX1 mRNA]; more ... | CTD | PMID:21552291 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Tacrolimus inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein]; more ... | CTD | PMID:12642403 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Tacrine inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein]; more ... | CTD | PMID:12414117 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of TP53 protein | CTD | PMID:12642403 more ... |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein] | CTD | PMID:20041988 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of TP53 mRNA | CTD | PMID:12414117 PMID:14689451 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of and affects the localization of TP53 protein | CTD | PMID:14689451 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | donepezil inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein]; more ... | CTD | PMID:19345205 |
| hydrogen peroxide | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Hydrogen Peroxide results in increased expression of CDKN1A mRNA] | CTD | PMID:8943236 |
| hydrogen peroxide | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:21552291 |
| hydrogen peroxide | multiple interactions | ISO | RGD:70502 | 6480464 | Pergolide inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein]; more ... | CTD | PMID:15081873 |
| hydrogen peroxide | increases phosphorylation | ISO | RGD:70502 | 6480464 | Hydrogen Peroxide results in increased phosphorylation of TP53 | CTD | PMID:21552291 |
| hydrogen peroxide | increases glutathionylation | ISO | RGD:70502 | 6480464 | Hydrogen Peroxide results in increased glutathionylation of TP53 protein | CTD | PMID:17555331 |
| hydrogen peroxide | increases expression | ISO | RGD:70502 | 6480464 | [Hydrogen Peroxide results in increased expression of TP53 protein] which results in increased expression of BAX protein; more ... | CTD | PMID:15081873 |
| hydrogen peroxide | increases expression | ISO | RGD:70502 | 6480464 | Hydrogen Peroxide results in increased expression of TP53 protein | CTD | PMID:9989825 PMID:15081873 |
| hydrogen peroxide | increases expression | ISO | RGD:70502 | 6480464 | Hydrogen Peroxide results in increased expression of TP53 | CTD | PMID:21552291 |
| hydrogen peroxide | increases activity | ISO | RGD:70502 | 6480464 | Hydrogen Peroxide results in increased activity of TP53 protein | CTD | PMID:15242773 |
| hydrogen peroxide | decreases expression | ISO | RGD:70502 | 6480464 | Hydrogen Peroxide results in decreased expression of TP53 mRNA | CTD | PMID:12419474 |
| hydrogen peroxide | multiple interactions | ISO | RGD:70502 | 6480464 | Hydrogen Peroxide promotes the reaction [TP53 protein binds to MDM2 promoter]; more ... | CTD | PMID:21552291 |
| hydrogen peroxide | multiple interactions | ISO | RGD:70502 | 6480464 | hesperetin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of TP53 protein]; more ... | CTD | PMID:15795422 |
| hydroquinone | increases expression | ISO | RGD:70502 | 6480464 | hydroquinone results in increased expression of TP53 protein | CTD | PMID:17875398 |
| hydroquinone | multiple interactions | ISO | RGD:70502 | 6480464 | WRN protein affects the reaction [hydroquinone results in increased acetylation of TP53 protein]; more ... | CTD | PMID:17875398 |
| hydroxyurea | increases expression | ISO | RGD:70502 | 6480464 | Hydroxyurea results in increased expression of TP53 protein | CTD | PMID:10978678 PMID:16005713 |
| hydroxyurea | increases expression | ISO | RGD:70502 | 6480464 | Hydroxyurea results in increased expression of TP53 protein | CTD | PMID:16005713 PMID:10978678 |
| hydroxyurea | multiple interactions | ISO | RGD:11440 | 6480464 | Hydroxyurea results in increased expression of and results in increased phosphorylation of TRP53 protein | CTD | PMID:16356682 |
| indomethacin | increases expression | ISO | RGD:70502 | 6480464 | Indomethacin results in increased expression of TP53 protein | CTD | PMID:11260862 PMID:10403534 |
| indomethacin | increases expression | ISO | RGD:70502 | 6480464 | Indomethacin results in increased expression of TP53 protein | CTD | PMID:10403534 PMID:11260862 |
| isatin | multiple interactions | ISO | RGD:70502 | 6480464 | [Copper binds to Isatin binds to trimethylenediamine] which results in increased expression of TP53 protein; more ... | CTD | PMID:17327230 |
| isoflurane | decreases expression | EXP | | 6480464 | Isoflurane results in decreased expression of TP53 mRNA | CTD | PMID:16978161 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of TP53 protein | CTD | PMID:19466570 |
| isotretinoin | increases expression | ISO | RGD:11440 | 6480464 | Isotretinoin results in increased expression of TRP53 | CTD | PMID:18652567 |
| kaempferol | multiple interactions | ISO | RGD:70502 | 6480464 | Caffeine inhibits the reaction [kaempferol results in increased phosphorylation of TP53 protein]; more ... | CTD | PMID:19028473 |
| kaempferol | multiple interactions | EXP | | 6480464 | kaempferol inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]; more ... | CTD | PMID:22155320 |
| kaempferol | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to kaempferol | CTD | PMID:19028473 |
| kaempferol | increases phosphorylation | ISO | RGD:70502 | 6480464 | kaempferol results in increased phosphorylation of TP53 protein | CTD | PMID:19028473 |
| kaempferol | increases expression | ISO | RGD:70502 | 6480464 | kaempferol results in increased expression of TP53 protein | CTD | PMID:19028473 |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of TP53 protein | CTD | PMID:20955365 |
| ketamine | increases expression | ISO | RGD:70502 | 6480464 | Ketamine results in increased expression of TP53 protein | CTD | PMID:19919587 |
| kojic acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TP53 mRNA | CTD | PMID:18544905 |
| kojic acid | multiple interactions | ISO | RGD:11440 | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of TRP53 mRNA | CTD | PMID:17917374 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [potassium bromate results in increased phosphorylation of TP53 protein] | CTD | PMID:20067818 |
| L-ascorbic acid | multiple interactions | ISO | RGD:70502 | 6480464 | Ascorbic Acid inhibits the reaction [Silicon Dioxide results in increased expression of TP53 protein]; more ... | CTD | PMID:22245848 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Potassium Dichromate results in increased localization of TP53 protein modified form]; more ... | CTD | PMID:21262251 |
| L-ascorbic acid | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]; more ... | CTD | PMID:20530418 |
| L-ascorbic acid | multiple interactions | ISO | RGD:11440 | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of TRP53 mRNA | CTD | PMID:17917374 |
| L-ascorbic acid | multiple interactions | ISO | RGD:70502 | 6480464 | Ascorbic Acid promotes the reaction [Cisplatin results in increased expression of TP53 protein] | CTD | PMID:21429301 |
| L-ascorbic acid | multiple interactions | ISO | RGD:70502 | 6480464 | Ascorbic Acid inhibits the reaction [potassium bromate results in increased phosphorylation of TP53 protein] | CTD | PMID:20067818 |
| lactacystin | multiple interactions | EXP | | 6480464 | lactacystin inhibits the reaction [Acetaminophen results in increased degradation of TP53 protein] | CTD | PMID:16330492 |
| lactacystin | increases ubiquitination | EXP | | 6480464 | lactacystin results in increased ubiquitination of TP53 protein | CTD | PMID:18463101 |
| lactacystin | multiple interactions | EXP | | 6480464 | lactacystin results in increased phosphorylation of and results in increased expression of TP53 protein | CTD | PMID:18463101 |
| lead(0) | decreases expression | ISO | RGD:70502 | 6480464 | Lead results in decreased expression of TP53 mRNA | CTD | PMID:19921347 |
| leptomycin B | multiple interactions | ISO | RGD:70502 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [leptomycin B results in increased expression of TP53 protein]; more ... | CTD | PMID:19751709 |
| leptomycin B | multiple interactions | ISO | RGD:70502 | 6480464 | leptomycin B inhibits the reaction [sodium arsenite results in increased degradation of TP53 protein mutant form] | CTD | PMID:21454520 |
| leptomycin B | multiple interactions | ISO | RGD:70502 | 6480464 | [leptomycin B co-treated with TP53 gene mutant form] results in decreased expression of DNMT1 mRNA; more ... | CTD | PMID:20803015 |
| leptomycin B | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 gene mutant form results in increased susceptibility to leptomycin B | CTD | PMID:20803015 |
| leptomycin B | increases expression | ISO | RGD:70502 | 6480464 | leptomycin B results in increased expression of TP53 protein | CTD | PMID:16467109 PMID:19751709 |
| leptomycin B | multiple interactions | EXP | | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [leptomycin B results in increased expression of TP53 protein]] | CTD | PMID:15459018 |
| leptomycin B | increases expression | EXP | | 6480464 | leptomycin B results in increased expression of TP53 protein | CTD | PMID:15459018 |
| leptomycin B | affects expression | EXP | | 6480464 | leptomycin B affects the expression of TP53 protein | CTD | PMID:11751435 |
| leptomycin B | multiple interactions | ISO | RGD:70502 | 6480464 | Pravastatin inhibits the reaction [leptomycin B results in decreased degradation of TP53 protein] | CTD | PMID:15625077 |
| leptomycin B | decreases degradation | ISO | RGD:70502 | 6480464 | leptomycin B results in decreased degradation of TP53 protein | CTD | PMID:15625077 |
| leptomycin B | increases expression | ISO | RGD:70502 | 6480464 | leptomycin B results in increased expression of TP53 protein | CTD | PMID:19751709 PMID:16467109 |
| leptomycin B | multiple interactions | ISO | RGD:70502 | 6480464 | leptomycin B inhibits the reaction [sodium arsenite affects the localization of TP53 protein]; more ... | CTD | PMID:19010883 |
| leptomycin B | multiple interactions | ISO | RGD:70502 | 6480464 | leptomycin B inhibits the reaction [TP53 protein results in increased susceptibility to trichostatin A] | CTD | PMID:16467109 |
| lidocaine | affects expression | ISO | RGD:11440 | 6480464 | Lidocaine affects the expression of TRP53 mRNA | CTD | PMID:18931217 |
| limonene | increases expression | ISO | RGD:70502 | 6480464 | limonene results in increased expression of TP53 protein | CTD | PMID:12921557 |
| linalool | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 results in increased susceptibility to linalool | CTD | PMID:19922762 |
| linalool | increases expression | ISO | RGD:70502 | 6480464 | linalool results in increased expression of TP53 protein | CTD | PMID:19922762 |
| lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Methotrexate results in increased expression of TP53 protein] | CTD | PMID:19900424 |
| lithium atom | multiple interactions | ISO | RGD:70502 | 6480464 | Lithium inhibits the reaction [GSK3B protein binds to TP53 protein] | CTD | PMID:15475000 |
| lithium atom | multiple interactions | ISO | RGD:70502 | 6480464 | Lithium inhibits the reaction [sodium arsenite results in increased expression of and affects the localization of TP53 protein] | CTD | PMID:17849503 |
| lithium atom | multiple interactions | ISO | RGD:11440 | 6480464 | TP53 affects the reaction [Lithium results in increased expression of CDKN1A protein] | CTD | PMID:11337498 |
| lithium chloride | increases expression | ISO | RGD:70502 | 6480464 | Lithium Chloride results in increased expression of TP53 protein | CTD | PMID:17210701 |
| lithium chloride | multiple interactions | ISO | RGD:11440 | 6480464 | Lithium Chloride results in decreased degradation of and results in increased expression of TRP53 protein | CTD | PMID:16055726 |
| losartan | affects expression | EXP | | 6480464 | Losartan affects the expression of TP53 protein | CTD | PMID:22000973 |
| lovastatin | multiple interactions | ISO | RGD:70502 | 6480464 | Lovastatin inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] | CTD | PMID:17088865 |
| lovastatin | increases expression | ISO | RGD:70502 | 6480464 | Lovastatin results in increased expression of TP53 mRNA | CTD | PMID:21199873 |
| lovastatin | multiple interactions | ISO | RGD:70502 | 6480464 | Lovastatin results in increased expression of and results in increased phosphorylation of TP53 protein | CTD | PMID:21199873 |
| LY294002 | multiple interactions | ISO | RGD:70502 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]; more ... | CTD | PMID:20856197 |
| LY294002 | increases expression | ISO | RGD:70502 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TP53 protein | CTD | PMID:15001399 |
| LY294002 | multiple interactions | ISO | RGD:70502 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of TP53 protein] | CTD | PMID:17534123 |
| LY294002 | multiple interactions | ISO | RGD:70502 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Nitric Oxide results in increased phosphorylation of TP53 protein]; more ... | CTD | PMID:16024610 |
| LY294002 | multiple interactions | ISO | RGD:70502 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ANGPT1 protein inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]] | CTD | PMID:15763944 |
| lycopene | decreases expression | ISO | RGD:70502 | 6480464 | lycopene results in decreased expression of TP53 mRNA | CTD | PMID:16886892 |
| magnesium dichloride | affects expression | EXP | | 6480464 | Magnesium Chloride affects the expression of TP53 mRNA | CTD | PMID:10506531 |
| malathion | multiple interactions | ISO | RGD:70502 | 6480464 | Atropine inhibits the reaction [Malathion results in increased expression of TP53 protein] | CTD | PMID:12762645 |
| malathion | multiple interactions | EXP | | 6480464 | [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of TP53 mRNA] | CTD | PMID:21628957 |
| malathion | increases expression | EXP | | 6480464 | Malathion results in increased expression of TP53 mRNA | CTD | PMID:21628957 |
| malathion | increases expression | ISO | RGD:70502 | 6480464 | Malathion results in increased expression of TP53 protein | CTD | PMID:12762645 PMID:19787260 |
| malathion | increases expression | ISO | RGD:11440 | 6480464 | Malathion results in increased expression of TRP53 protein | CTD | PMID:12505448 |
| malathion | increases expression | ISO | RGD:70502 | 6480464 | Malathion results in increased expression of TP53 mRNA | CTD | PMID:18204794 |
| malathion | increases expression | ISO | RGD:70502 | 6480464 | Malathion results in increased expression of TP53 protein | CTD | PMID:19787260 PMID:12762645 |
| maleimide | multiple interactions | ISO | RGD:70502 | 6480464 | maleimide analog binds to and results in increased activity of TP53 protein mutant form | CTD | PMID:15998635 |
| maneb | multiple interactions | ISO | RGD:11440 | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of TRP53 protein; more ... | CTD | PMID:20964710 |
| manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of TP53 mRNA | CTD | PMID:17623882 |
| mechlorethamine | increases expression | ISO | RGD:70502 | 6480464 | Mechlorethamine results in increased expression of TP53 protein | CTD | PMID:16738803 |
| mechlorethamine | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the susceptibility to Mechlorethamine | CTD | PMID:12185594 |
| melatonin | increases expression | ISO | RGD:70502 | 6480464 | Melatonin results in increased expression of TP53 protein | CTD | PMID:12071473 PMID:19012662 |
| melatonin | multiple interactions | ISO | RGD:11440 | 6480464 | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased activity of TRP53 protein modified form]; more ... | CTD | PMID:20964710 |
| melatonin | increases expression | ISO | RGD:70502 | 6480464 | Melatonin results in increased expression of TP53 protein | CTD | PMID:19012662 PMID:12071473 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TP53 protein] | CTD | PMID:14993511 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein] | CTD | PMID:20041988 |
| menadione | multiple interactions | ISO | RGD:70502 | 6480464 | SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased phosphorylation of TP53 protein] | CTD | PMID:19082730 |
| menadione | increases expression | ISO | RGD:70502 | 6480464 | Vitamin K 3 results in increased expression of TP53 protein | CTD | PMID:21533478 |
| methamphetamine | increases expression | ISO | RGD:11440 | 6480464 | Methamphetamine results in increased expression of TRP53 protein modified form | CTD | PMID:17234339 |
| methamphetamine | increases expression | ISO | RGD:11440 | 6480464 | Methamphetamine results in increased expression of TRP53 protein | CTD | PMID:11457507 |
| methamphetamine | multiple interactions | ISO | RGD:11440 | 6480464 | SOD1 protein affects the reaction [Methamphetamine results in increased expression of TRP53 protein]; more ... | CTD | PMID:11457507 |
| methamphetamine | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the susceptibility to Methamphetamine | CTD | PMID:12050851 PMID:9369336 |
| methamphetamine | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the susceptibility to Methamphetamine | CTD | PMID:9369336 PMID:12050851 |
| methamphetamine | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein affects the reaction [Methamphetamine affects the expression of SLC6A4 protein] | CTD | PMID:9369336 |
| methotrexate | multiple interactions | ISO | RGD:70502 | 6480464 | BRCA1 mutant form promotes the reaction [TP53 mutant form results in increased susceptibility to Methotrexate] | CTD | PMID:21875941 |
| methotrexate | decreases expression | ISO | RGD:70502 | 6480464 | Methotrexate results in decreased expression of TP53 mRNA | CTD | PMID:17400583 |
| methotrexate | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Methotrexate results in increased expression of TP53 protein] | CTD | PMID:19900424 |
| methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of TP53 protein | CTD | PMID:19900424 |
| methotrexate | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [Methotrexate results in increased expression of CASP8 protein]; more ... | CTD | PMID:17637740 |
| methotrexate | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 mutant form results in increased susceptibility to Methotrexate | CTD | PMID:21875941 |
| methotrexate | multiple interactions | ISO | RGD:70502 | 6480464 | nutlin 3 promotes the reaction [Methotrexate results in increased expression of TP53 protein]; more ... | CTD | PMID:21624110 |
| methotrexate | increases expression | ISO | RGD:70502 | 6480464 | Methotrexate results in increased expression of TP53 protein | CTD | PMID:21624110 |
| methoxsalen | increases expression | ISO | RGD:70502 | 6480464 | Methoxsalen results in increased expression of TP53 protein | CTD | PMID:22796345 |
| methyl isocyanate | affects expression | ISO | RGD:70502 | 6480464 | methyl isocyanate affects the expression of TP53 protein | CTD | PMID:19513903 |
| methyl isocyanate | decreases expression | ISO | RGD:11440 | 6480464 | methyl isocyanate results in decreased expression of TRP53 protein | CTD | PMID:22223508 |
| methyl methanesulfonate | multiple interactions | ISO | RGD:70502 | 6480464 | Methyl Methanesulfonate results in increased expression of and results in increased activity of TP53 protein; more ... | CTD | PMID:10531375 |
| methyl methanesulfonate | multiple interactions | ISO | RGD:11440 | 6480464 | TRP53 protein affects the reaction [Methyl Methanesulfonate results in increased expression of BTG2 mRNA] | CTD | PMID:22003191 |
| methyl methanesulfonate | increases activity | ISO | RGD:70502 | 6480464 | Methyl Methanesulfonate results in increased activity of TP53 protein | CTD | PMID:20655369 |
| methyl methanesulfonate | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Methyl Methanesulfonate results in increased expression of CDKN1A mRNA] | CTD | PMID:17079232 |
| microcystin-LR | increases expression | ISO | RGD:70502 | 6480464 | cyanoginosin LR results in increased expression of TP53 | CTD | PMID:16624733 |
| microcystin-LR | increases expression | ISO | RGD:70502 | 6480464 | cyanoginosin LR results in increased expression of TP53 protein | CTD | PMID:18214937 PMID:20421190 |
| microcystin-LR | increases phosphorylation | ISO | RGD:70502 | 6480464 | cyanoginosin LR results in increased phosphorylation of TP53 protein | CTD | PMID:20421190 |
| microcystin-LR | increases expression | ISO | RGD:70502 | 6480464 | cyanoginosin LR results in increased expression of TP53 protein | CTD | PMID:20421190 |
| midostaurin | multiple interactions | ISO | RGD:70502 | 6480464 | 4'-N-benzoylstaurosporine affects the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]; more ... | CTD | PMID:15542774 |
| mifepristone | decreases expression | ISO | RGD:11440 | 6480464 | Mifepristone results in decreased expression of TRP53 mRNA | CTD | PMID:12605714 |
| minocycline | decreases expression | EXP | | 6480464 | Minocycline results in decreased expression of TP53 protein | CTD | PMID:15172883 |
| mitomycin C | increases expression | ISO | RGD:70502 | 6480464 | Mitomycin results in increased expression of TP53 protein | CTD | PMID:12082016 |
| mitomycin C | increases stability | ISO | RGD:70502 | 6480464 | Mitomycin results in increased stability of TP53 protein | CTD | PMID:20536192 |
| mitomycin C | multiple interactions | ISO | RGD:70502 | 6480464 | [Mitomycin results in increased stability of TP53 protein] which results in increased expression of CDKN1A mRNA; more ... | CTD | PMID:20536192 |
| mitomycin C | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Mitomycin | CTD | PMID:20000476 PMID:15182437 |
| mitomycin C | increases expression | ISO | RGD:70502 | 6480464 | Mitomycin results in increased expression of TP53 mRNA | CTD | PMID:18647660 |
| mitomycin C | increases expression | ISO | RGD:70502 | 6480464 | Mitomycin results in increased expression of TP53 | CTD | PMID:19834285 |
| mitomycin C | multiple interactions | ISO | RGD:70502 | 6480464 | Mitomycin promotes the reaction [TP53 protein results in increased expression of CCNB1 mRNA]; more ... | CTD | PMID:18647660 |
| mitomycin C | multiple interactions | ISO | RGD:70502 | 6480464 | TRP53 protein affects the reaction [Mitomycin results in increased expression of TRP73 protein] | CTD | PMID:17530733 |
| mitomycin C | multiple interactions | ISO | RGD:70502 | 6480464 | silybin inhibits the reaction [Mitomycin results in increased expression of TP53] | CTD | PMID:19834285 |
| mitomycin C | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Mitomycin | CTD | PMID:15182437 PMID:20000476 |
| mitomycin C | increases expression | ISO | RGD:70502 | 6480464 | Mitomycin results in increased expression of TP53 protein modified form | CTD | PMID:16186332 |
| mono(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:11440 | 6480464 | Selenomethionine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TRP53 protein]; more ... | CTD | PMID:20659492 |
| mono(2-ethylhexyl) phthalate | increases activity | ISO | RGD:70502 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased activity of TP53 protein | CTD | PMID:21515331 |
| mono(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:70502 | 6480464 | Selenomethionine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of TP53 protein]; more ... | CTD | PMID:21515331 |
| mono(2-ethylhexyl) phthalate | increases expression | ISO | RGD:11440 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of TRP53 protein | CTD | PMID:20659492 |
| monocrotophos | increases expression | EXP | | 6480464 | Monocrotophos results in increased expression of TP53 protein; more ... | CTD | PMID:20957986 |
| monocrotophos | increases expression | EXP | | 6480464 | Monocrotophos results in increased expression of TRP53 protein; more ... | CTD | PMID:21445290 |
| morphine | multiple interactions | ISO | RGD:70502 | 6480464 | Morphine inhibits the reaction [Dactinomycin results in increased expression of TP53 protein modified form]; more ... | CTD | PMID:12927789 |
| morphine | increases expression | ISO | RGD:70502 | 6480464 | Morphine results in increased expression of TP53 mRNA | CTD | PMID:19397953 |
| morphine | multiple interactions | ISO | RGD:70502 | 6480464 | Morphine results in increased phosphorylation of and results in increased stability of TP53 protein; more ... | CTD | PMID:12702572 |
| morphine | multiple interactions | ISO | RGD:70502 | 6480464 | Morphine results in increased phosphorylation of and results in increased activity of TP53 protein; more ... | CTD | PMID:19397953 |
| myo-inositol hexakisphosphate | multiple interactions | ISO | RGD:70502 | 6480464 | Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 mRNA]; more ... | CTD | PMID:16357363 |
| myo-inositol hexakisphosphate | multiple interactions | EXP | | 6480464 | Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 protein] | CTD | PMID:16357363 |
| N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of TP53 protein | CTD | PMID:12587291 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [TP53 protein results in increased abundance of Reactive Oxygen Species] | CTD | PMID:15059885 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [arsenite results in increased expression of TP53 protein] | CTD | PMID:22260869 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:11440 | 6480464 | Acetylcysteine inhibits the reaction [[Excitatory Amino Acid Agents results in increased abundance of Reactive Oxygen Species] which results in increased expression of TRP53 mRNA]; more ... | CTD | PMID:20955365 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:11440 | 6480464 | Acetylcysteine inhibits the reaction [dihydrolipoic acid results in increased expression of TRP53 mRNA] | CTD | PMID:21462292 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:11440 | 6480464 | Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of TRP53 mRNA] | CTD | PMID:21549813 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:11440 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of and results in increased phosphorylation of TRP53 protein] | CTD | PMID:21565247 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [Capsaicin results in increased phosphorylation of TP53 protein] | CTD | PMID:14871840 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein] | CTD | PMID:20530418 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:11440 | 6480464 | Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of TRP53 protein] | CTD | PMID:18996350 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:11440 | 6480464 | Acetylcysteine inhibits the reaction [Zinc results in increased expression of TRP53 protein] | CTD | PMID:11864783 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [perfosfamide results in increased expression of TP53] | CTD | PMID:18034189 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [oxaliplatin results in increased expression of TP53 protein] | CTD | PMID:19728331 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [diallyl disulfide results in increased expression of TP53 protein] | CTD | PMID:19202565 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of and results in increased activity of TP53 protein]; more ... | CTD | PMID:10951577 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of TP53] | CTD | PMID:15496615 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [ATM protein promotes the reaction [Doxorubicin results in increased activity of TP53 protein]]; more ... | CTD | PMID:15489221 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [Camptothecin results in increased expression of TP53 protein modified form]; more ... | CTD | PMID:17555331 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70502 | 6480464 | [Acetylcysteine co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] inhibits the reaction [[Zinc Sulfate co-treated with prolinedithiocarbamate] results in decreased expression of TP53 protein]; more ... | CTD | PMID:18951928 |
| N-acetyl-L-cysteine | decreases activity | ISO | RGD:70502 | 6480464 | Acetylcysteine results in decreased activity of TP53 protein | CTD | PMID:15059885 |
| N-ethyl-N-nitrosourea | increases mutagenesis | EXP | | 6480464 | Ethylnitrosourea results in increased mutagenesis of TP53 gene | CTD | PMID:16495775 |
| N-ethyl-N-nitrosourea | increases mutagenesis | ISO | RGD:11440 | 6480464 | Ethylnitrosourea results in increased mutagenesis of TRP53 gene | CTD | PMID:15790496 PMID:16724327 |
| N-ethyl-N-nitrosourea | increases response to substance | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form results in increased susceptibility to Ethylnitrosourea | CTD | PMID:16436596 |
| N-ethyl-N-nitrosourea | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 affects the susceptibility to Ethylnitrosourea | CTD | PMID:11053539 |
| N-ethyl-N-nitrosourea | increases mutagenesis | ISO | RGD:11440 | 6480464 | Ethylnitrosourea results in increased mutagenesis of TRP53 gene | CTD | PMID:16724327 PMID:15790496 |
| N-ethyl-N-nitrosourea | increases mutagenesis | ISO | RGD:11440 | 6480464 | Ethylnitrosourea results in increased mutagenesis of TRP53 exon | CTD | PMID:16357521 |
| N-hydroxy-2-acetamidofluorene | increases expression | EXP | | 6480464 | Hydroxyacetylaminofluorene results in increased expression of TP53 protein | CTD | PMID:9163691 |
| N-hydroxy-4-aminobiphenyl | multiple interactions | ISO | RGD:70502 | 6480464 | [N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of TP53 gene | CTD | PMID:11275476 |
| N-methyl-4-phenylpyridinium | increases acetylation | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased acetylation of TP53 protein | CTD | PMID:17583434 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | RGD:70502 | 6480464 | Methylnitronitrosoguanidine results in increased expression of TP53 mRNA | CTD | PMID:12634122 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | RGD:11440 | 6480464 | Methylnitronitrosoguanidine results in increased expression of TRP53 protein | CTD | PMID:11516527 PMID:12135628 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:11440 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of TRP53 mRNA | CTD | PMID:12135628 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:11440 | 6480464 | Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TRP53 protein] | CTD | PMID:11516527 PMID:12135628 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | EXP | | 6480464 | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TP53 protein] | CTD | PMID:19851710 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases expression | EXP | | 6480464 | Methylnitronitrosoguanidine results in decreased expression of TP53 protein | CTD | PMID:19851710 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Methylnitronitrosoguanidine results in increased acetylation of TP53 protein] | CTD | PMID:17147953 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases acetylation | EXP | | 6480464 | Methylnitronitrosoguanidine results in increased acetylation of TP53 protein | CTD | PMID:17147953 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Methylnitronitrosoguanidine | CTD | PMID:15589979 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein mutant form results in decreased susceptibility to Methylnitronitrosoguanidine | CTD | PMID:15589979 |
| N-methyl-N-nitrosurea | multiple interactions | EXP | | 6480464 | Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased phosphorylation of TP53 protein] | CTD | PMID:18593901 |
| N-methyl-N-nitrosurea | increases phosphorylation | ISO | RGD:11440 | 6480464 | Methylnitrosourea results in increased phosphorylation of TRP53 protein | CTD | PMID:21285353 PMID:18593901 |
| N-methyl-N-nitrosurea | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the susceptibility to Methylnitrosourea | CTD | PMID:12185594 |
| N-methyl-N-nitrosurea | increases response to substance | ISO | RGD:11440 | 6480464 | TRP53 gene mutant form results in increased susceptibility to Methylnitrosourea | CTD | PMID:11536039 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:11440 | 6480464 | PARP1 protein affects the reaction [Methylnitrosourea affects the activity of TRP53 protein]; more ... | CTD | PMID:11850828 |
| N-methyl-N-nitrosurea | increases phosphorylation | ISO | RGD:11440 | 6480464 | Methylnitrosourea results in increased phosphorylation of TRP53 protein | CTD | PMID:18593901 PMID:21285353 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:11440 | 6480464 | MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein] | CTD | PMID:21285353 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:11440 | 6480464 | MGMT protein inhibits the reaction [TRP53 gene mutant form results in increased susceptibility to Methylnitrosourea] | CTD | PMID:11536039 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:11440 | 6480464 | Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein]; more ... | CTD | PMID:18593901 |
| N-methyl-N-nitrosurea | increases phosphorylation | EXP | | 6480464 | Methylnitrosourea results in increased phosphorylation of TP53 protein | CTD | PMID:18593901 |
| N-methyl-N-nitrosurea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of TP53 mRNA | CTD | PMID:17412507 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:11440 | 6480464 | AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of TRP53 mRNA] | CTD | PMID:19996281 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | Plant Extracts inhibits the reaction [Diethylnitrosamine results in increased expression of TP53 protein] | CTD | PMID:18367157 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TP53 protein | CTD | PMID:11751435 more ... |
| N-nitrosodiethylamine | increases expression | ISO | RGD:70502 | 6480464 | Diethylnitrosamine results in increased expression of TP53 protein | CTD | PMID:21776270 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TP53 protein | CTD | PMID:11751435 more ... |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of TP53 mRNA | CTD | PMID:21167192 PMID:21554863 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TP53 protein | CTD | PMID:11751435 more ... |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TP53 protein | CTD | PMID:19254457 more ... |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TP53 mRNA | CTD | PMID:14555611 more ... |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in increased expression of TP53 protein; more ... | CTD | PMID:21907755 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TP53 protein | CTD | PMID:9163691 more ... |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TP53 protein | CTD | PMID:14555611 more ... |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TP53 mRNA | CTD | PMID:19874807 more ... |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | lanreotide inhibits the reaction [Diethylnitrosamine results in increased expression of TP53 mRNA] | CTD | PMID:19874807 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TP53 protein | CTD | PMID:14555611 more ... |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TP53 mRNA | CTD | PMID:14555611 more ... |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of TP53 mRNA | CTD | PMID:21554863 PMID:21167192 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [5,7-dimethoxyflavone co-treated with Diethylnitrosamine] results in increased expression of TP53 mRNA; more ... | CTD | PMID:21554863 |
| N-nitrosodiethylamine | increases phosphorylation | EXP | | 6480464 | Diethylnitrosamine results in increased phosphorylation of TP53 protein | CTD | PMID:11751435 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TP53 protein | CTD | PMID:14555611 more ... |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TP53 mRNA | CTD | PMID:20360939 PMID:14555611 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of TP53 mRNA | CTD | PMID:21167192 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TP53 mRNA | CTD | PMID:18544905 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of TP53 mRNA | CTD | PMID:14633663 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TP53 mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of TP53 protein; more ... | CTD | PMID:11915028 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of TP53 protein | CTD | PMID:11003613 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | chrysin inhibits the reaction [Diethylnitrosamine results in decreased expression of TP53 mRNA]; more ... | CTD | PMID:21167192 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [Diethylnitrosamine results in increased expression of TP53 protein]; more ... | CTD | PMID:11751435 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in decreased expression of TP53 mRNA] | CTD | PMID:20360939 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | AHR protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of TP53 protein]]; more ... | CTD | PMID:15459018 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Acetoxyacetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TP53 protein | CTD | PMID:10741303 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:11440 | 6480464 | MG 262 inhibits the reaction [XRCC6 protein inhibits the reaction [Diethylnitrosamine results in decreased expression of TRP53 protein]] | CTD | PMID:18506893 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:11440 | 6480464 | Diethylnitrosamine results in increased expression of TRP53 protein | CTD | PMID:19919837 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:11440 | 6480464 | Diethylnitrosamine results in decreased expression of TRP53 mRNA | CTD | PMID:19996281 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:11440 | 6480464 | Diethylnitrosamine results in decreased expression of TRP53 protein | CTD | PMID:18506893 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:11440 | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of TRP53 mRNA | CTD | PMID:17917374 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:11440 | 6480464 | CLOCK protein promotes the reaction [Diethylnitrosamine results in increased expression of and results in increased phosphorylation of TRP53 protein] | CTD | PMID:21167249 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:11440 | 6480464 | ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of TRP53 protein] | CTD | PMID:19919837 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | ISO | RGD:70502 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in decreased phosphorylation of and results in increased activity of TP53 protein; more ... | CTD | PMID:12821135 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | decreases expression | ISO | RGD:11440 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of TRP53 protein | CTD | PMID:11536013 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to Tosylphenylalanyl Chloromethyl Ketone | CTD | PMID:12821135 |
| NAD zwitterion | multiple interactions | ISO | RGD:70502 | 6480464 | [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of TP53 gene; more ... | CTD | PMID:10334203 |
| NAD zwitterion | multiple interactions | ISO | RGD:11440 | 6480464 | NAD promotes the reaction [Acetaminophen results in decreased expression of TRP53 protein] | CTD | PMID:11461765 |
| NAD zwitterion | decreases expression | ISO | RGD:70502 | 6480464 | NAD results in decreased expression of TP53 protein | CTD | PMID:12390773 |
| NAD(+) | multiple interactions | ISO | RGD:70502 | 6480464 | [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of TP53 gene; more ... | CTD | PMID:10334203 |
| NAD(+) | multiple interactions | ISO | RGD:11440 | 6480464 | NAD promotes the reaction [Acetaminophen results in decreased expression of TRP53 protein] | CTD | PMID:11461765 |
| NAD(+) | decreases expression | ISO | RGD:70502 | 6480464 | NAD results in decreased expression of TP53 protein | CTD | PMID:12390773 |
| naloxone | multiple interactions | ISO | RGD:70502 | 6480464 | Naloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in increased expression of TP53 protein modified form]] | CTD | PMID:12927789 |
| naloxone | decreases expression | EXP | | 6480464 | Naloxone results in decreased expression of TP53 mRNA | CTD | PMID:17522070 |
| naloxone | multiple interactions | ISO | RGD:70502 | 6480464 | Naloxone inhibits the reaction [Morphine results in increased expression of TP53]; more ... | CTD | PMID:19397953 |
| naphthalene | affects response to substance | ISO | RGD:11440 | 6480464 | TRP53 protein affects the susceptibility to naphthalene | CTD | PMID:10802220 |
| naphthalene | multiple interactions | ISO | RGD:70502 | 6480464 | [naphthalene binds to pyrrolo(2,1-c)(1,4)benzodiazepine] which results in increased expression of TP53 protein | CTD | PMID:21732540 |
| nickel atom | multiple interactions | ISO | RGD:70502 | 6480464 | [Quercetin analog co-treated with Nickel] results in increased expression of TP53 protein | CTD | PMID:20577783 |
| nickel dichloride | increases expression | ISO | RGD:11440 | 6480464 | nickel chloride results in increased expression of TRP53 mRNA | CTD | PMID:12839937 |
| nickel dichloride | increases phosphorylation | ISO | RGD:70502 | 6480464 | nickel chloride results in increased phosphorylation of TP53 protein | CTD | PMID:21466819 |
| nickel dichloride | increases expression | ISO | RGD:11440 | 6480464 | nickel chloride results in increased expression of TRP53 mRNA | CTD | PMID:12839937 PMID:12426141 |
| nickel dichloride | increases expression | ISO | RGD:11440 | 6480464 | nickel chloride results in increased expression of TRP53 mRNA | CTD | PMID:12426141 PMID:12839937 |
| nickel sulfate | increases expression | ISO | RGD:70502 | 6480464 | nickel sulfate results in increased expression of TP53 protein | CTD | PMID:21776270 |
| nicotinamide | multiple interactions | ISO | RGD:70502 | 6480464 | Niacinamide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TP53 protein] | CTD | PMID:12782109 |
| nicotinamide | multiple interactions | ISO | RGD:70502 | 6480464 | [Niacinamide results in decreased activity of SIRT1 protein] promotes the reaction [Hydrogen Peroxide results in increased acetylation of TP53 protein] | CTD | PMID:18681908 |
| nicotinamide | multiple interactions | ISO | RGD:70502 | 6480464 | Niacinamide results in decreased activity of [SIRT1 protein results in decreased acetylation of TP53 protein] | CTD | PMID:18482975 |
| nicotinamide | decreases expression | ISO | RGD:70502 | 6480464 | Niacinamide results in decreased expression of TP53 protein | CTD | PMID:12782109 |
| nicotinic acid | affects expression | EXP | | 6480464 | Niacin deficiency affects the expression of TP53 protein | CTD | PMID:17516866 |
| nicotinic acid | multiple interactions | EXP | | 6480464 | Niacin deficiency inhibits the reaction [Etoposide results in increased expression of TP53 protein] | CTD | PMID:17516866 |
| nicotinic acid | decreases expression | EXP | | 6480464 | Niacin deficiency results in decreased expression of TP53 mRNA | CTD | PMID:17516866 |
| nifedipine | increases activity | ISO | RGD:70502 | 6480464 | Nifedipine results in increased activity of TP53 protein | CTD | PMID:12082016 |
| nitric oxide | increases phosphorylation | ISO | RGD:70502 | 6480464 | Nitric Oxide results in increased phosphorylation of TP53 protein | CTD | PMID:16024610 |
| nitric oxide | increases glutathionylation | ISO | RGD:70502 | 6480464 | Nitric Oxide results in increased glutathionylation of TP53 protein | CTD | PMID:17555331 |
| nitric oxide | increases expression | ISO | RGD:70502 | 6480464 | Nitric Oxide results in increased expression of TP53 protein | CTD | PMID:15979383 |
| nitric oxide | multiple interactions | ISO | RGD:70502 | 6480464 | [Nitric Oxide Donors results in increased abundance of Nitric Oxide] which results in increased expression of TP53 protein | CTD | PMID:10608825 |
| nitric oxide | multiple interactions | ISO | RGD:70502 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Nitric Oxide results in increased phosphorylation of TP53 protein]; more ... | CTD | PMID:16024610 |
| nitric oxide | multiple interactions | ISO | RGD:11440 | 6480464 | [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of TRP53 mRNA | CTD | PMID:7673702 |
| nitric oxide | decreases expression | ISO | RGD:11440 | 6480464 | Nitric Oxide results in decreased expression of TRP53 protein | CTD | PMID:14634119 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased expression of TP53 protein | CTD | PMID:8982730 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [NOS2 protein results in increased abundance of Nitric Oxide] which results in increased expression of TP53 protein | CTD | PMID:9743513 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [7-nitroindazole results in decreased chemical synthesis of Nitric Oxide] inhibits the reaction [Paraquat results in increased phosphorylation of TP53 protein] | CTD | PMID:20478973 |
| nitric oxide | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to Nitric Oxide | CTD | PMID:16024610 |
| nitroprusside | multiple interactions | EXP | | 6480464 | cilostazol inhibits the reaction [Nitroprusside results in increased phosphorylation of TP53 protein] | CTD | PMID:18311796 |
| nitroprusside | increases phosphorylation | EXP | | 6480464 | Nitroprusside results in increased phosphorylation of TP53 protein | CTD | PMID:18311796 |
| nitroprusside | increases expression | ISO | RGD:70502 | 6480464 | Nitroprusside results in increased expression of TP53 protein | CTD | PMID:15979383 |
| nocodazole | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein affects the reaction [Nocodazole results in increased phosphorylation of JUN protein]; more ... | CTD | PMID:12221076 |
| nocodazole | increases expression | ISO | RGD:70502 | 6480464 | Nocodazole results in increased expression of TP53 protein | CTD | PMID:21559451 |
| norethisterone | multiple interactions | ISO | RGD:70502 | 6480464 | Norethindrone results in increased expression of and results in increased activity of TP53 protein | CTD | PMID:15905198 |
| ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of TP53 mRNA | CTD | PMID:19562491 |
| ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of TP53 mRNA | CTD | PMID:19562491 PMID:23208426 |
| ochratoxin A | increases phosphorylation | ISO | RGD:11440 | 6480464 | ochratoxin A results in increased phosphorylation of TRP53 protein | CTD | PMID:19445961 |
| ochratoxin A | increases expression | ISO | RGD:70502 | 6480464 | ochratoxin A results in increased expression of TP53 protein | CTD | PMID:19367635 |
| okadaic acid | affects localization | ISO | RGD:70502 | 6480464 | Okadaic Acid affects the localization of TP53 protein | CTD | PMID:21512803 |
| okadaic acid | decreases expression | ISO | RGD:70502 | 6480464 | Okadaic Acid results in decreased expression of TP53 protein | CTD | PMID:18937299 |
| olanzapine | increases expression | ISO | RGD:70502 | 6480464 | olanzapine results in increased expression of TP53 mRNA | CTD | PMID:16160616 |
| oxaliplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Acetylcysteine inhibits the reaction [oxaliplatin results in increased expression of TP53 protein]; more ... | CTD | PMID:19728331 |
| oxaliplatin | increases expression | ISO | RGD:70502 | 6480464 | oxaliplatin results in increased expression of TP53 protein modified form | CTD | PMID:20708607 PMID:19735649 |
| oxaliplatin | increases expression | ISO | RGD:70502 | 6480464 | oxaliplatin results in increased expression of TP53 protein | CTD | PMID:19728331 more ... |
| oxaliplatin | increases expression | ISO | RGD:70502 | 6480464 | oxaliplatin results in increased expression of TP53 protein | CTD | PMID:20708607 more ... |
| oxaliplatin | multiple interactions | ISO | RGD:70502 | 6480464 | [pifithrin results in decreased activity of TP53 protein] results in decreased susceptibility to [oxaliplatin results in increased activity of CASP3 protein]; more ... | CTD | PMID:20708607 |
| oxaliplatin | increases expression | ISO | RGD:70502 | 6480464 | oxaliplatin results in increased expression of TP53 protein modified form | CTD | PMID:19735649 PMID:20708607 |
| oxaliplatin | increases expression | ISO | RGD:70502 | 6480464 | oxaliplatin results in increased expression of TP53 protein | CTD | PMID:19015155 more ... |
| oxaliplatin | increases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in increased susceptibility to oxaliplatin | CTD | PMID:16227409 |
| oxaliplatin | multiple interactions | ISO | RGD:70502 | 6480464 | TP53 protein promotes the reaction [oxaliplatin results in increased expression of CDKN1A protein] | CTD | PMID:16227409 |
| oxaliplatin | affects response to substance | ISO | RGD:70502 | 6480464 | TP53 protein affects the susceptibility to oxaliplatin | CTD | PMID:15041737 |
| oxaliplatin | increases expression | ISO | RGD:70502 | 6480464 | oxaliplatin results in increased expression of TP53 protein modified form | CTD | PMID:19735649 |
| oxaliplatin | increases expression | ISO | RGD:70502 | 6480464 | oxaliplatin results in increased expression of TP53 protein | CTD | PMID:19728331 PMID:19015155 |
| oxaliplatin | multiple interactions | ISO | RGD:70502 | 6480464 | oxaliplatin promotes the reaction [TP53 protein binds to DUT promoter]; more ... | CTD | PMID:19015155 |
| oxaliplatin | affects localization | ISO | RGD:70502 | 6480464 | oxaliplatin affects the localization of TP53 protein modified form | CTD | PMID:19735649 |
| oxaliplatin | multiple interactions | ISO | RGD:70502 | 6480464 | Caffeine inhibits the reaction [oxaliplatin results in increased expression of TP53 protein modified form]; more ... | CTD | PMID:19735649 |
| oxirane | increases expression | ISO | RGD:11440 | 6480464 | Ethylene Oxide results in increased expression of TRP53 protein | CTD | PMID:17162533 |
| paclitaxel | multiple interactions | ISO | RGD:70502 | 6480464 | [Doxorubicin co-treated with Paclitaxel] results in increased expression of TP53 protein; more ... | CTD | PMID:16168113 |
| paclitaxel | increases expression | ISO | RGD:70502 | 6480464 | Paclitaxel results in increased expression of TP53 protein | CTD | PMID:11774260 more ... |
| paclitaxel | increases expression | ISO | RGD:70502 | 6480464 | Paclitaxel results in increased expression of TP53 protein | CTD | PMID:16601104 more ... |
| paclitaxel | increases expression | ISO | RGD:70502 | 6480464 | Paclitaxel results in increased expression of TP53 protein | CTD | PMID:16601104 more ... |
| paclitaxel | increases expression | ISO | RGD:70502 | 6480464 | Paclitaxel results in increased expression of TP53 protein | CTD | PMID:16601104 more ... |
| paclitaxel | decreases response to substance | ISO | RGD:70502 | 6480464 | TP53 protein results in decreased susceptibility to Paclitaxel | CTD | PMID:15990222 PMID:16734730 |
| paclitaxel | increases expression | ISO | RGD:70502 | 6480464 | Paclitaxel results in increased expression of TP53 protein | CTD | PMID:12082016 more ... |
| paclitaxel | increases expression | ISO | RGD:70502 | 6480464 | Paclitaxel results in increased expression of TP53 protein | CTD | PMID:19815708 |